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Mono-(2-ethylhexyl) phthalate (MEHP), the toxic metabolite of di-(2-ethylhexyl) 
phthalate (DEHP), can cause testicular injury in animal models. This thesis examines the 
molecular mechanisms which lead to the loss of germ cells following MEHP exposure in 
the testis through germ cell apoptosis and germ cell detachment. MEHP-induced Sertoli 
cell injury in peri-pubertal rodents results in the stimulation of germ cell apoptosis 
through the FasL/Fas signaling pathway. In the seminiferous tubules, Sertoli cells express 
FasL while germ cells produce Fas. In this thesis, I report that following MEHP exposure, 
Sertoli cells transcriptionally up-regulate the expression of the FasL gene through 
activation of the transcription factors NFκB and Sp-1. MEHP also induces an increase in 
the production of soluble TNF-α in germ cells, which mediates NF-κB activation and 
 vii
causes robust increases in Sertoli cell FasL, indicating the participation of germ cells in 
triggering their own cell death in response to Sertoli cell injury. Metalloproteinases (MPs) 
and tissue inhibitors of metalloproteinases (TIMPs) are essential for processing the 
TNF-α precursor to its soluble form which is required for its ability to bind to TNFR-1. 
TIMP-2 is predominately expressed in primary rat Sertoli cells, and its protein level 
decreases time-dependently after MEHP exposure, which contributes to MMP-2 
activation in the seminiferous tubule. The addition of SB-3CT, a specific gelatinase 
inhibitor, decreases the activity of MMP-2 and significantly reduces MEHP-enhanced 
soluble TNF-α production as well as MEHP-induced testicular germ cell apoptosis. 
Therefore, the decrease in Sertoli cell TIMP-2 expression may be the initial injury 
following MEHP exposure, which further stimulates the process of germ cell apoptosis 
by activating MMP-2. Local cell-cell communication through junctional complexes is 
crucial in the regulation of mammalian spermatogenesis and in the development of the 
male phenotype, so the disturbance of junctional complexes within the seminiferous 
epithelium may contribute to MEHP-induced abnormal spermatogenesis. MEHP 
exposure decreases occludin expression, possibly contributing to the opening of tight 
junctions between adjacent Sertoli cells. MEHP exposure also suppresses the expression 
of laminin-γ3 and integrin-β1 in apical ectoplasmic specializations in a time-dependent 
manner. MMP-2 activation enhances the disconnection of germ cells from Sertoli cells, 
and specific MMP-2 inhibitors (TIMP-2 and SB-3CT) significantly suppress 
MEHP-induced germ cell sloughing by altering the expression of junction proteins in 
vitro and in vivo, suggesting that MEHP-activated MMP-2 plays an important role in 
 viii
regulating the physical contact between Sertoli cells and germ cells. Interestingly, the 
addition of the caspase inhibitor (z-VAD-FMK) does not inhibit MEHP-induced germ 
cell detachment, indicating that MEHP-induced germ cell sloughing is independent of 
germ cell apoptosis. Taken together, the observations in this thesis indicate a distinct role 
of TIMP-2 and MMP-2 in response to toxicant-induced Sertoli cell injury, providing 
further insights into the mechanism by which Sertoli cells control the sensitivity of germ 
cells to undergo apoptosis during the peri-pubertal period. 
 ix
Table of Contents 
 
List of Figures ……………………………………………………………………… xvii
List of Tables ……………………………………………………………………….. xxii
List of Abbreviations ……………………………………………………………..... xxiii
  
Chapter 1. Introduction …………………………………………………………… 1 
1.1 Significance of research in germ cell apoptosis and spermatogenesis …... 1 
1.2 Overview of testes …………………………................................................... 4 
 1.2.1 The organization of mammalian testes ……………………………..... 4 
 1.2.2 Spermatogenesis ……………………………………………………. 9 
 1.2.3 Cycles of the seminiferous epithelium and the first wave of 
spermatogenesis ………………………….......................................... 
 
13 
 1.2.4 The role of Sertoli cells in maintaining homeostatic status of germ 
cells …………………………………………………………………. 
 
15 
1.3 Dynamic junctional communication in the testis ………............................. 18 
 1.3.1 The junctional communication as a signaling mediator between 
neighboring cells ……..……………………………………………….
 
18 
 1.3.2 Dynamic remodeling of junctional complex during testes 
development ………………………………….................................... 
 
20 
1.4 Apoptosis ….……………………………………………………………...... 23 
 1.4.1 The characteristics of apoptosis ……………………............................ 23 
 x
1.4.2 The activation of caspases: Hallmarks of apoptotic events ….............. 25 
 1.4.3 Apoptotic pathways – Intrinsic and extrinsic pathways ……………... 27 
1.5 Mono-(2-ethylhexyl)phthalate (MEHP) injury model in the testis ………. 31 
 1.5.1 Phthalates and mono-(2-ethylhexyl)phthalate (MEHP) ……………... 31 
 1.5.2 Cellular target in response to MEHP-induced testicular injury ……… 35 
 1.5.3 MEHP-induced germ cell apoptosis and the participation of FasL/Fas 
signaling ………………………………………………………………
 
37 
 1.5.4 MEHP-induced disruption of junctional structures and germ cell 
depletion ……………………………...………………………………
 
38 
1.6 Dissertation aims ……………………………………………………………. 40 
    
Chapter 2. Materials and Methods ………………………………………………... 43 
2.1 Sertoli cell lines ………………………. ……………………........................... 43 
2.2 Animals ……………………………………………………………………….. 44 
2.3 Preparation of primary Sertoli cell-germ cell co-cultures ……………………. 44 
2.4 MEHP treatment in vitro………………………………………......................... 44 
2.5 MEHP treatment in vivo………………………………………………………. 45 
2.6 Real-time quantitative RT-PCR (RTQ-RT-PCR) ……………........................... 46 
2.7 Preparation of nuclear extracts ……………………………………………….. 46 
2.8 Total protein preparation ……………………………………........................... 47 
2.9 Western blot analysis …………………………………………......................... 47 
2.10 Construction of luciferase reporter gene ……………………........................... 48 
 xi
2.11 Transfection and luciferase activity assay ……………………......................... 50 
2.12 DpnI-mediated site-directed mutagenesis ……………………………………. 51 
2.13 Electrophoretic mobility shift assay (EMSA) ………………........................... 52 
2.14 Chromatin immunoprecipitation (ChIP) ……………………............................ 52 
2.15 NF-κB and Sp-1 inhibitor treatments in vitro ………………............................ 53 
2.16 Antibody neutralization by anti-TNF-α primary antibody in vitro …………… 54 
2.17 Measurement of soluble MMP-2 and TNF-α in primary Sertoli cell-germ cell 
co-cultures by ELISA ...……………………………………………………….
 
54 
2.18 Recombinant protein treatment in vitro ………………………......................... 55 
2.19 Zymography ………………………..…………………………………………. 55 
2.20 Testicular histopathology ……………………………………………………... 56 
2.21 Terminal deoxy-nucleotidyl transferase-mediated digoxigenin-dUTP nick end 
labeling (TUNEL) assay ………….…………………………………………...
 
56 
2.22 Gelatinase inhibitor SB-3CT treatment in vivo and in vitro ………………….. 56 
2.23 Transmission electron microscope (TEM) …………………………………… 57 
2.24 Immunohistochemistry (IHC) ………………………………............................ 57 
2.25 Germ cell detachment ………………………………………………………… 58 
2.26 Testicular spermatid head count ……………………………………………… 59 
2.27 Statistical analysis …………………………………………………………….. 59 
  
Chapter 3. Transcriptional Regulation of FasL Expression and Participation of 
Soluble TNF-α in Response to Sertoli Cell injury ………………………………...
 
61 
 xii
3.1 Introduction and Rationale …………………….…………............................ 61 
3.2 Results ……………………………………………………………………….. 62 
 3.2.1 FasL expression in ASC-17D cells and in C57BL/6J mouse testis is 
induced by MEHP in a time-dependent manner …………...................
 
62 
 3.2.2 Cis-regulatory elements in -500 to -324 and -1250 to -1000 regions 
are responsible for MEHP-induced FasL expression ………...............
 
63 
 3.2.3 MEHP-induced FasL expression is enhanced through transcriptional 
regulation of NF-κB and Sp-1 ……………………………………..... 
 
63 
 3.2.4 FasL expression in ASC-17D cells is controlled by Sp-1 and NF-κB 
pathway in the presence of MEHP ……………………………….…..
 
69 
 3.2.5 MEHP exposure leads to up-regulation of TNF-α expression in vivo .. 69 
3.2.6 Induction of FasL expression in the testis is mediated by TNF-α 
through NF-κB regulation ……………………………………………
 
72 
3.3 Discussion ……………………………………………………......................... 75 
   
Chapter 4. TNF-α-Mediated Disruption of Spermatogenesis in Response to 
Sertoli Cell Injury is Partially Regulated by MMP-2 ………….............................
 
86 
4.1 Introduction and Rationale …………………………………………………. 86 
4.2 Results ………………………………………………………………………... 87 
 4.2.1 A decrease in TIMP-2 expression and an increase in MMP-2 were 
observed in the rodent testis after MEHP exposure …..........................
 
87 
 4.2.2 The gelatinase inhibitor SB-3CT decreased MMP-2 activity and  
 xiii
suppressed soluble TNF-α production in primary rat Sertoli 
cell-germ cell co-cultures …………………………………………….
 
88 
 4.2.3 Recombinant MMP-2 protein increased soluble TNF-α production in 
primary rat Sertoli cell-germ cell co-cultures ……………………….. 
 
91 
 4.2.4 SB-3CT decreased soluble TNF-α and suppressed MEHP-induced 
germ cell apoptosis in vivo ………………………………………….. 
 
91 
 4.2.5 MEHP-induced germ cell apoptosis was the consequence of 
MMP-2-mediated TNF-α processing…………………………………
 
96 
4.3 Discussion ……………………………………………………......................... 100 
    
Chapter 5. Disruption of junctional communications in the seminiferous 
epithelium by MEHP exposure …………………………………………………….
 
107 
5.1 Introduction/Rationale ……………………………………………………… 107 
5.2 Results ………………………………………………………………………... 109 
 5.2.1 MEHP exposure causes the testicular injury in the seminiferous 
epithelium …………………………………………………………….
 
109 
 5.2.2 Occludin expression is decreased by MEHP exposure......................... 110 
 5.2.3 MEHP exposure facilitates the opening of the BTB ............................ 114 
 5.2.4 The expressions of laminin-γ3 and integrin-β1 are decreased by 
MEHP exposure ………………………………………………………
 
115 
 5.2.5 MEHP exposure modulates the remodeling of anchoring junction ….. 117 
 5.2.6 Germ cell detachment is increased in response to MEHP through  
 xiv
MMP-2 activation ……………………………………………………. 117 
 5.2.7 SB-3CT administration suppresses MEHP-inhibited junction protein 
expressions …………………………....................................................
 
122 
 5.2.8 MEHP-induced germ cell detachment is independent upon germ cell 
apoptosis after MEHP exposure ……………………………………...
 
125 
5.3 Discussion ……………………………………………………......................... 125 
    
Chapter 6. Concluding Remarks…………………………………………………... 134 
    
Chapter 7. Supplement ……………………….……………………………………. 142 
7.1 Introduction and Rationale …………………………………………………. 142 
7.2 MEHP-induced the testicular injury: a dose-response experiment …….... 143 
 7.2.1 Testicular histopathology of C57BL/6J in response to MEHP 
exposure ……………………………………........................................
 
144 
 7.2.2 MEHP-induced expression of apoptotic related genes is increased in 
a dose-dependent manner …………………………………………….
 
144 
 7.2.3 MEHP exposure triggers germ cell apoptosis ……………………….. 147 
7.3 The ultrastructure of mice testes in vivo and cell morphology in vitro …... 147 
 7.3.1 Ultrastructures of mice testes examined by TEM …............................ 147 
 7.3.2 The morphology of Sertoli cell lines and primary co-cultures ………. 151 
7.4 Apoptotic wave of germ cells in mice during the testicular development .. 151 
7.5 Characterization of germ cell apoptosis and testicular histology in  
 xv
TNFR1/2 gene-deficient mice …………………............................................. 157 
7.5.1 Physiological features of TNFR-1/2 gene deficient mice …………… 157 
 7.5.2 Germ cell apoptosis in TNFR-1/2-/- mice was altered by MEHP 
exposure ………………………………………………………………
 
157 
    
Chapter 8. Summary ………………………. …………………………………........ 164 
References ……………………………………………………………………........... 167 
Vita ……………………………………………………………………....................... 209 
    
    
 
 
 xvi
List of Figures 
 
Figure. 1-1. The schematic chart of phthalate toxicity in male reproduction ... 3 
Figure. 1-2. The morphology of the seminiferous tubule and the interstitial 
space …………………………………………………………….. 
 
6 
Figure. 1-3. The ultrastrucutre of interstitial space and the basal compartment 
of the seminiferous tubule ………………………………………. 
 
7 
Figure. 1-4. The ultrastructure of Sertoli cell ………………………………… 8 
Figure. 1-5. The organization of cells in the seminiferous epithelium ………. 10 
Figure. 1-6. Spermatogenesis ………………………………………………… 11 
Figure. 1-7. The balance between germ cell division and germ cell apoptosis 
by Sertoli cells …………………………………………………... 
 
16 
Figure. 1-8. The location of blood-testis barrier (BTB) in the basal 
compartment……………………………………………………... 
 
21 
Figure. 1-9. The location of anchoring junctions in the adluminal 
compartment ………………………………..…………………... 
 
22 
Figure. 1-10. The extrinsic apoptosis pathway (death-receptor-mediated 
pathway: using FasL/Fas signaling as an example) …………….. 
 
30 
Figure. 1-11. The metabolism of MEHP ………………………………………. 34 
Figure. 1-12. Apoptotic germ cells ……………………………………………. 39 
Figure. 3-1. Influence of MEHP on FasL expression in Sertoli cells ………... 64 
Figure. 3-2. Transcription factor binding sites of 5’-UAS of murine FasL  
 xvii
promoter ………………………………………………………… 65 
Figure. 3-3. Sequences of transcription factor binding sites of 5’-UAS of 
murine FasL promoter …………………………………………... 
 
66 
Figure. 3-4. Functional deletion mapping and activity of the 5’-UAS of FasL 
promoter …………………………………………………………. 
 
68 
Figure. 3-5. NF-κB and Sp-1 binding activity to FasL promoter in response 
to MEHP ………………………………………………………… 
 
70 
Figure. 3-6. MEHP-induced FasL expression in ASC-17D cells is partially 
mediated by NF-κB regulation ………………………………….. 
 
71 
Figure. 3-7. sTNF-α levels in response to MEHP exposure in vivo ………….. 73 
Figure. 3-8. Influence of sTNF-α on NF-κB and FasL expression …………... 74 
Figure. 3-9. Relative participation of MEHP and sTNF-α on FasL expression 76 
Figure. 3-10. A model indicating both (a) direct effects on Sertoli cells and (b) 
indirect responses by germ cells that play a role in increasing the 
expression of FasL by Sertoli cells as a consequence of 
MEHP-induced injury …………………………………………… 
 
 
 
84 
Figure. 4-1. Levels of testicular TIMPs and MPs in response to MEHP 
exposure …………………………………………………………. 
 
89 
Figure. 4-2. The activity of MMP-2 and the level of soluble MMP-2 in 
primary Sertoli cell-germ cell co-cultures ………………………. 
 
90 
Figure. 4-3. Participation of MMP-2 on the processing of TNF-α and the 
inhibitory effect of SB-3CT on TNF-α activation in vitro ……… 
 
92 
 xviii
Figure. 4-4. The inhibitory effect of SB-3CT on TNF-α expression and germ 
cell apoptosis in vivo ……………………………………………. 
 
93 
Figure. 4-5. The inhibitory effect of SB-3CT on testicular histology in vivo ... 94 
Figure. 4-6. The inhibitory effect of SB-3CT on germ cell apoptosis in vivo ... 95 
Figure. 4-7. The effect of MEHP exposure on apoptosis protein expression in 
the testis ...……………………………………………………….. 
 
97 
Figure. 4-8. Germ cell apoptosis by MEHP exposure in the testis …………… 98 
Figure. 4-9. Testicular histopathology in response to MEHP exposure ……… 99 
Figure. 4-10. A refined model of the complex Sertoli cell-germ cell interaction 
describing the mechanism by which Sertoli cells trigger germ 
cell apoptosis following MEHP-induced Sertoli cell injury …….. 
 
 
106 
Figure. 5-1. Abnormal spermatogenesis was observed in response to MEHP 
exposure in vivo …………………………………………………. 
 
111 
Figure. 5-2. MEHP exposure altered the expression of tight junction proteins 
in vitro and in vivo ………………………………………………. 
 
112 
Figure. 5-3. MEHP exposure altered the expression of tight junction proteins 113 
Figure. 5-4. The ultrastructure of the blood-testis barrier between Sertoli cells 
in the seminiferous epithelium ………………………………….. 
 
115 
Figure. 5-5. MEHP exposure decreased the expression of adherens junction 
proteins in vitro and in vivo ……………………………………... 
 
116 
Figure. 5-6. MEHP exposure decreased the expression of adherens junction 
proteins ………………………………………………………….. 
 
118 
 xix
Figure. 5-7. The ultrastructure of anchoring junctions between Sertoli cells 
and spermatocytes in the seminiferous epithelium ……………… 
 
119 
Figure. 5-8. The ultrastructure of anchoring junctions between Sertoli cells 
and early developing spermatids in the seminiferous epithelium 
 
120 
Figure. 5-9. The ultrastructure of anchoring junctions between Sertoli cells 
and late developing spermatids in the seminiferous epithelium 
 
121 
Figure. 5-10. Effects of MMP-2 activation on germ cell detachment …………. 123 
Figure. 5-11. Effects of SB-3CT administration on the expression of tight 
junction and adherens junction proteins in vivo and in vitro ……. 
 
124 
Figure. 5-12. MEHP-induced germ cell detachment is independent on germ 
cell apoptosis ……………………………………………………. 
 
126 
Figure. 5-13. A refined model: MEHP-induced MMP-2 activation disrupts 
junctional complex in the serminiferous epithelium ……………. 
 
133 
Figure. 7-1. The testicular histopathology in response to MEHP exposure ….. 145 
Figure. 7-2. Apoptotic related protein expression in mice testes in response to 
MEHP …………………………………………………………… 
 
146 
Figure. 7-3. Apoptotic index in mice testes after MEHP exposure …………... 148 
Figure. 7-4. The ultrastructure of the seminiferous tubule in 28-day-old 
C57BL/6J mice ………………………………………………….. 
 
149 
Figure. 7-5. The ultrastructure of tight junctions and anchoring junctions in 
28-day-old C57BL/6J mice ……………………………………... 
 
150 
Figure. 7-6. The ultrastructure of different types of germ cells in 28-day-old  
 xx
C57BL/6J mice ………………………………………………….. 152 
Figure. 7-7. The morphology of Sertoli cell line, TM4 ………………………. 154 
Figure. 7-8. The morphology of Sertoli cell line, ASC-17D …………………. 155 
Figure. 7-9. The morphology of primary rat Sertoli cell-germ cell co-cultures 156 
Figure. 7-10. Germ cell apoptosis during testicular development …………….. 158 
Figure. 7-11. The testicular histology of TNFR-1/2+/+ mice and TNFR-1/2-/- 
mice ……………………………………………………………... 
 
161 
Figure. 7-12. The functional participation of TNF-α/TNFR signaling in germ 
cell apoptosis …………………………………………………….  
 
162 
Figure. 7-13. The functional participation of TNF-α/TNFR signaling in germ 
cell apoptosis ……………………………………………………. 
 
163 
Figure. 8-1. Working model indicated the effect of MEHP exposure on 
dynamic interaction of Sertoli cells and germ cells, leading to 
abnormal spermatogenesis ………………………………………. 
 
 
166 
 
 xxi
List of Tables 
 
Table. 2-1 Nucleotide sequence of PCR primers used to generate sequential 
deletions in the upstream activating sequence of the murine Fas 
Ligand gene ……………………………………………………... 
 
 
49 
Table. 7-1 Physiological parameters of the testis in TNFR-1/2+/+mice and 
TNFR-1/2-/-mice ………………………………………………… 
 
159 
 
 xxii
List of Abbreviations 
 
ABP Androgen binding protein 
AIF Apoptosis inducing factor 
AP-1 Activator protein-1 
Apaf-1 Apoptotic protease activating factor-1 
BTB Blood-testis barrier 
CARD Caspase recruitment domain 
Caspase Cysteniyl aspartate-specific protease 
COX-2 Cyclooxygenase 2 
DAB Diaminobenzidine  
DD Death domain 
DED  Death effector domain 
DEHP Di-(2-ethylhexyl)phthalate  
DISC Death inducing signaling complex 
DMEM Dulbecco’s modified Eagle’s media 
EDTA Ethylenediamine tetra acetic acid 
EGF Epidermal growth factor 
ERM Ets-related molecule 
ES Ectoplasmic specialization 
FADD Fas associated death domain protein 
FAK Focal adhesion kinase 
FasL Fas ligand 
FSH Follicle stimulating hormone 
GAPDH Glyceraldehydes-3-phosphate dehydrogenase 
GDNF Glial cell derived neurotrophic factor 
IFN-1 Interferon regulatory factor-1 
JAM Junctional adhesion molecule 
LH Luteinizing hormone 
 xxiii
MEHP Mono-(2-ethylhexyl)phthalate 
MMA Mithramycin A 
MMP Matrix metalloproteinase 
MP Metalloproteinase  
NFAT Nuclear factor in activated T cells 
NF-κB Nuclear factor κB 
PARP-1 Poly(ADP-ribose) polymerase-1 
PDTC Pyrrolidine dithiocarbamate 
PI3K Phosphoinositide-3-kinase 
PP Peroxisome proliferator 
PPAR Peroxisome proliferators activated receptor 
Prx3 Peroxiredoxin 3 
PVC Poly vinyl chloride 
PVDF Poly vinylidene fluoride 
RTQ-RT-PCR Real-time quantitative reverse transcription polymerase 
chain reaction 
SDS Sodium dodecyl sulphate 
Sp-1 Specificity protein-1 
SSC Spermatogonial stem cell 
StAR Steroidogenic acute regulatory 
TGF Transforming growth factor 
TIMP Tissue inhibitors of metalloproteinase 
TNF Tumor necrosis factor 
TNFR Tumor necrosis factor receptor 
TRAIL TNF related apoptosis inducing ligand 
TUNEL Terminal deoxynucleotidyl transferase mediated 
digoxigenin-dUTP nick end labeling 
UAS Upstream activating sequence 
ZO Zonula occluden 
 
 xxiv
 1
Chapter 1. Introduction 
 
1.1. Significance of research in germ cell apoptosis and spermatogenesis 
 
Approximately 15-20% of couples in the United States each year face difficulties 
with fertility, and male infertility is involved in 40% of the 2.6 million infertile married 
couples [1]. About 50% of these men experience irreversible infertility and can not have 
children. A small number of these cases are caused by a medical treatment, such as 
treatments for testicular cancer [2, 3]. To date, the causes of male infertility and other 
male reproductive disorders are still unclear, and no direct and efficient treatments for 
these problems are available [1]. Increasing studies indicate that male reproductive 
problems have been linked to an increase in the presence of environmental contaminents 
released in the air, soil, water and food [4-8]. Therefore, investigating the molecular basis 
of toxicant-induced testicular malfunction can provide a great potential to clinics for 
determining biomarkers for new diagnostic methods and identifying effective targets for 
fertility therapies. 
Germ cells spontaneously die in the testis through a process called “apoptosis”, a 
necessary process for controlling the number of germ cells in the testis and to maintain 
functional spermatogenesis [9]. Although many studies in humans have associated 
alterations in the incidence of germ cell apoptosis with conditions of abnormal 
spermatogenesis and male infertility [10-12], the cellular processes that regulate germ 
cell apoptosis in the testis remain poorly characterized. In order to extend the knowledge 
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of mechnisms that control spermatogenesis, this thesis focuses on the paracrine 
interaction between Sertoli cells and germ cells in response to Sertoli cell injury. 
Phthalates are a class of environmental toxicants that can adversely affect 
spermatogenesis in juvenile male mammals and induce developmental variations and 
malformations as a result of prenatal exposure [13-16]. The overall goal in this research is 
to explore the participation of Sertoli cells and germ cells in modulating germ cell 
apoptosis and germ cell detachment following toxicant treatment in peri-pubertal rodents. 
What is the molecular mechanism of toxicant-induced Sertoli cell injury? How do germ 
cells respond to toxicant-induced Sertoli cell injury? It is anticipated that the results in 
this thesis will provide insights into the crosstalk that occurs between germ cells and 
Sertoli cells and allow for the prediction and prevention of environmental 
toxicant-induced testicular diseases. 
In order to appreciate toxicant-induced testicular injury, understanding the 
background regarding general concepts of the male reproductive system as well as the 
mechanisms of phthalate toxicity should be understood. The following sections in this 
chapter cover: (1) the cellular organization of mammalian testes and the process of 
spermatogenesis (section 1.2), (2) the junctions in the seminiferous tubule (section 1.3), 
(3) the signaling pathway of apoptosis in the testis (section 1.4), and (4) the general 
mechanism of phthalates-induced toxicity in the reproductive tract (section 1.5). The 
outline of this chapter is represented as a flowchart in Figure 1-1 to describe the linkage 
between different concepts in this thesis.  
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Figure. 1-1. The schematic chart of phthalate toxicity in male reproduction. 
Phthalate-induced testicular injury and the relevance to human reproductive disorders are 
represented as a flowchart. Abnormal spermatogenesis is a consequence of 
phthalate-injury. Spermatogenesis is the process by which spermatogonia develop into 
spermatozoa (section 1.2). General background regarding germ cell-cell junctions and 
cell apoptosis are described in section 1.3 and 1.4, respectively. Phthalates target Sertoli 
cells and decrease their supportive capacity of germ cells and initiate germ cell apoptosis 
and germ cell detachment in the seminiferous epithelium (section 1.5). Studying the 
interaction of Sertoli cells and germ cells and the process of spermatogenesis provide 
great insights into human reproductive issue such as male infertility, testicular dysgenesis 
and male contraceptives. SC: Sertoli cell, GC: germ cell. 
 4
 
1.2. Overview of the testes 
 
1.2.1. The organization of mammalian testes 
    The testis functions to generate mature sperms and sex hormones, androgen and 
estrogen [17-19]. A basic understanding of the structure and organization of the testes is 
required in order to comprehend the complex interaction between different cell types in 
the teses. Testes are composed of two major organizational structures: the interstitial 
space (or intertubular space) and the seminiferous tubule (Figure 1-2). The interstitial 
space contains blood and lymphatic vessels (Figure 1-3), and the organization of the 
intertubular tissues in the testis varies between species [20]. Leydig cells and 
macrophages are two major types of cells located in the interstium. It is well-known that 
Leydig cells produce steroid hormones, including testosterone. Leydig cells contain 
round vesicular nuclei, and abundant smooth endoplasmic reticulum and mitochondria, 
which are important for steroid metabolism [21, 22]. Testosterone synthesis in Leydig 
cells is initiated by luteinizing hormone (LH) released by the anterior pituitary. LH acting 
on its receptor activates a cAMP-dependent pathway and regulates the transport of 
cholesterol from the bloodstream into Leydig cells as well as the stimulation of gene 
expression of steroidogenic enzymes [23].  
Testicular macrophages are also located within the intertubule region. Macrophages 
influence Leydig cell development and steroidogenesis by cell-cell interactions and the 
secretion of cytokines [24]. Under normal conditions, macrophages provide essential 
factors for Leydig cells. However, activated macrophages trigger inflammatory response 
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and produce pro-inflammatory cytokines, such as interleukin-1 (IL-1) and tumor necrosis 
factor (TNF), which can down-regulate the gene expression of steroidogenic enzymes in 
Leydig cells [25]. 
 Seminiferous tubules are convoluted loops within the testis, and are bounded by 
several layers which contain peritubular myoid cells, lymphatic endothelium, and 
boundary connective tissues. Peritubular myoid cells are smooth muscle cells rich in actin 
filaments [26]. Myoid cells are responsible for the transport of spermatozoa and testicular 
fluid, and are also involved in maintaining Sertoli cell function by secreting extracellular 
matrix components [27] and growth factors such as PModS [28] and activin-A [29]. 
The epithelium of seminiferous tubules contains Sertoli cells and various subtypes 
of spermatogenic cells. This thesis focuses on the cross-talk between Sertoli cells and 
germ cells within the seminiferous tubule in response to phthalate induced Sertoli cell 
injury in order to undertand the mechanisms controlling germ cell apoptosis. Therefore, 
detailed information is provided to emphasize the importance of cell-cell interactions in 
this field. Sertoli cells, which were first described by Enrico Sertoli in 1865 [30], are 
somatic cells surrounding the germ cells within the seminiferous epithelium. Normal 
Sertoli cells have a distinctive tripartite nucleolus in the nucleus and show irregular 
shapes extending from the basal lamina to the lumen of the seminiferous tubule (Figure 
1-4). The size of Sertoli cells varies from 75-100 μm. The proliferation and differentiation 
of Sertoli cells depends on hormone regulation, especially follicle stimulating hormone 
(FSH) released from anterior pituitary [31]. During the pubertal stage of development, 
mature Sertoli cells stop dividing and start differentiating, forming tight junctions as well  
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Figure. 1-2. The morphology of the seminiferous tubule and the interstitial space. 
Cross-sections (5 μm) of paraffin-embedded mouse testes show the morphology of the 
seminiferous tubule and the interstitial space in 28-day-old C57BL/6J mice testes by 
PAS-H staining. 
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Figure. 1-3. The ultrastructure of the interstitial space and the basal compartment 
of the seminiferous tubule. The interstitial space and the basal compartment of the 
seminiferous tubule in 28-day-old C57BL/6J mice are examined by transmission electron 
microscope. The arrow head indicates the blood-testis barrier (BTB) between neighboring 
Sertoli cells in the basal compartment. SC-N: Sertoli cell nucleus; L: Leydig cell; M: 
mitochondrion. The bar represents 2 μm with magnification x8900. 
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Figure. 1-4. The ultrastructure of the Sertoli cell. The morphology of Sertoli cells in 
28-day-old C57BL/6J mice are examined by transmission electron microscope. (A) A 
prototypical Sertoli cell nucleous with tripartite nucleoli (arrow heads). (B) The 
cytoplasm of Sertoli cells contains “donut-like” mitochondria, Golgi apparatus (arrow) 
and other organelles. SC-N: Sertoli cell nucleus; L: Leydig cell; M: mitochondrion. The 
bar represents 2 μm with magnification x3500 (A) and x8900 (B). 
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as releasing nutrients for supporting germ cell development. The number of mature 
Sertoli cells remains stable for the entire life of the mammal, and therefore their 
supportive capacity for germ cell development is determined at the beginning of puberty 
[32]. Sertoli cells divide the seminiferous tubules into a basal compartment and an 
adluminal compartment by developing the blood-testis barrier (BTB) between adjacent 
Sertoli cells (Figure 1-5). The BTB is a physical barrier formed by tight junctions, 
adherens junctions and demosome-like junctions [33]. The basal compartment below the 
BTB allows for exposure to elements from the circulatory system, and the spermatogonia 
and primary spermatocytes reside in the basal compartment. However, the adluminal 
compartment above the BTB restricts the nutrient supply to germ cells due to the 
presence of these tight junctions. Germ cells in the adluminal compartment, containing 
secondary spermatocytes and spermatids, have to receive nutrients and other elements 
from Sertoli cells [34]. The BTB opens without leakage at specific times, which allows 
for the progression of primary spermatocytes into the adluminal compartment to further 
develop into spermatids [35, 36]. 
 
1.2.2. Spermatogenesis 
Spermatogenesis is the process by which spermatogonia undergo cell division, 
meiosis and differentiation to eventually form spermatozoa (Figure 1-6). This process 
allows for the production of haploid gametes which undergo further maturation in the 
epididymis before being released from the body.  
Generally, spermatogenesis can be separated into three phases: spermatocytogenesis,  
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Figure. 1-5. The organization of cells in the seminiferous epithelium. Sertoli cell 
cytoplasm extends from the basement membrane to the lumen and is connected to 
different types of germ cells. Spermatogonia are surrounded by the basal laminia on one 
side and Sertoli cells on the other. The BTB formed between neighboring Sertoli cells 
divides the seminifous epithelium into the basal compartment and the adluminal 
compartment. Spermatogonia, preleptotene and leptotene spermatocytes are located 
beneath the BTB. Preleptotene and leptotene spermatocytes move across the BTB and 
develop into pachytene spermatocytes. Round spermatids show the acrosome structure 
around the nucleus and further become elongate spermatids which contain the tail 
structure. The apical ectoplasmic specialization (ES) is important for connecting 
spermatids and Sertoli cells. Elongated spermatids become mature spermatozoa and are 
released into the lumen during spermiation. 
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Figure. 1-6. Spermatogenesis. Spermatogensis is the process defining how 
spermatogonial stem cells develop into mature spermatozoa. Spermatogonial stem cells 
show the ability to self-renew and maintain the basal level of the stem cell population. 
The rest of the spermatogonia undergo several rounds of mitotic division and produce 
primary spermatocytes. Spermatocytes further develop into spermatids through two 
meiotic divisions. Spermatids continue to differentiate into mature spermatozoa. Arrows 
indicate spermatogonia and arrow heads indicate elongate spermatids. Images on the right 
side indicate a magnified view of the organization of germ cells in one seminiferous 
tubule from a 28-day-old C57BL/6J mouse by PAS-H staining. 
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meiosis, and spermiogensis. Spermatocytogenesis is the first phase of spermatogenesis 
and begins with the rapid cell division of spermatogonia, resulting in the formation of 
primary spermatocytes. In mice, seven types of A spermatogonia (Asingle, Apaired, Aaligned, 
and A1-4), intermediate spermatogonia (In) and type B spermatogonia (B) are present. 
Spermatogonial stem cells (SSCs, Asingle) are able to self-renew without further 
differentiation, but also produce differentiating daughter cells through many mitotic 
divisions, resulting in proliferative spermatogonia (Apaired and Aaligned) and differentiated 
spermatogonia (A1-4, In and B)[37]. After several rounds of cell division, preleptotene 
spermatocytes are developed from type B spermatogonia at the end of 
spermatocytogenesis. Theoretically, more than one thousand spermatocytes can be 
produced from a single spermatogonia; however, only 25% of the possible number of 
preleptotene spermatocytes are actually present in the basal compartment of seminiferous 
epithelium, suggesting that early germ cells are eliminated during this progression [38]. 
Preleptotene spermatocytes start to differentiate into leptotene spermatocytes and 
DNA synthesis occurs at the same time. Preleptotene and leptotene spermatocytes cross 
the BTB and move into the adluminal compartment of the seminiferous epithlieum when 
tight junctions are transiently broken-down and reformed. Afterwards, meiosis, the 
second phase of spermatogenesis, is initiated in the adluminal compartment. Meiosis in 
the seminiferous epithelium refers to diploid primary spermatocytes undergoing meiotic 
division to produce haploid gametes. During meiosis I, a primary spermatocyte (leptotene, 
zygotene, pachytene and diplotene spermatocytes) produces two secondary 
spermatocytes and then rapidly converts into four round spermatids during meiosis II.  
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The third phase of spermatogenesis is spermiogenesis. Once round spermatids are 
formed, they stop cell division and undergo a dramatic differentiation in the nucleus and 
cytoplasm to form elongate spermatids. The morphological changes include nuclear 
condensation, the formation of acrosomes, the development of tails, the formation of 
mitochondrial spiral and the removal of extraneous cytoplasm. The process of 
spermiogenesis ends with the release of spermatozoa from Sertoli cells into the lumen 
[21]. 
Overall, spermatogenesis involves cell proliferation, the maintenance of a reserved 
germ cell population, the reduction of chromosome number and an increase in genetic 
variations through recombination. The molecular regulation of spermatogenesis is present 
at the transcription, translation and post-translational levels. Many recent studies have 
reported functional analyses of gene/protein profiles during spermatogenesis by 
microarray or proteomic approach [39-41], and address molecular targets that are 
required for normal spermatogenesis. For example, endocrine control of spermatogenesis 
plays an important role in the development of testes, including LH, FSH, estrogens and 
testosterone [18, 42-44]. However, the paracrine interaction between germ cells and 
somatic cells is also critical for controlling spermatogenesis through the initiation of germ 
cell apoptosis [44]. The dysfunction of Sertoli cells appears to influence the homeostasis 
of the germ cell population in the testis [32]. Therefore, exploring the participation of 
Sertoli cells and germ cells in regulating spermatogenesis is the main goal in this thesis.  
 
1.2.3. Cycles of the seminiferous epithelium and the first wave of spermatogenesis 
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 During spermatogenesis, different types of germ cells develop synchronously within 
the seminiferous tubule. Histological cross-sections of seminiferous tubules display 
cellular associations termed stages. The development of the seminiferous epithelium 
represents 12 stages in mice, 14 stages in rats and 6 stages in human. Different stages are 
easily distinguished by recognizing the development of acrosome associated with 
spermatids. The series of changes in cellular associations (stages) occurring in an orderly 
sequence of developmental progression is called one cycle of the seminiferous epithelium. 
For example, a cycle begins from the proliferation of spermatogonia and ends with the 
release of spermatozoa. Spermatogenesis occurs in repeated cycles of sequential waves 
along the length of the seminiferous tubule so that spermatozoa are produced at various 
periods of time. One tubule can contain numerous complete waves, which ensures that 
spermatozoa are continuously produced. 
  The first wave of spermatogenesis, also called the initial round of spermatogenesis, 
is a key process in the development of testis maturation, normally occurring during the 
first six weeks after birth in rats [45] and the first three weeks in mice [43]. In mice, 
spermatozoa first appear in the lumen of seminiferous tubules around 35 days after birth 
[9], while the whole process of spermatogenesis in humans takes approximately 64 days 
[46]. The first wave of spermatogenesis may have a distinct program than the subsequent 
rounds of spermatogenesis. Instead of being derived from undifferentiated spermatogonia, 
the first wave of spermatogenesis in mice starts directly from gonocytes [47]. In addition, 
somatic cells in the testis are still proliferating and maturing during the first wave of 
spermatogenesis, but may cease proliferating (Sertoli cells) or show different 
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characteristics in mature spermatogenesis (Leydig cells and peritubular myoid 
cells)[48-50]. Interestingly, it has been reported that the first wave of spermatogenesis 
during puberty is less efficient because of massive apoptosis of germ cells in the testis 
[51]. The initial wave of germ cell apoptosis is important for functional mature 
spermatogenesis in order to maintain the proper cell number ratio between Sertoli cells 
and germ cells [51, 52]. Therefore, the supportive capacity of Sertoli cells established in 
the first wave of spermatogenesis is possibly the key to regulate normal spermatogenesis 
by balancing germ cell proliferation with germ cell apoptosis (Figure 1-7). More detailed 
mechanisms regarding common apoptosis and stress-induced apoptosis are described in 
sections 1.4. 
 
1.2.4. The role of Sertoli cells in maintaining homeostatic status of germ cells 
Sertoli cells provide structural and functional support to the development of germ 
cells. Physically, Sertoli cells extend from the basement membrane to the lumen of the 
seminiferous tubule and contact with about 30-50 different types of germ cells in rats [53]. 
Tight junctions between adjacent Sertoli cells separate the circulatory system from the 
adluminal compartment and prevent the backflow of fluids from the lumen to the lymph 
system [54]. Therefore, Sertoli cells are important for maintaining testis structure. 
The number of Sertoli also determines the number of germ cells in the seminiferous 
epithelium as well as testis size and daily sperm production [32, 55, 56]. Sertoli cells 
transmit signals for the coordination during spermatogenesis based on endocrine 
regulation. For example, the secretion of androgen binding protein (ABP) by Sertoli cells 
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Figure. 1-7. The balance between germ cell division and germ cell apoptosis by 
Sertoli cells. During spermatogenesis, Sertoli cells provide nutrients and physical support 
for germ cell development. Therefore, the supportive capacity of Sertoli cells is the key 
for maintaining the proper number of germ cells in the seminiferous tubule through the 
regulation of germ cell division and germ cell apoptosis. 
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is essential for controlling normal testis development. ABP is a testicular glycoprotein 
which binds androgen, transports androgen into the epididymis and facilitates sperm 
maturation [57, 58]. A new concept recently demonstrates the effect of Sertoli cells on 
early stem cell differentiation, referring to the “spermatogonial stem cell (SSC) niche”. 
SSC is capable of self-renewing and generates a large number of differentiated germ cells. 
It has been shown that a balance between SSC renewal and differentiation is critical for 
maintaining normal spermatogenesis and male fertility [59]. The SSC niche is formed 
early during postnatal development in mice, and at the same time Sertoli cells are 
maturing. Ets-related molecule (ERM), belonging to Ets transcription factor superfamily, 
is produced by Sertoli cells in the testis [60]. The disruption of ERM results in failure of 
self-renewal of the SSC as well as the first wave of spermatogenesis by interfering with 
downstream gene expression in Sertoli cells, such as glial cell derived neurotrophic factor 
(GDNF) and CXCL5 [60, 61]. These findings suggest that Sertoli cells are very important 
in creating the SSC niche, allowing for the rapid proliferation and growth of SSC in the 
basal compartment. In addition, due to the disconnection with the circulatory system, 
Sertoli cells deliver nutrients to germ cells, such as lactate as an energy source for 
metabolism [62], demonstrating a uniqe requirement of Sertoli cells in supporting germ 
cell development in this specialized adluminal microenvironment. Other regulatory 
factors secreted by Sertoli cells include transferrin as a shuttle protein to transport ferric 
ions into germ cells [63], proteases which are involved in tissue remodeling and 
metabolism [64], and growth factors (insulin-like growth factor-1 and transforming 
growth factor α/β)[65, 66] which directly influence the growth and proliferation of germ 
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cells as well as Sertoli cells themselves. Therefore, understanding how Sertoli cells 
develop their capacity to support spermatogenesis, and evaluating the consequence of 
Sertoli cell injury, are both extremely critical. 
 
1.3. Dynamic junctional connection in the testis 
 
1.3.1. The junctional connections as a signaling mediator between neighboring cells 
Cell-cell communication is important for multicellular organisms. Understanding the 
biological complexities of cell-cell contact and intercellular communication in different 
tissues, including cells in the testis, can provide knowledge of how cells respond to 
stimuli and send signal to neighboring cells. Before discussing the importance of 
junctional complexes in maintaining testis integrity, basic concepts of junctional 
connections will be introduced. Many studies demonstrate the function of junctional 
complexes in the cellular membrane, including forming a barrier between individual cells, 
maintaining structural integrity of cell sheets and controlling the permeability across the 
membrane [67-70]. Other than the function of structural support, junctional complexes 
are also responsible for regulating signal transduction, cell differentiation, cell 
proliferation and development [71-73]. Spontaneous or engineered mutations in junction 
proteins cause male sterility, growth retardation, abnormal skin barrier function and  
disruption in epidermal differentiation, leading to many different human diseases such as 
autosomal-recessive deafness/renal disorders, skin diseases, hypotrichosis and blindness 
[71].  
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Generally, several types of intercellular junctions have been identified in epithelial 
and endothelial cells, including tight junctions (TJs), adherens junctions (AJs), 
desmosomes (DMs), and gap junctions (GJs) [70, 74]. Both tight junctions and adherens 
junctions are associated with actin filaments [74, 75]. Tight junctions hold cells together 
to form a semi-permeable barrier which can be size- or ion-specific, and also restrict the 
diffusion of substances through the intercellular space [70]. Three types of 
transmembrane proteins are present in tight junctions: junctional adhesion molecules 
(JAMs), claudin family proteins and occludin [76]. Some peripheral membrane proteins 
are associated with these transmembrane proteins, for example, the zonula occludens (ZO) 
family that act as scaffolding proteins [77]. Adherens junctions play important roles in 
holding neighboring cells together by forming a continuous adhesion. Major protein 
complexes in adherens junctions include the nectin-afadin complex and the 
cadherin-catenin complex [78]. Gap junctions, also called communicating junctions, 
allow different molecules to pass between cells, and also allow adjacent cells to share 
their cytoplasm [79, 80]. Connexin proteins are building blocks for gap junctions [81, 82]. 
Desmosomes associate with intermediate filaments and are responsible for intercellular 
adhesion, and are made up of desmogleins and desmocollins [83-85]. Adherens junctions, 
focal adhesion complexes and desmosomes are also grouped together as anchoring 
junctions [67, 75]. Therefore, the appreciation that different types of junctions associate 
together to maintain the biological and physiological function of cells, such as the 
importance of testicular junctions in spermatogenesis as well as testicular development, 
should be emphasized.    
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1.3.2. Dynamic remodeling of junctional complex during testes development 
Testicular junctions play critical roles in regulating normal spermatogenesis and 
testis development. It is important to understand that, even though junctions are thought 
to maintain the stable structure between adjacent cells, they are dynamic and highly 
regulated. Local cell-cell communication through junctional complexes is crucial in the 
regulation of mammalian spermatogenesis and in the development of the male phenotype. 
During spermatogenesis, differentiating germ cells (preleptotene and leptotene 
spermatocytes) have to move from the basal compartment to the adluminal compartment 
of the seminiferous epithelium [86, 87]. Mature spermatozoa have to be released into the 
lumen of the tubule at the end of spermiogenesis. Therefore, the integrity of different cell 
junctions and the regulation of dynamic junction proteins are critical, especially in 
controlling germ cell migration. In rodents, these critical steps occur at stages VII-VIII 
during the cycle of the seminiferous epithelium. In the testis, tight junctions between 
Sertoli cells together with anchoring junctions form the blood-testis barrier (BTB) 
(Figure 1-8), allowing for the protection of developing germ cells from the harmful 
immune system and creating the specialized adluminal microenvironment [88]. When 
spermatocytes move across the BTB, tight junctions are rapidly disrupted and 
subsequently reassembled [89], and germ cells continue to anchor to Sertoli cells by 
forming anchoring junctions. The actin filament-based anchoring junctions (Figure 1-9) 
and intermediate filament-based desmosomes are also responsible for maintaining fluid  
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Figure. 1-8. The relative location of blood-testis barrier (BTB) in the basal 
compartment. Testicular cross-sections of testes from 28-day-old C57BL/6J mice are 
examined by PAS-H staining and TEM. Sertoli cells, preleptotene spermatocytes and 
spermatogonia are major components in the basal compartment. The relative location of 
BTB (arrow head) in between adjacent Sertoli cells separates the basal and adluminal 
compartments. 
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Figure. 1-9. The relative location of anchoring junctions in the adluminal 
compartment. Testicular cross-sections of testes from 28-day-old C57BL/6J mice are 
examined by PAS-H staining and TEM. Sertoli cells, pachytene spermatocytes and 
spermatids are major components in the adluminal compartment. Pink area represents the 
acrosomes. White arrow head indicates the relative location of the apical ectoplasmic 
specialization between Sertoli cells and spermatids. Other anchoring junctions between 
Sertoli cells and germ cells are represented by black arrow head. A: acrosome. 
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secretion, the movement of molecules in the testis, and the release of mature spermatids 
into the lumen [90]. Ectoplasmic specializations (ES) are testis-specific anchoring 
junctions. Two types of ES are identified in the seminiferous epithelium: one is the apical 
ES which are located between Sertoli cells and spermatids in the adluminal compartment 
and the other is the basal ES which is part of the BTB [21].  
In vitro and in vivo studies at the molecular level provide scientific evidence 
showing that testicular junctions are essential for development. The loss-of-function in 
testicular gap junctions causes spermatogenic arrest, seminoma and prostate 
adenocarcinoma [91], demonstrating the importance of gap junctions in maintaining 
normal function of the male reproductive system. Mice gene-deficient for anchoring 
junction proteins show severe problems during the development [90]. β-catenin-/-, 
afadin-/-, integrin-α6-/- and integrin-β1-/- mice display developmental defects that lead to 
either embryonic lethality or newborn death [71, 92, 93]. Nectin-2-/- mice are infertile due 
to abnormal spermatids [94]. Taken together, we can predict that disrupted junctions 
between Sertoli cells and germ cells will influence the movement of germ cells in the 
seminifeorus epithelium, consequently leading to premature germ cells depletion, which 
has been found in phthalate-injured testes (section 1.5)[95]. 
 
1.4. Apoptosis 
  
1.4.1. The characteristics of apoptosis 
Apoptosis is a highly-regulated process referring to cell death without inflammatory 
 24
responses, and is essential for embryonic development, immune-system function and 
other physiological process in multicellular organisms [96, 97]. The coordination of 
apoptosis and cell proliferation is responsible for maintaining cellular homeostasis. For 
example, cells in-between the toes undergo apoptosis allowing for the separation of toes 
during embryonic development [98, 99], and ineffective T-lymphocytes can be removed 
by the induction of apoptosis [100, 101]. However, cancer cells do not have normal 
cellular signaling involving apoptosis and cell growth, resulting in out-of-control cell 
proliferation without cell death [102]. Too much apoptosis occurring in the nervous 
system causes the progressive loss of neurons, which is a typical symptom of Parkinson 
or Alzheimer’s Diseases [103, 104]. Too much apoptosis in germ cells can lead to 
infertility [105]. Apoptosis can be initiated and inhibited by various stimuli in many types 
of cells, suggesting it is a common and basic biological phenomenon [106, 107].  
Apoptosis is important for early development, but is also essential for the removal of 
old or damaged cells in adult bodies without causing inflammation. However, apoptosis 
also can be initiated by stress stimulation, including DNA damage, heat shock, oxidative 
stress, growth factor withdrawal, radiation injury, and chemical toxicants, especially 
when damaged cells lose their ability to self-repair [108]. 
Generally, apoptotic cells show progressive changes in their morphology, including 
cleavage of laminin and actin filament, shrinkage of the cell, breakdown of chromatin, 
DNA fragmentation, translocation of phosphatidylserine (PS) from the inside of plasma 
membrane to the outside, formation of apoptotic bodies, and membrane blebbing [109, 
110]. PS is normally a component of lipid bilayer on the cytoplasmic side of the plasma 
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membrane; however, the asymmetric distribution of phospholipids is disturbed during the 
apoptotic process by inactivating translocases and flippases, or activating scramblases 
and floppases, to facilitate the translocation of PS toward the extracellular side of plasma 
membrane [108]. The recognition of the “flipped-over” PS in the lipid bilayer is a 
common method of detecting apoptotic cells. Apoptotic cells can be removed through 
phagocytosis by macrophages without inducing an inflammatory response [111, 112]. In 
the testis, apoptotic germ cells are also rapidly eliminated through phagocytosis by 
Sertoli cells [112]. Sertoli cells recognize apoptotic germ cells by binding to the PS on 
the surface of apoptotic germ cells, and loss of ability to undergo phagocytosis results in 
a decrease in the number of epididymis sperm [113, 114], demonstrating the importance 
of functional Sertoli cells in normal spermatogenesis. The significant apoptosis 
accomplished during the first wave of spermatogenesis is critical for further development; 
however, apoptosis in adult testes is limited in certain types of germ cells at certain stages 
of spermatogenesis [115-118], suggesting different mechanisms may be involved in 
initiating germ cell apoptosis at critical period of time. 
 
1.4.2. The activation of caspases: Hallmarks of apoptosis 
 Apoptosis, compared to necrosis, is a highly regulated form of cell death. The 
activation of cysteinyl aspartate-specific proteases (caspases) is often detected in the 
early stage of apoptosis. Caspases belong to the cysteine proteases family and are present 
as inactive forms when they are synthesized in the cytoplasm. Caspases require cleavage 
to form active enzymes, and are then able to initiate apoptosis. Caspases contain a 
 26
conserved active site, a cysteine side chain, in their protein structure. Caspases recognize 
the substrates carrying an aspartate residue at the P1 site, initiating cleavage of the 
substrates at one or multiple sites [115]. More than 100 caspase substrates have been 
identified [119], and the cleavage of these substrates leads to activation/inactivation of 
proteins or the remodeling of protein complexes. Active caspases can break-down 
structural or nuclear proteins such as actin, histone H1 and poly(ADP-ribose) 
polymerase-1 (PARP-1), consequently disturbing the normal cellular functions, especially 
DNA repair [120, 121]. Caspases also activate DNases to cleave chromosomal DNA in 
the nucleus, causing DNA fragmentation [122-124]. Caspases cleave different types of 
lamin causing changes in the structure of nuclear lamina and the organization of 
heterochromatin [125-127]. Moreover, caspases are also responsible for the regulation of 
cell adhesion and the structure of the cytoskeleton by cleaving focal adhesion molecules 
(FAKs) and cytoskeletal proteins (actin, vimentin and tubulin) [128-130]. Recently, more 
and more evidence shows that caspases are also responsible for non-apoptotic functions, 
such as the regulation of T-cells proliferation and differentiation of diverse cell types, 
depending upon which substrates are targeted [131-133]. Caspases may be activated 
independently without inducing an apoptotic cascade.  
Caspase zymogens contain three domains: an N-terminal prodomain, a small subunit 
(p10) and a large subunit (p20). The activation of caspases involves the first cleavage to 
release the p10 domain, and further cleavage between the p20 and the prodomain. Two 
p20 domains carrying two catalytic active sites and two p10 domains form a 
heterotetramer [p102-p202] and become an active caspase [130]. To date, 15 caspases 
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have been identified in different mammals [130, 134], and are generally divided into two 
major groups: inflammatory caspases (caspase-1, -4, -5, -11, -12, -13 and -14) and 
apoptotic caspases (caspase-2, -3, -6, -7, -12, -8, -9 and -10).  Caspase-4, -5, -10 and -14 
are only present in humans, caspase-11 and -12 are only found in mice, while caspase-15 
is absent in humans and mice. Inflammatory caspases mediate the proteolytic activation 
of different inflammatory cytokines. Apoptotic caspases are further divided into two 
sub-groups: initiator caspases and effector caspases. Initiator caspases have longer 
prodomains and contain either a death effector domain (DED) (caspase-8 and -10) or a 
caspase-recruitment doman (CARD) (caspase-2 and -9). DED and CARD domains are 
important for the recruitment of initiator caspases into death signaling complexes, which 
triggers proteolytic autoactivation, resulting in the initiation of apoptosis. Caspase-3, -6 
and -7 are effector caspases with shorter prodomains. Initiator caspases can be activated 
by self-activation or by signals from the oligomerization of death receptors, while 
effector caspases are activated by other proteases, most commonly initiator caspases [96, 
135].  
 
1.4.3. Apoptotic pathways – Intrinsic and extrinsic pathways 
Generally, cellular apoptosis can be triggered by two signaling pathways: the 
intrinsic pathway or the extrinsic pathway. The intrinsic apoptotic pathway is initiated by 
the release of cytochrome C from mitochondria, and triggered by various extracellular 
and intracellular stresses, such as growth-factor withdrawal, hypoxia, DNA damage and 
oncogene induction [136]. Furthermore, a series of events are induced in response to 
 28
these apoptotic signals, resulting in changes in the permeability of the outer membrane of 
the mitochondria, release of cytochrome C and apoptotic inducing factor (AIF), 
formation of the apoptosome complex, and activation of specific caspases. The 
apoptosome is a large protein complex containing cytochrome C, which interacts with 
apoptotic protease activating factor (Apaf)-1 and ATP, and can recognize inactive 
caspase-9 [96, 97, 136]. The formation of the apoptosome allows for maintaining the 
correct conformation of caspase-9, as well as the autocatalytic activation. Active 
caspase-9 cleaves the precursor of the inactive effector, caspase-3, which in turn cleaves a 
series of cellular substrates, leading to the biochemical and morphological changes that 
define apoptosis [137, 138]. The members of the Bcl-2 family, including anti-apoptotic 
proteins (Bcl-2 and Bcl-xl) and pro-apoptotic proteins (Bak, Bik and Bid), are responsible 
for the initiation of mitochondrial-mediated apoptosis [139, 140]. Bax and Bak generate 
oligomeric pores on mitochondrial membranes, which further facilitate the release of 
cytochrome C. Most of Bcl-2 family of proteins carry three conserved BH domains, 
BH-1, -2 and -3. However, activated BH-3 only proteins typically block the activity of 
anti-apoptotic Bcl-2 proteins and are considered therapeutic agents in cancer [141, 142].  
The extrinsic apoptotic pathway is activated by the clustering of death receptors on 
the cell surface [143-146]. Death receptors belonging to tumor necrosis factor (TNF) 
receptor family include TNFR1 (TNFRSF1A), TNFR2 (TNFRSF1B), death receptor 3 
(DR-3, TNFRSF25, Apo-3), Fas (TNFRSF6, Apo-1, CD95), DR4 (TRAIL-R1, 
TNFRSF10A), DR5 (TRAIL-R2, TNFRSF10B), DR6 (TNFRSF21), decoy receptor -1 
(DcR1, TNFRSF10C), DcR2 (TNFRSF10D), nerve growth factor receptor (NGFR, 
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TNFRSF16) and osteoprotegrin (OPG, TNFRSF11B) [96]. The structure of these 
receptors includes a cysteine-rich motif in the extracellular domain, a transmembrane 
domain and a cytosolic domain containing the death domain (DD). Except for DcR and 
OPG, other death receptors function to transmit death signals through their DD domain, 
and are activated by binding to their cognate ligands as trimer.  
Death ligands also belong to the TNF superfamily, including TNF, FasL (TNFSF6, 
Apo-1L, CD95L), Apo-3L (TNFSF12) and TNF related apoptosis inducing ligand 
(TRAIL, TNFSF10, Apo-2L). Binding of death ligands to their cognate receptors induces 
the formation of the death-induced signaling complex (DISC) [147, 148]. For example, 
the FasL/Fas signaling pathway is present in many mammalian cells (Figure 1-10). The 
binding of FasL to Fas recruits the adapter protein, Fas associated death domain protein 
(FADD), to interact with the cytosolic tail of Fas [135]. This pro-apoptotic adaptor 
molecule recruits the initiator caspase-8 to form the DISC. DISC formation then triggers 
the auto-cleavage and activation of caspase-8, resulting in the cleavage and activation of 
a cascade of caspases [149]. Further characteristic structural and morphological changes 
are induced to initiate apoptosis as described in section 1.4.1 and 1.4.2. 
Dysregulation of FasL/Fas signaling severely impairs the functional integrity and 
maintenance of immune homeostasis [150, 151], involving the activation of cell death 
and the alteration of sensitivity in T-cell and NK cell-mediated cytotoxicity [152]. 
Activated T-cells enhance FasL expression and further induce CXCR3 chemokine leading 
to hepatic damage [153-156]. Therefore, the biological and physiological functions of 
FasL/Fas signaling are broad. 
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Figure. 1-10. The extrinsic apoptosis pathway (death-receptor-mediated pathway: 
using FasL/Fas signaling as an example). FasL and its receptor, Fas, both belong to the 
TNF superfamily. Once FasL trimers binds to Fas, three Fas receptors cluster together on 
the cell surface. Trimer of Fas receptors recruit FADD through recognition of DD domain. 
FADD further recruits pro-caspase-8 through the DED domain. 
FasL/Fas/FADD/pro-caspase-8 forms a death-induced signaling complex (DISC). 
Pro-caspase-8 is auto-cleaved in the DISC. Two caspase-8 molecules bind to each other 
and form active caspase-8. Active caspase-8 further activates caspase-3 and then triggers 
apoptosis. 
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  In the seminiferous tubule, a number of studies indicate that Sertoli cells are the 
main cells expressing FasL [153], and that Fas is localized in specific germ cell subtypes 
[157, 158]. Two reports from the same laboratory indicate that some germ cell sub-types 
may also express FasL [159-161]. Previous reports have demonstrated that the Fas/FasL 
paracrine signaling mechanism between Sertoli cells and germ cells plays a key role in 
mediating germ cell apoptosis in the testis after Sertoli cell injury [162]. The Fas/FasL 
signaling pathway is therefore a target to assess the molecular function of apoptosis in 
controlling normal spermatogenesis. 
 
1.5. Mono-(2-ethylhexyl)phthalate (MEHP) injury model in the testis 
 
1.5.1. Phthalates and mono-(2-ethylhexyl)phthalate (MEHP) 
Phthalates are synthetic chemicals which are widely used as plasticizers in order to 
provide flexibility to plastics, and can be found in polyvinyl chloride (PVC) products, 
such as plastic bags, food packaging, blood-storage containers, medical devices, and 
children’s toys [163]. Phthalates are also used as inert ingredients in cosmetics, perfumes 
and pesticides [164], or as adhesives and solvents in many industrial processes. 
Phthalates are not covalently bound to plastic products, and therefore can easily leach 
into the environment. Human populations can be exposed to phthalates through direct 
contact or general environmental contamination [165]. The total concentration of 
inhalable phthalates from indoor air may range from <1 μg/m3 to >10 μg/m3 [166-168] 
and from indoor dust (0.15-1.24 mg/g), which may lead to allergic diseases [169]. 
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However, up to 53 mg/kg of phthalates have been detected in food [170]. The estimated 
infant exposure to phthalates is about 13 μg/kg/day in formula milk and 21 μg/kg/day in 
breast milk [170, 171]. Unfortunately, infants are considered to be easily exposed to 
phthalates due to several different sources of phthalates in the environment, including 
breast milk from exposed mothers, containers of infant formula and baby food, and 
indoor air [172, 173]. Recent studies have shown that phthalate metabolites can be 
detected in the urine, serum, breast milk and saliva of human [174, 175], indicating a 
significant daily exposure. 
    To date, the evaluation of environmental phthalate exposure from human studies is 
still limited. Most research results are based on animal studies. Animal studies, together 
with limited studies in human populations, indicate a positive correlation between 
phthalate exposure and reproductive disorders. It remains controversial whether human 
health is of concern due to the different sensitivity and the possible exposure dosage 
among various species [176]. Phthalate induced toxicity occurs in the liver, kidneys, 
thyroid gland and testes In acute and long-term studies in rodents [177]. Investigations in 
human population indicate that phthalate exposure may decrease semen quality [178] and 
disrupt androgen action [173]. Phthalate exposure in utero causes significant decreases in 
sperm counts, ejaculated volume, testis size, and accessory gland weight of 12-weeks-old 
rabbits [179] and rats [180]. In human studies, phthalates may also affect the perinatal 
testicular and genital development [174]. These physiological data suggest that 
phthalate-induced toxicity is tissue- and age-specific. 
 The most common phthalate used in plastic products is di(2-ehtylhexyl)phthalate 
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(DEHP). The National Toxicology Program’s Center for the Evaluation of Risks to 
Human Reproduction (NTP-CERHR) estimates that the maximum daily exposure to 
DEHP for the general population is about 3-30 μg/kg/day [165]. However, exposure to 
DEHP from blood transfusions can be as high as 8.5 mg/kg/day [174]. The Food and 
Drug Administration (FDA) also estimates a tolerable intake (TI) value of 0.6 mg/kg/day 
for DEHP [181]. DEHP is a diester of phthalic acid with two eight-carbon chains and 
easily accumulate in adipose tissue due to its lipophilic property [182, 183]. Once in the 
body, DEHP is first rapidly hydrolyzed to mono(2-ethylhexy)phthalate (MEHP) and 
2-ethylhexyanol (2-EH) by lipase and esterase in the intestine, pancreas, liver, kidney, 
testes and other organs [170, 184](Figure 1-11). Some MEHP can be conjugated with 
glucuronic acid for excretion. The remaining MEHP can be further oxidized into different 
sub-metabolites by cytochrome P450-4A, alcohol dehydrogenases or aldehyde 
dehydrogenase. Therefore, species and age differences in the metabolism of DEHP 
depend on the activity of these enzymes [185].  
 Many reports demonstrate that MEHP induces testicular toxicity and is considered 
the primary, active metabolite of DEHP [186, 187]. DEHP influences the development 
and organization of the male reproductive system by causing the degeneration of germ 
cells, damage to somatic cells such as Sertoli cells, and disruption of steriodogenesis. 
DEHP treatment also triggers abnormal proliferation by activating peroxisome 
proliferators-activated receptors (PPARs), leading to hepatocarcinogenesis [183, 188]. 
Interestingly, DEHP-induced testicular damage is more severe in young rodents than in 
adults [189]. These observations encourage us to determine the molecular target of  
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Figure. 1-11. The metabolism of MEHP. DEHP can be metabolized into different 
metabolites by enzyme-catalytic reactions. Lipases or esterases remove 2-ethylhexanol 
from DEHP to form MEHP, the active metabolite. 
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MEHP in peri-pubertal rodents which initiates germ cell apoptosis and germ cell 
sloughing. 
 
1.5.2. Cellular target in response to MEHP-induced testicular injury 
 Sertoli cells are considered the primary target of MEHP-induced testicular toxicity 
both in vitro and in vivo. Morphological changes in Sertoli cells after MEHP exposure 
include vacuolization of cytoplasm, disruption of actin and vimentin filament, disruption 
of ectoplasmic specializations and changes in the configuration of the plasma membrane 
[190, 191]. In neonatal rats, DEHP and MEHP significantly inhibit Sertoli cell 
proliferation resulting in a decrease in the number of Sertoli cells [192-194], and further 
alter the supportive capacity of Sertoli cells during spermatogenesis. It has been shown 
that MEHP strongly decreases FSH-stimulated cAMP accumulation in Sertoli cells 
independent of the age of the animal [195-197], consequently altering the gene 
expression pattern in Sertoli cells. Some essential energy substances for germ cells, such 
as lactate and pyruvate, are provided by Sertoli cells and controlled via a FSH-dependent 
pathway. MEHP decreases the production of pyruvate and stimulates lactate formation, 
influencing the lactate/pyruvate ratio [198]. Since the development of germ cells depends 
on using pyruvate to produce ATP, the inhibition of their energy source causes reduced 
Krebs cycle activity and alters the metabolism in germ cells. In addition, MEHP rapidly 
reduces ABP expression as well as transferrin [95] in Sertoli cells, and suppresses the 
secretion of seminiferous tubule fluid [95, 199], which are both important for germ cell 
growth and differentiation. Therefore, these studies can provide some explanation of the 
age-dependent effect of MEHP exposure on testicular injury due to a decrease in the 
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supportive capacity of Sertoli cells established during the critical perinatal or 
peri-pubertal period and the difference in the metabolic rate. Similar results demonstrate 
that the detachment of germ cells from the seminiferous epithelium and germ cell 
apoptosis in young rodents are increased following MEHP exposure [183]. More 
descriptions regarding MEHP-induced germ cell apoptosis and MEHP-induced germ cell 
detachment are discussed in the following sections (section 1.5.3 and 1.5.4). Since young 
animals are more sensitive to MEHP-induced Sertoli cell injury, MEHP exposure in 
peri-pubertal rodents is a good model to test the interaction between Sertoli cells and 
germ cells by decreasing Sertoli cell support. 
In addition to primarily causing damage to Sertoli cells, MEHP exposure also 
influences the biological function of other cells in the testis. Leydig cells are the primary 
source of steroidogenesis in the male reproductive system. Recent studies report that the 
number and size of Leydig cells are decreased by DEHP exposure in immature rats, 
resulting in a decrease in testosterone levels in the testis [200]. MEHP (250 μM) directly 
inhibits the production of testosterone in primary rat Leydig cells, which may be 
associated with the decrease in steroidogenic acute regulatory (StAR) protein [201]. On 
the other hand, low dose of MEHP (25-100 μM) stimulates basal steroid synthesis in 
mouse Leydig tumor cells, suggesting premature puberty may occur [15]. Direct 
exposure to MEHP suppresses the proliferation of rat spermatocytes without inducing cell 
death in vitro; however, increased expression in spermatocyte mitochondrial 
peroxiredoxin 3 (Prx3) and cyclooxygenase 2 (COX-2) are observed [202], 
demonstrating that MEHP changes the cellular oxidation-reduction homeostasis in germ 
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cells. Similar results in vivo also suggest that an oxidative stress is induced in germ cells 
by MEHP due to an injury in mitochondrial function [38]. According to these 
observations, we interpret that MEHP-induced germ cell apoptosis occurs secondary to 
MEHP-caused Sertoli cell injury.   
 
1.5.3. MEHP-induced germ cell apoptosis and the participation of FasL/Fas signaling 
As mentioned in section 1.2.4, the supportive capacity of Sertoli cells to germ cell 
development is critical, and therefore the number of Sertoli cells restricts the number of 
germ cells in the seminiferous tubule [51, 52]. During the first wave of spermatogenesis, 
the associated germ cell apoptosis is important for functional mature spermatogenesis 
[51]. It appears both extrinsic and intrinsic apoptotic pathways are involved in the 
regulation of first wave of germ cell apoptosis. The supportive evidence includes Bcl-xl- 
or Bcl-2-overexpressed mice show a marked abnormal spermatogenesis and those mice 
are sterile [9]. Bax expression is increased in mouse testes during 1-3 weeks after birth; 
Bax-knockout adult mice contain excessive number of spermatogonia, and preleptotene 
spermatocytes [203]. Caspase-8 inhibitor significantly reduces the number of apoptotic 
germ cells in pubertal rats [204]. Up-regulated Fas transcription is associated with 
spermatocyte apoptosis during the first wave of spermatogenesis [159-161, 205, 206]. 
However, the FasL/Fas signaling pathway may play a primary role in the initiation of 
germ cells after the stress-induced injury [14].  
Phthalates can adversely affect spermatogenesis in juvenile male mammals and 
induce developmental variations and malformations after prenatal exposure [159, 161, 
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189, 207, 208]. Dr. Richburg’s group previously identified detailed mechanisms by which 
MEHP-induced Sertoli cell injury leads to an increase in the incidence of testicular germ 
cell apoptosis [159, 161, 206, 209, 210] (Figure 1-12). The functional participation of 
Fas/FasL signaling in directly triggering germ cell apoptosis after MEHP-induced Sertoli 
cell injury has been described [161]. Although Sertoli cells express a basal level of FasL, 
a robust increase in FasL expression appears to be a prerequisite for MEHP-induced 
increases in germ cell apoptosis [160, 206, 209]. Similar results are shown in 
2,5-hexanedione or nitrobenzene-treated animals [211]. Immunohistochemical studies 
also indicate that mice exposed to DEHP reveal an increase in the expression of FasL in 
Sertoli cells [159, 212]. gld mice carrying a dysfunctional FasL gene due to a point 
mutation in the C-terminus show significant protection from MEHP-induced germ cell 
apoptosis [213], demonstrating the participation of the FasL/Fas signaling pathway in 
initiation of toxicant-induced germ cell apoptosis. It has been shown that 
MEHP-enhanced FasL/Fas signaling triggers germ cell apoptotsis through a 
p53-dependent pathway [95, 199, 214]. However, the exact mechanim of inducible 
Sertoli cell FasL expression in response to MEHP is still unknown. Therefore, it is 
important to understand the mechanisms of germ cell apoptosis specifically controlled by 
the induced expression of FasL, and the effect of MEHP on the dynamic interactions 
between Sertoli cells and germ cells.  
 
1.5.4. MEHP-induced disruption of junctional structures and germ cell depletion 
MEHP-induced germ cell detachment and sloughing from the seminiferous  
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Figure. 1-12. Apoptotic germ cells. Apoptotic germ cells (arrow heads) in 28-day-old 
C57BL/6J mice testes are examined by TUNEL assay and present as brown spots (DAB 
staining) compared to blue, non-apoptotic cell (hematoxylin staining). The upper panel 
displays fewer apoptotic germ cells in control mice, and the lower panel shows an 
increase in apoptotic germ cells after MEHP exposure for 12h. Circles indicate the Sertoli 
cell vacuolization. The bar represents 100μm. 
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epithelium has been observed and reported by several research groups [215]; however, 
the molecular mechanisms triggering the premature depletion of germ cells from Sertoli 
cells in response to MEHP exposure are still poorly understood.  
In utero exposure to phthalates causes testicular dysgenesis in rats by decreasing gap 
junction alpha-1 (Gja-1) gene expression [216]. Gap junction intracellular 
communication (GJIC) in hamster embryo cells is inhibited by many kinds of chemicals, 
including DEHP [217]. Similar results in rodent and primate studies indicate several 
different phthalate monoesters inhibit gap junctional communication and induce 
peroxisomal β-oxidation in primary cultured hepatocytes [218]. These observations 
suggest that junctional connections between Sertoli cells and germ cells could be the 
primary target of phthalates. Decreases in tight junction protein and F-actin expression 
are also shown in primary Sertoli cells following monophthalate exposure [161, 212]. 
Therefore, MEHP-induced germ cell depletion may be the consequence of disrupted 
junctional complexes in the seminiferous tubule. 
 
1.6. Dissertation aims 
 
Maintaining germ cell homeostasis is critical for functional mature spermatogenesis. 
However, the cellular processes that regulate germ cell apoptosis in the testis remain 
poorly characterized. This study begins with the determination of the mechanisms 
responsible for initiating the increased transcription of FasL in Sertoli cells after 
MEHP-induced injury. The hypothesis in this thesis is that MEHP decreases Sertoli cell 
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supportive capacity by decreasing tissue inhibiror of metalloproteinase (TIMP)-2 
expression in Sertoli cells, which further accounts for changing the sensitivity of germ 
cells to undergo apoptosis through the TNF-α-mediated FasL/Fas signaling pathway as 
well as triggering germ cells to prematurely detach through the activation of matrix 
metalloproteinase (MMP)-2. Supportive experiments and results are presented in the 
following chapters and are discussed in order to extend our knowledge and appreciation 
of the complex interaction between Sertoli cells and germ cells, and its influence on 
spermatogenesis through apoptosis and junctional connections. 
The Fas/FasL signaling pathway has previously been demonstrated to be critical for 
triggering germ cell apoptosis in response to MEHP-induced Sertoli cell injury [219-221]. 
In this thesis, the first evaluation by which the transcriptional regulation of 
MEHP-induced FasL expression in Sertoli cells is carried out by promoter assays. The 
participation and characterization of the TNF-α signaling pathway involved in the 
regulation of FasL in Sertoli cells are also evaluated (chapter 3). Second, we determine 
whether MEHP-exposure influences the activity of metalloproteinases (MPs) in the testis 
and if it is responsible for regulating the release of soluble TNF-α by germ cells as well 
as FasL-induced germ cell apoptosis. Direct measurement of protein levels of MPs and 
their inhibitors, TIMPs are first analyzed. Furthermore, the influence of inhibiting certain 
MP activities on TNF-α and FasL production and consequent germ cell apoptosis is 
determined (chapter 4). Third, the mechanisms by which MEHP causes the alteration of 
junctional connections in the seminiferous epithelium and increases the detachment of 
germ cells are assessed. The functional mechanism of MEHP-activated MPs on the 
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disruption of junction complexes is tested (chapter 5). 
The novel observations in this thesis reveal that MEHP exposure results in an 
increased production of soluble TNF-α in germ cells. It is the first evidence indicating the 
participation of germ cells in their own “suicide” process through regulating 
pro-apoptotic gene/protein expression in Sertoli cells. Furthermore, TNF-α processing 
depends on the proteolytic activity of MPs, which also plays important roles in 
maintaining dynamic communication in the seminiferous epithelium. The balance of MPs 
and TIMPs seems to be critical in controlling the interaction of germ cells and Sertoli 
cells. This thesis demonstrates that the decrease in TIMP-2 expression by Sertoli cells is 
the key to activate MMP-2-mediated TNF-α processing as well as MMP-2-mediated 
junctional disruption following MEHP exposure. The results presented in subsequent 
chapters can answer questions on the signaling pathway of MEHP-induced Sertoli cell 
injury and its influence on the interaction of Sertoli cells and germ cells, which offer new 
insight into the molecular mechanisms of testicular disorders. 
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Chapter 2. Material and Methods 
 
2.1. Sertoli cell lines  
The adult rat Sertoli cell line, ASC-17D (a gift from Ann Clark, Serono Research 
Institute, Rockland, MA; originally created by the laboratory of Dr. Ken Roberts)[213], 
was cultivated in cell culture media consisting of Dulbecco’s modified Eagle’s media 
(DMEM)/Ham’s F12 (F12) supplemented with 4% fetal bovine serum and 1% antibiotic 
penicillin-streptomycin (all Invitrogen, Gaithersburg, MD). ASC-17D cells were created 
with a temperature-sensitive mutant of the SV40 virus that allows for propagation of 
these cells at the permissive temperature (33°C) and differentiation at the nonpermissive 
temperature (40°C). Cells were seeded and incubated at 33°C for 24 h and then 
transferred to 40°C for 48 h prior to experimental initiation.  
The mouse Sertoli cell line, TM4 (ATCC. #CRL-1715), was cultivated in cell 
culture media consisting of Dulbecco’s modified Eagle’s media (DMEM)/Ham’s F12 
(F12) supplemented with 2.5% fetal bovine serum, 5% horse serum and 1% antibiotic 
penicillin-streptomycin (Invitrogen, Gaithersburg, MD). TM4 cells were seeded in 6-well 
plates and incubated at 37 °C. Cell morphology was imaged using a Nikon TMF-F 
inspection microscope and captured with a Canon-5D digital camera. 
 
2.2. Animals  
28-day-old male wild-type C57BL/6J mice were purchased from the Jackson 
Laboratory (Bar Harbor, ME). 28-day-old Fisher rats were purchased from Harlan 
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Sprague Dawley, Inc. (Indianapolis, IN). Breeding pairs of mice homozygous for both the 
Tnfrsf1atm1Imx and Tnfrsf1btm1Imx/J targeted mutations (TNFR1/2, p55/p75 deficient) on a 
129S7/SvEvBrd x C57BL/6 mixed background were originally purchased from the 
Jackson Laboratory and colonies were maintained to obtain sufficient offspring. The 
climate of the animal room was kept at a constant temperature (22±0.5°C) at 35-70% 
humidity with a 12L:12D photoperiod. Animals were given standard lab chow and water 
ad libitum. All procedures involving animals were performed in accordance with the 
guidelines of the University of Texas at Austin’s Institutional Animal Care and Use 
Committee in compliance with guidelines established by the National Institutes of Health. 
 
2.3. Preparation of primary Sertoli cell-germ cell co-cultures 
Testes from 28-day-old Fisher rats were detunicated and subjected to series of 
enzymatic digestions. Primary co-culture cells (2x106) were seeded on 35 mm 
laminin-coated culture dishes containing DMEM/F12 media (Invitrogen) with epidermal 
growth factor (EGF; 1 ng/ml; Sigma, St. Louis, MO), ITS+premix (insulin, transferrin, 
selenious acid, BSA, and linoleic acid, 10 μg/ml; BD Biosciences, San Jose, CA), 
gentamicin (50 μg/ml, Invitrogen) and 1% penicillin-streptomycin (Invitrogen), and then 
incubated at 37˚C. After 48 h, germ cells were detached from the Sertoli cells by 
replacing the conditioned media with 20 mM Tris-HCl (pH7.4). 
 
2.4. MEHP treatment in vitro  
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ASC-17D cells (5x105) or primary Sertoli cell-germ cell co-cultures (2x106) were 
treated with 200 μM MEHP (TCI America, Portland, OR) diluted in DMSO for various 
time periods. To determine the appropriate dosage, the viability of MEHP-treated cells 
was evaluated using the trypan blue dye exclusion method and AO/EtBr staining. 
 
2.5. MEHP treatment in vivo 
To evaluate MEHP-triggered gene expression in the testis in vivo, 28-day-old 
C57BL/6J mice were given a single dose of MEHP (1 g/kg) by oral gavage, a standard 
procedure for the investigation of MEHP-induced testicular toxicity [222]. Animals were 
given MEHP in corn oil at a volume equal to 4 ml/kg. Control animals received a similar 
volume of vehicle (corn oil). After treatment, vehicle and MEHP-treated animals were 
killed by CO2 inhalation. The testes were either immediately frozen in liquid N2 for 
protein analysis or fixed in Bouin’s solution (Polysciences, Inc., Warrington, PA) and 
paraffin-embedded for histological evaluation. 
 
2.6. Real-time quantitative RT-PCR (RTQ-RT-PCR)  
To measure the level of FasL mRNA expression in ASC-17D cells, real-time 
quantitative reverse transcription-PCR (RTQ-RT-PCR) was performed. Total RNA was 
isolated using Trizol reagent (Invitrogen Corp., Carlsbad, CA). First strand cDNA was 
prepared using 2 μg of total RNA with Superscript II reverse transcriptase and oligo-dT 
primer (all Invitrogen). The detailed procedure of RTQ-RT-PCR described by Dr. Chen 
[223] was followed with minor modifications. Briefly, all reactions were carried out in 50 
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μl volumes containing 25 μl of SYBR Green PCR master mix (Applied Biosystems Inc., 
Foster City, CA). The forward and reverse primers used to detect rat FasL expression 
level were F441: 5’-ACC AAC CAC AGC CTT AGA GTA TCA TC-3’ and R493: 
5’-TGT TAA GTG GGC CAC ACT CCT T-3’. Glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) was quantified as an internal control using the forward and 
reverse primers F811: 5’-AAC CTG CCA AGT ATG ATG ACA TCA-3’ and R843: 
5’-AAG GTG GTG AAG CAG GCG GCC-3’. DNA amplification was carried out using 
an ABI 7700 Sequence Detection System (Applied Biosystems). Each assay including a 
standard curve and a non-template control was performed in triplicate. The relative 
expression level of FasL against that of GAPDH was defined 
as –ΔCT=–[CTFasL–CTGAPDH]. The FasL mRNA/GAPDH mRNA ratio was calculated as 
2–ΔCT x K (K being a constant).  
 
2.7. Preparation of Nuclear Extracts  
ASC-17D cells were scraped into cold PBS, centrifuged, and resuspended in 400 μl 
of cold hypotonic buffer [10 mM HEPES (pH 7.9), 1.5 mM MgCl2, 10 mM KCl, 0.5 mM 
DTT, and 0.2 mM phenylmethylsulfonyl fluoride]. Cells were lysed on ice for 10 min 
and then centrifuged at 5,000 xg for 5 min at 4°C. The nuclear pellet was resuspended in 
80 μl of cold high salt buffer [20 mM HEPES (pH 7.9), 25% glycerol, 1.5 mM MgCl2, 
420 mM NaCl, 0.2 mM EDTA, 0.5 mM DTT, and 0.2 mM phenylmethylsulfonyl 
fluoride], incubated on ice for 20 min, and centrifuged at 17,800 xg for 5 min at 4°C. The 
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supernatant containing the nuclear extract was collected and flash frozen in liquid N2 and 
stored at -80°C. 
 
2.8. Total protein preparation  
Cultured cells were trypsinized with 0.25% trypsin-EDTA and centrifuged at 1200 
rpm for 5 min at 4°C. Pellets were resuspended in homogenization buffer containing 
RIPA buffer (1% NP-40, 0.5% Sodium deoxycholate and 0.1% SDS in 1X PBS) with 
100 μM Na3VO4, 10 μM E64 and protease inhibitor cocktail (Roche, Indianapolis, IN), 
and incubated on ice for 30 min. After centrifugation at 14,000 rpm for 20 min at 4°C, 
the supernatant containing total proteins was collected and stored at -80°C. 
Frozen mice testes were homogenized in homogenization buffer containing RIPA 
buffer with 0.01 mg/ml aprotinin, 100 μM Na3VO4, 100 μg/ml PMSF. 10 μM E64 and 2 
μg/ml leupeptin, and incubated on ice for 30 min. After centrifugation at 14,000 rpm for 
20 min at 4°C, the supernatant containing total proteins was collected and stored at 
-80°C. 
 
2.9. Western blot analysis 
Total cellular proteins and nuclear extracts were detected by standard western blot 
analysis using primary antibodies against FasL (1:500, Santa Cruz Biotenchnology Inc., 
Santa Cruz, CA), TNF-α (1:500, R&D System Inc., Minneapolis, MN), phospho-IκBα 
(1:500, Cell Signaling Technology, Inc., Beverly, MA), NF-κB (1:500, Santa Cruz 
Biotenchnology Inc.), Sp-1 (1:500, Santa Cruz Biotenchnology Inc.), TIMP-1, -2, -3 and 
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-4 (1:1000, Chemicon, Temecula, CA), MMP-2 and -9 (1:1000, Abcam Inc., 
Cambridge, MA), ADAM-10 (1:500, R&D System Inc.), ADAM-17 (1:500, Abcam Inc.), 
claudin-11 (1:500, Santa Cruz Biotenchnology Inc.), occludin (1:1000, Abcam Inc.), 
ZO-1 (1:1000, Zymed, Gaithersburg, MD), laminin-γ3 (1:250, Santa Cruz 
Biotenchnology Inc.), integrin-β1 (1:250, Santa Cruz Biotenchnology Inc.), FLIP (1:500, 
Santa Cruz Biotenchnology Inc.), DR5 (1:500, Santa Cruz Biotenchnology Inc.), TRAIL 
(1:1000, R&D System Inc.) and β-actin (1:500, Santa Cruz Biotenchnology Inc.). The 
ECL chemiluminescent substrate (Amersham Bioscicence, Piscataway, NJ) was used as 
the detection reagent and β-actin as the loading control. Densitometry for bands on 
western blots was determined by ImageJ software (National Institute of Mental Health, 
Bethesda, Maryland). 
 
2.10. Construction of luciferase reporter gene  
Expression of the luciferase gene driven by the FasL promoter and 5’ upstream 
activating sequence (5’-UAS) (GeneBankTM, ACC. AF045739) was used to evaluate the 
effects of MEHP exposure on the Sertoli cell line ASC-17D. FasL-P1500, a 1500 bp 
region, upstream of the FasL promoter, was PCR-amplified using a mouse BAC clone 
(RP24-253-H8, BACPAC resources, The Children’s Hospital Oakland Research Institute, 
Oakland, CA). Varying lengths of the 5’ end of FasL promoter, FasL-P500, FasL-P1000 
and FasL-P1250, were generated by PCR using FasL-P1500 fragment as the template. 
Reverse and forward primers used for each successive fragment are shown in Table 2-1. 
Primers were designed to contain overhanging sites for the restriction enzymes HindIII  
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Table. 2-1. Nucleotide sequence of PCR primers used to generate sequential deletions in 
the upstream activating sequence of the murine Fas Ligand gene 
  
  
Deletion clone Primer sequencea  
  
  
FasL-Luc-P1500 F: 5’-CAG CTA GCT CTC TCG TTC CTT TCA G-3’ 
 R: 5’-CCA AGC TTC AGC CCC AGG AAA-3’ 
FasL-Luc-P1250 F: 5’-CAG CTA GCT GGA TGA TCA GGG TGG-3’ 
 R: 5’-CCA AGC TTC AGC CCC AGG AAA-3’ 
FasL-Luc-P1000 F: 5’-CAG CTA GCT GCC AAA AAG GTG GAA TA-3’ 
 R: 5’-CCA AGC TTC AGC CCC AGG AAA-3’ 
FasL-Luc-P500 F: 5’-CAG CTA GCT TGA ACA CCT GGC ACA-3’ 
 R: 5’-CCA AGC TTC AGC CCC AGG AAA-3’ 
   
  
aRestriction enzyme cutting sites located within PCR primers are underlined. NheI site: 
GCTAGC; HindIII site: AAGCTT 
F: forward primer; R: reverse primer 
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and NheI, which allowed for directional cloning into the multiple cloning site of the 
luciferase expressing vector pGL3-enhancer (Promega Corp., Madison, WI). FasL-P138, 
FasL-P253, FasL-P298, FasL-P309, FasL-P324 and FasL-P689 fragments cloned in a 
pGL3-basic vector were kindly provided by Dr. Ratliff at the University of Iowa [224, 
225], and were subcloned into pGL3-enhancer vector. The composition of all of the 
constructs was confirmed by restriction endonuclease digestion and DNA sequencing. 
 
2.11. Transfection and luciferase activity assay  
All transfections were carried out in triplicate in six-well cell culture plates. 2x105 
ASC-17D cells were transiently transfected using Lipofectamine™ Transfection Reagent 
(Invitrogen) according to the manufacturer’s instructions. 10 μg of the luciferase reporter 
constructs described above, along with the mock plasmid (promoter-less), were 
co-transfected with 1 μg of the β-galactosidase construct, pCMV-β (Promega). Cells were 
incubated in transfection mixture for 6 h and then lysed in lysis buffer (Luciferase Assay 
Kit, Roche) after further incubation for 24 h. Luminescence was estimated in cell lysates 
after addition of luciferase substrates on a Victor2 1420 Multilabel Counter (Wallac, 
Perkin Elmer, Wellesley, MA). β-galactosidase activity of the control vector pCMV-β 
was assayed on the same counter using the cell extract with β-galactosidase substrate 
reagents (β-galactosidase Assay Kit, Roche). Luciferase activity was normalized by 
dividing the mean relative luciferase units by the mean relative β-galactosidase units. 
Luciferase-expressing plasmids were transiently co-transfected with pCMV-β into 
ASC-17D cells, and the luciferace activity was measured after exposure to MEHP. 
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Promoter activity of each construct was expressed as the ratio of its luciferase activity 
units relative to the mock construct and normalized against its β-galactosidase activity. 
All experiments were performed in triplicate. Non-transfected and mock-transfected cells 
were used as negative controls. 
 
2.12. DpnI-mediated site-directed mutagenesis  
In order to confirm that the identified cis-regulatory elements were essential for 
MEHP-induced FasL up-regulation, DpnI-mediated site-directed mutagenesis [226] was 
employed to alter distinct sequences. DpnI endonucluease targeting sequence 
5’-GmATC-3’ is specific for methylated and hemiethylated DNA. The procedure outlined 
below was performed to disrupt the NF-κB and Sp-1 binding sites on the the FasL 
promoter. The designed sequence specific primers overlapping with and flanking with the 
NF-κB binding site (-374 to -362) were 5’-aactccttggtcttttaaacatgcctcagcaccaa-3’ and 
5’-ttggtgctgaggcatgtttaaaagaccaaggagtt-3’. For the Sp-1 binding site (-1234 to -1222), 
the designed sequence specific primers were 5’-aggcctggatgatcattttggggcggggagggtg-3’ 
and 5’-caccctccccgccccaaaatgatcatccaggcct-3’.  The mutation sites are identified by 
underlines. pGL3-enhancer-FasL-P500 and pGL3-enhancer-FasL-P1250 plasmids were 
used as templates for the PCR reaction: 12 cycles of 95°C for 30 sec, 55°C for 1 min and 
68°C for 15 min with 2.5 units of Pfu DNA polymerase. 10 units of DpnI were applied to 
PCR products and incubated at 37°C for 1 h. The methylated, nonmutated parental 
plasmid DNA was digested and fragmented while the nascent PCR fragment was left 
intact. The nicked plasmid containing the mutation was transformed into E. coli to screen 
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for mutant colonies and then the sequence was verified.  
 
2.13. Electrophoretic mobility shift assay (EMSA) 
Double-stranded oligonucleotides containing Sp-1 or NF-κB binding sequence were 
designed for EMSA as follows: Sp-1, forward: 5’-CCT GGA TGA TCA GGG TGG GGC 
G -3’ and reverse: 5’-CGC CCC ACC CTG ATC ATC CAG G -3’. NF-κB, forward: 
5’-CTC CTT GGT CTT TTC CCC ATG C -3’ and reverse: 5’-GCA TGG GGA AAA 
GAC CAA GGA G -3’. The forward and reverse oligonucleotides were annealed to each 
other to generate double-stranded binding fragments. Equal amounts of nuclear extract (5 
ng) from ASC-17D cells, grown in the absence or presence of MEHP, were incubated 
with the double-stranded Sp-1 or NF-κB binding fragments at room temperature for 20 
min using a Electrophoretic Mobility Shift Assay kit (Invitrogen), according to the 
manufacturer’s instructions [227].The products of the hybridization reaction were 
resolved by electrophoresis on 6% nondenaturing polyacrylamide gels at 150V in 0.5X 
TBE buffer for 30 min at 4°C. DNA and protein binding activities were determined by 
staining gels with SYBR Green and SYRPO Ruby, respectively. The gel was stained in 
SYBR Green EMSA stain (1:10,000) for 20 min at room temperature, and rinsed twice 
with deionized H2O. The same gel was then stained in SYPRO Ruby EMSA stain for 3 h 
with gentle agitation, and destained in buffer containing 10% methanol and 7% acetic 
acid. The gels were visualized and analyzed using a FLA-3000 Fluorescent Imager 
(Amersham Bioscicence) at 473 nm excitation, and 520/580 nm of emission wavelength 
settings. 
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2.14. Chromatin immunoprecipitation (ChIP) 
ChIP assays were performed by using a Chromatin Immunoprecipitation Assay Kit 
(Upstate, Temecula, CA). ASC-17D cells (1x106) were cultured in 10 cm culture dishes, 
and after treatment with 200 μM MEHP for 12 h, cells were cross-linked with 1% 
formaldehyde and sonicated at 30% output setting (Sonic Dismembrator 550, Fisher 
Scientific, Houston, TX) followed by centrifugation for 15 min at 16,000 xg at 4°C. 
Supernatant (50 µl) was taken as an input control and the rest of the sample was divided 
into four portions. Immunoprecipitating antibodies against NF-κB, Sp-1, α-tubulin, and 
normal rabbit-IgG (2 µg; all Santa Cruz Biotenchnology Inc.) were individually added to 
each portion. After overnight incubation at 4°C, antibody/histone/DNA complexes were 
sequentially washed with low salt buffer, high salt buffer, LiCl immune buffer and TE 
buffer. Precipitates were eluted and incubated at 65°C overnight to reverse formaldehyde 
cross-linking. DNA was purified by phenol/chloroform extraction and ethanol 
precipitation. The chromatin fragments were amplified by PCR using primers flanking 
the NF-κB and Sp-1 binding sites of FasL 5’-UAS as follows: NF-κB, F483: 5’-CTG 
GCA CAC ATT CCT GGT TG-3’ and R329: 5’-TGT GTC CTG AGA GGC CTG TTG-3’; 
Sp-1, F1333: 5’-CAC AAA AGA CTC ATC TGG TAC AGG G-3’ and R1163: 5’-CAA 
TCT CAG GCT GTT CCT TCC TT-3’. 
 
2.15. NF-κB and Sp-1 inhibitor treatments in vitro  
Various concentrations of NF-κB inhibitor peptide (SN50; EMD Biosciences, Inc., 
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San Diego, CA), NF-κB specific inhibitor (pyrrolidine dithiocarbamate, PDTC; Sigma, 
Inc.) and Sp-1 inhibitor (mithramycin A, MMA; Sigma) were applied to ASC-17D cells 
or primary co-cultures in the presence of MEHP for 12 h. SN50 peptide 
(H-Ala-Ala-Val-Ala-Leu-Leu-Pro-Ala-Val-Leu-Leu-Ala-Leu-Leu-Ala-Pro-Val-Gln-Arg-
Lys-Arg-Gln-Lys-Leu-Met-Pro-OH) contains the nuclear localization sequence of NF-κB 
and causes the inhibition of NF-κB translocation in endothelial and monocytic cells 
treated with lipopolysaccharide or TNF-α [228]. PDTC, a metal chelator, inhibits 
IκB-ubiquitin ligase activity and blocks NF-κB activation [229]. MMA binding to DNA 
in native chromatin results in the suppression of transcription and protein synthesis [222].  
 
2.16. Antibody neutralization by anti-TNF-α primary antibody in vitro  
Various concentrations of anti-TNF-α primary antibody (Santa Cruz Biotechnology, 
Inc.) were added to primary Sertoli cell-germ cell co-cultures for 12 h. Nuclear extracts 
and total protein were isolated as previously described. NF-κB and FasL expression in the 
nucleus and total protein, respectively, were detected by western blot analysis. 
Anti-rabbit-IgG was used as a negative control. 
 
2.17. Measurement of soluble MMP-2 and TNF-α in primary Sertoli cell-germ cell 
co-cultures by ELISA 
To determine the production of soluble MMP-2 and TNF-α, 2x106 primary Sertoli 
cell-germ cell co-cultures were exposed to 200 μM MEHP. After 12 h incubation, culture 
media was collected and centrifuged to remove cellular debris, and the supernatant was 
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frozen at -80°C until assayed for soluble MMP-2 and TNF-α by ELISA according to the 
manufacturer's instructions (R&D Systems, Inc.). MEHP-exposed cells were rinsed twice 
with PBS and counted to normalize the protein expression assayed by ELISA. All 
experiments were performed in triplicate. 
 
2.18. Recombinant protein treatment in vitro 
5x105 ASC-17D cells were incubated with mouse TNF-α recombinant protein (0, 0.1, 
1, 5, 10, 50 ng/ml, R&D Systems, Inc.) for 12 h. NF-κB and FasL protein levels were 
measured in both nuclear extracts and in total protein by western blot analysis. In order to 
determine the effect of MMP-2 on TNF-α processing, recombinant MMP-2 protein (0, 5, 
10, 50 ng/ml, R&D Systems, Inc.) was added to primary co-culture cells for 12 h, and the 
media were collected for ELISA. 
 
2.19. Zymography  
The MMP-2 and MMP-9 gelatinolytic activity in primary co-culture media was 
assayed by gelatin zymography with minor modifications [230]. Briefly, 12 h after the 
addition of MEHP (200 μM) or vehicle (DMSO, 0.04%) to the co-cultures, conditioned 
media were collected and directly applied to a 10% polyacrylamide gel containing 2 
mg/ml of gelatin (Sigma). After electrophoresis, the gels were washed twice for 15 min 
with 2.5% Triton X-100 in 50mM Tris-HCl (pH 7.5) to remove the SDS and restore 
enzyme activity and incubated overnight at 37˚C in activation buffer (50 mM Tris-HCl, 
pH 7.5, 200 mM NaCl, 10 mM CaCl2 and 0.02% sodium azide). The gels were then 
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stained with 30% methanol/10% acetic acid containing 0.5% (w/v) Coomassie Brilliant 
blue G-250 for 30 min and destained in the same solution without dye. Clear bands 
shown on the blue background indicate enzyme activity. 
 
2.20. Testicular histopathology  
Bouin’s-fixed testes were washed in 70% ethyl alcohol-Li2CO3 saturated solution 
and embedded in paraffin for histological analysis. Cross-sections (5 μm) of 
paraffin-embedded tissues were evaluated by periodic acid-Schiffs-Hematoxylin (PAS-H) 
staining [231] and then imaged using a Nikon E800 microscope and captured with a 
Canon-5D digital camera. At least three mice in each treatment group were examined. 
The average diameter of the lumen was determined by measuring the diameters of 20 
seminiferous tubules per testicular cross-section and two sections from each mouse were 
examined. 
 
2.21. Terminal deoxy-nucleotidyl transferase-mediated digoxigenin-dUTP nick end 
labeling (TUNEL) assay 
Apoptotic fragmentation of DNA in mouse paraffin-embedded testis cross sections 
was determined by TUNEL analysis using the ApopTagTM kit (Chemicon). The apoptotic 
index was calculated as the percentage of seminiferous tubules containing more than 
three TUNEL-positive germ cells in each cross-section. At least two testicular 
cross-sections per mouse and at least three mice in each treatment group were analyzed. 
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2.22. Gelatinase inhibitor SB-3CT treatment in vivo and in vitro  
SB-3CT is a gelatinase-specific inactivator that inhibits MMP-2 and MMP-9 by 
binding the active site of the enzymes [212]. In vitro, SB-3CT (Chemicon) (0, 5, 10 and 
20 μM) was added to primary Sertoli cell-germ cell co-cultures for 12 h in the presence 
of MEHP. Primary co-culture cells were harvested for protein analysis, and conditioned 
media were collected to determine TNF-α levels by ELISA. In vivo, SB-3CT (5 mg/kg) 
and the vehicle solution (10% DMSO in normal saline) were injected intraperitoneally 
into 28-day-old C57BL/6J wild-type mice. After 6 h, MEHP (1g/kg) was administrated to 
SB-3CT pre-treated C57BL/6J mice by oral gavage for another 12 h. One testis was 
collected and prepared for paraffin embedding, and the other testis was immediately 
frozen at -80˚C for protein analysis. 
 
2.23. Transmission electron microscope (TEM) 
Control and MEHP-treated mice testes were fixed in 2.5% Glutaradehyde and 2% 
paraformaldehyde in 0.1M sodium cacodylate, and post-fixed with 2% OsO4 (all Electron 
Microscopy Science, Hatfield, PA). After dehydration with ethanol, testes were 
embedded in Epon 812 (Electron Microscopy Science). Thin sections (~60 nm) were cut 
using Leica Ultracut UCT microtome and transferred to 200 mesh copper grids, followed 
by double-staining with uranyl acetate and lead citrate. Testicular ultrastructures were 
examined using a Philips EM 208 Transmission Electron Microscope (provided by 
Microscopy Core Facility in Institute for Cellular and Molecular Biology at UT-Austin). 
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2.24. Immunohistochemistry (IHC) 
Expression and localization of ZO-1, occludin, claudin-11, laminin-γ3 and 
integrin-β1 in the seminiferous epithelium were determined by immunohistochemstry. 
Cross-sections (5 µm) of paraffin-embedded testes were deparaffinized and rehydrated, 
and antigens were unmasked in heated 10mM sodium citrate. Sections were incubated 
with 3% H2O2 to block endogenous peroxidase activity and then incubated in blocking 
buffer containing 10% horse serum. Primary antibodies used in this study were 
rabbit-anti-ZO-1 (1:100, Zymed), rabbit anti-occludin (1:100, Abcam Inc.), rabbit 
anti-claudin-11 (1:100, Santa Cruz Biotenchnology Inc.), goat anti-laminin-γ3 (1:100, 
Santa Cruz Biotenchnology Inc.) and goat anti-integrin-β1 (1:100, Santa Cruz 
Biotenchnology Inc.). Sections were incubated with primary antibodies at 4°C for 
overnight. Immunoreaction was performed by standard procedure using VectaStain ABC 
kit (Vector Lab, Burlingame, CA) and DAB substrate (Vector Lab). All sections were 
imaged using a Nikon E800 microscope and captured with a Canon-5D digital camera. 
 
2.25. Germ cell detachment  
Primary Sertoli cell-germ cell co-cultures from 28-day-old Fisher rats were seeded 
in 6-well culture plates and treated with 200 µM MEHP. In order to determine the 
number of germ cells detached from Sertoli cells, cells in the conditioned media were 
collected, stained with 0.4% trypan-blue (Invitrogen), and counted using a 
hemocytometer. The specific gelatinase inhibitor, SB-3CT (5 and 10 μM), or TIMP-2 
recombinant protein (50 ng/ml) was added to primary rat co-cultures in the presence of 
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MEHP to suppress MEHP-induced MMP-2 activation, and detached germ cells were 
counted after 6 h of incubation. In order to determine the relationship between germ cell 
apoptosis and germ cell detachment by MEHP exposure, primary rat co-culture cells were 
pre-treated with caspase inhibitor zVAD-FMK (20 μM, Sigma, St. Louis, MO) for 2 h 
and then exposed to 200 µM MEHP for 3 and 6 h. At the same time, additional 
zVAD-FMK was added into primary rat co-culture cells. Detached germ cells were 
counted. All experiments were performed in triplicate. 
 
2.26. Testicular spermatid head count   
In order to determine the number of mature elongate spermatids in the seminiferous 
tubules, testicular spermatid heads were counted by using previously described methods 
with slight modifications [232]. Briefly, testes from 44-day-old mice were homogenized 
in DMSO/saline solution containing 0.9% (w/v) NaCl and 10% (v/v) DMSO, and 
spermatid heads were counted using a hemocytometer. The average number of spermatid 
heads was determined from 6 TNFR-1/2+/+ mice and 4 TNFR-1/2-/- mice. Each testis 
sample was counted three times. The daily sperm production per testis was calculated by 
using 4.84 days as the time divisor [141, 233]. 
 
2.28. Statistical analysis  
All experiments were performed in triplicate and repeated at least three times. The 
results are presented as the individual means ± SEM. The data were subjected to Student 
t-test or a parametric one-way analysis of variance (ANOVA) followed by Tukey test for 
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post hoc comparisons. Statistical significance was considered to be achieved when 
p<0.05.
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Chapter 3. Transcriptional Regulation of FasL Expression and Participation of  
Soluble TNF-α in Response to Sertoli Cell Injury 
 
3.1. Introduction and Rationale 
 
Fas ligand (FasL), a type II transmembrane protein belonging to the tumor necrosis 
factor (TNF) superfamily, is a well-characterized apoptosis initiating protein [96, 234, 
235]. An interaction between FasL and its cognate receptor Fas stimulates the formation 
of the death-inducing signaling complex (DISC) that ultimately leads to the orderly death 
of the cell [159-161]. Previous reports have demonstrated that the Fas/FasL paracrine 
signaling mechanism between Sertoli cells and germ cells plays a key role in mediating 
germ cell apoptosis in the testis after Sertoli cell injury [211]. Immunohistochemical 
studies indicate that mice exposed to DEHP reveal an increasing distribution of FasL in 
the Sertoli cell [189, 196, 236, 237]. MEHP, the active metabolite of DEHP, is a 
well-known Sertoli cell toxicant [206, 209], and exposure of rodents to MEHP causes an 
early induction in FasL expression [234, 238].  
    The transcriptional regulation of FasL is important for controlling the death 
signaling pathway in the testis, eyes, placenta and brain [239]. Some transcription factors 
have been implicated in the regulation of FasL gene expression, including specificity 
protein-1 (Sp-1) [240], interferon regulatory factor-1 (IFN-1) [241, 242], nuclear factor in 
activated T cells (NFAT) [243] and nuclear factor-κB (NF-κB) [244]. The constitutive 
basal regulation of FasL transcription in Sertoli cells has been reported to be controlled 
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by Sp-1 [238, 245]. Sp-1 also acts co-operatively with other transcription factors, such as 
activator protein-1 (AP-1), Ets-1, NF-κB, signal transducers and activators of 
transcription-1 (STAT-1) and E2F [159, 161, 189, 207, 208]. However, the exact 
regulation of Sertoli cell FasL gene expression in response to MEHP, as well as the 
regulation of its inducible expression in the testis, is still unknown. 
This chapter investigates the transcriptional regulation of FasL in Sertoli cells in 
response to MEHP using in vitro and in vivo experimental approaches. Sequential 
deletion of the FasL promoter sequence was used to analyze differential transcriptional 
activity levels after MEHP treatment. I identify at least two transcription factors that 
participate in MEHP-induced FasL expression: NF-κB and Sp-1. Furthermore, this 
chapter demonstrates that NF-κB controlled FasL expression in Sertoli cells is triggered 
by soluble TNF-α released from germ cells. These results reiterate the importance of 
paracrine interactions between Sertoli cells and germ cells after MEHP-induced Sertoli 
cell injury. 
 
3.2. Results 
 
3.2.1. FasL expression in ASC-17D cells and in C57BL/6J mouse testes is induced by 
MEHP in a time-dependent manner  
Rat adult Sertoli cell line ASC-17D cells were exposed to 200 μM MEHP for the 
indicated time-points (Figure 3-1A). After 8 h, FasL mRNA and protein expression level 
were significantly increased (~4- and ~3-fold, respectively) (Figure 3-1A, 3-1B). In vivo, 
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FasL expression in whole testis homogenates from C57BL/6J mice was significantly 
induced (~2-fold) as early as 3 h after exposure to 1g/kg MEHP (Figure 3-1C). 
 
3.2.2. Cis-regulatory elements in -500 to -324 and -1250 to -1000 regions are responsible 
for MEHP-induced FasL expression  
To determine whether the regulatory region controls MEHP-induced FasL gene 
expression in Sertoli cells, a series of fragments were generated in the 5’-UAS (upstream 
activating sequence) of the FasL promoter (AF045739, GenBankTM database) (Figure 3-2) 
and cloned into pGL3-enhancer vector to drive the luciferase expression. Several 
constructs were generated based on the presence of putative transcription factor binding 
sites (Figure 3-3), and each construct resulted in the deletion of specific regulatory 
elements. Cells transfected with constructs containing 1250 bp upstream of the initiation 
codon (FasL-Luc-P1250) or 500 bp upstream (FasL-Luc-P500) showed an approximately 
40-fold increase in basal luciferase activity. All other constructs were only slightly 
different from the mock construct (Figure 3-4A). In response to MEHP, FasL-Luc-P1250 
demonstrated a significant increase in luciferase activity, while the luciferase activity of 
FasL-Luc-P500 was slightly increased. Therefore, the -1250 to -1000 and -500 to -324 
regions of the FasL 5’-UAS may contain elements important for the basal and inducible 
expression of FasL, revealing the presence of putative Sp-1 NFE2, TFIID and NF-κB 
transcription factor binding sequences, respectively (Figure 3-3).   
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Figure. 3-1. Influence of MEHP on FasL expression in Sertoli cells. (A) FasL mRNA 
expression in MEHP-treated ASC-17D cells was determined by RTQ-RT-PCR. The 
asterisk denotes significant difference from control (p<0.05). (B) FasL protein expression 
in MEHP-treated ASC-17D cells was measured by western blot analysis. After incubation 
for 8 h, increases in FasL protein levels were readily apparent. (C) Total protein from 
whole testis homogenates of 28-day-old C57BL/6J mice exposed to 1g/kg vehicle (corn 
oil) or MEHP were analyzed by western blot analysis and revealed a significant induction 
of FasL expression in a time-dependent manner. β-actin served as the loading control. 
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Figure. 3-2. Sequences of transcription factor binding sites in the 5’-UAS of the 
murine FasL promoter (GeneBankTM, ACC. AF045739). 
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Figure. 3-3. Transcription factor binding sites in the 5’-UAS of the murine FasL 
promoter. Ten 5’ deletion constructs of FasL 5’-UAS are illustrated. The transcriptional 
start site in the fragment is indicated by an arrow and +1. The designate name of each 
construct is shown on the right portion of the 5’-UAS deletion construct. Putative 
transcription binding sites are shown by different boxes. 
 
 67
3.2.3. MEHP-induced FasL expression is enhanced through the transcriptional 
regulation of NF-κB and Sp-1  
To determine whether DNA binding by multiple transcription factors is required for 
MEHP-induced expression of FasL, two mutant constructs containing either the mutated 
Sp-1 or NF-κB binding sites (P1250-Δsp1 and P500-ΔNFκB) were generated. 
P1250-Δsp1 and P500-ΔNFκB constructs were co-transfected with pCMV-β into 
ASC-17D cells as previously described, and assayed for the relative luciferase activity. 
Both mutant constructs showed significantly reduced luciferase activities after MEHP 
exposure (Figure 3-4B), indicating that Sp-1 and NF-κB were both essential for 
MEHP-induced FasL expression in ASC-17D cells. An additional transcription factor 
binding site for NFE2 was identified immediately downstream of the NF-κB binding site 
(Figure 3-3). DpnI-mediated site-directed mutagenesis of this putative binding site 
(P500-ΔNFE2) was used to evaluate NFE2 dependent FasL expression and it was 
demonstrated that NFE2 is not important for regulating either the basal or 
MEHP-inducible expression in ASC-17D cells (data not shown). 
Electrophoretic mobility shift assays (EMSA) were performed to determine whether 
endogenous Sp-1 and NF-κB could bind to these putative binding sites and if their 
transcriptional activity was altered after exposure to MEHP. Double-stranded DNA 
fragments encompassing the putative Sp-1 (-1234 to -1222) and NF-κB binding site (-374 
to -362) in the FasL 5’-UAS were incubated with nuclear extracts from ASC-17D cells 
treated with or without MEHP, and resolved on a nondenaturing polyacrylamide gel as 
described. The specific binding of both Sp-1 and NF-κB proteins to the putative binding  
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Figure. 3-4. Functional deletion mapping and activity of the 5’-UAS in the FasL 
promoter. (A) Each construct (10 μg) was transiently co-transfected with 1 μg pCMV-β 
into ASC-17D cells in the presence (solid bars) or absence (open bars) of MEHP and 
results were expressed as relative luciferase activity with arbitrary units. In the presence 
of MEHP, FasL-Luc-P1250 and FasL-Luc-P500 had significant increases in luciferase 
activities, indicating that the -1250 to -1000 and -500 to -324 regions of the FasL 5’-UAS 
are essential for MEHP-mediated induction in ASC-17D cells. (*p<0.05, Student t-test) 
(B) Site-directed mutagenesis to mutated elements (Sp-1 and NF-κB) in the FasL 5’-UAS 
for the reporter constructs were performed by DpnI-mediated PCR method. As predicted, 
luciferase activity of P1250-ΔSp1 was decreased and similar results were also seen in 
P500-ΔNFκB in the presence of MEHP. Significant differences (p<0.05, ANOVA) 
between groups are denoted by bars with different letters. Transfections were carried out 
in duplicate and the individual experiments were repeated three times. 
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site sequences was observed (Figure 3-5A), and increased DNA-binding activity of all 
three Sp-1 and NF-κB isoforms was observed in response to MEHP exposure. However, 
these two proteins lost binding activity in the presence of the mutant binding sequences 
(ΔSp-1 and ΔNF-κB). These observations indicate that functional Sp-1 and NF-κB were 
present in the nuclear extracts of ASC-17D cells and their DNA-binding activity was 
induced by MEHP exposure. Chromatin immunoprecipitation (ChIP) assays with 
anti-Sp-1 and anti-NF-κB antibodies showed that both antibodies pulled down higher 
amounts of cellular DNA fragments containing the FasL promoter in the presence of 
MEHP (Figure 3-5B), indicating the direct interaction between Sp-1 and NF-κB and the 
FasL promoter. 
 
3.2.4. FasL expression in ASC-17D cells is controlled by Sp-1 and NF-κB pathway in the 
presence of MEHP  
NF-κB and Sp-1 protein levels in the nucleus were measured in ASC-17D cells after 
MEHP treatment. NF-κB and Sp-1 expression in ASC-17D cells were increased in a 
time-dependent manner after MEHP exposure (Figure 3-6A). At 12 h, NF-κB expression 
in the nucleus was increased by 1.66-fold while Sp-1 expression was elevated 2.08-fold 
at 6 h. The addition of specific inhibitors of Sp-1 (MMA) or NF-κB (SN50) resulted in a 
dose-dependent reduction in the expression of FasL in ASC-17D cells (Figures 3-6B, 
3-6C), indicating that both proteins influence the expression of FasL in vitro.   
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Figure. 3-5. NF-κB and Sp-1 binding activity to the FasL promoter in response to 
MEHP. (A) Electrophoresis mobility shift assay (EMSA). Nuclear extracts from 
untreated or MEHP-treated ASC-17D cells were reacted with double-stranded 
oligonucleotides containing Sp-1 or NF-κB binding sequences specific to FasL 5’-UAS 
(Sp-1 and NF-κB), and mutated oligonucleotides (ΔSp-1 and ΔNF-κB). The three arrows 
indicate increased oligonucleotide-protein complexes after MEHP stimulation. Left 
image: SYBR Green EMSA DNA stain. Right image: SYPRO Ruby EMSA protein stain. 
(B) Chromatin immunoprecipitation (ChIP). PCR was performed on DNA extracted from 
lysates subjected to immunoprecipitation with anti-NF-κB or anti-Sp-1 antibody. Specific 
primers to FasL promoter amplified -483 to -329 and -1333 to -1163 regions containing 
NF-κB and Sp-1 binding sites, respectively. The input represented the amplification of 
the unprecipitated DNA. PCR amplification of irrelevant immunoprecipitation against 
anti-α-tubulin antibody and normal rabbit-IgG were used as negative controls. 
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Figure. 3-6. MEHP-induced FasL expression in ASC-17D cells is partially mediated 
by NF-κB regulation. (A) Nuclear extracts (30 μg) from ASC-17D cells treated with 200 
μM MEHP were subjected to 10% SDS-PAGE and analyzed by western blot analysis 
using antibodies against NF-κB. After incubation for 12 h, NF-κB expression was 
increased to 1.66-fold (compared with 0 h control). (B) Suppression of FasL induction in 
ASC-17D cells by the NF-κB activation inhibitor, SN50, was assessed by western blot 
analysis. The indicated concentration of SN50 was added to 5x105 ASC-17D cells and 
incubated for 12 h. FasL protein expression was inhibited by SN50 in a dose-dependent 
manner (down to 0.21-fold, compared with control). (C) Similar analysis was performed 
to measure the dose-dependent inhibition of FasL level in ASC-17D cells by the Sp-1 
inhibitor, MMA (down to 0.05-fold, compared with control). β-actin served as the loading 
control. 
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3.2.5. MEHP exposure leads to an up-regulation of soluble TNF-α in vivo  
TNF-α production was measured in whole testis homogenates from MEHP-treated 
C57BL/6J mice by western blot analysis. Within 1.5 h of exposure, TNF-α expression 
was increased by 2.67-fold (Figure 3-7A) as compared to vehicle treated controls. 
Additionally, increased secretion of soluble TNF-α was observed from MEHP-exposed 
Sertoli cell-germ cell co-cultures in a time-dependent manner by ELISA (~4-fold at 24 
h)(Figure 3-7B).  
 
3.2.6. Induction of FasL expression in the testis is mediated by TNF-α through the NF-κB 
pathway 
To evaluate the influence of TNF-α on FasL expression levels in the testis, NF-κB 
and FasL protein expression was measured by western blot analysis. ASC-17D cells 
demonstrated an approximately 12-fold increase in nuclear NF-κB (Figure 3-8A). The 
addition of anti-TNF-α antibody resulted in a dose-dependent reduction in 
TNF-α-induced nuclear localization of NF-κB in primary Sertoli cell-germ cell 
stimulated with various concentrations of mouse TNF-α recombinant protein co-cultures 
(Figure 3-8C). Furthermore, downstream effects of TNF-α-dependent NF-κB activation 
were demonstrated by assessing FasL protein expression. Addition of various 
concentrations of recombinant mouse TNF-α protein resulted in increased expression of 
FasL (Figure 3-8B), which could be inhibited by the addition of anti-TNF-α antibody in a 
dose dependent manner (Figure 3-8D). These data indicate that the increase in FasL 
protein expression in the testis is regulated by TNF-α through the NF-κB pathway. 
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Figure.3-7. sTNF-α levels in response to MEHP exposure in vivo. (A) Western blot 
analysis of testes from 28-day-old C57BL/6J mice exposed to 1g/kg vehicle or MEHP 
show significant increases in sTNF-α levels in a time-dependent manner. TNF-α 
expression increased 2.67-fold (compared with 0 h control) 1.5 h after MEHP exposure. 
β-actin was used as the loading control. (B) Induction of sTNF-α expression in primary 
co-culture cells. 2x106 co-culture cells were exposed to 200 μM MEHP for 12 h and 
co-culture media was collected to assess TNF-α levels via ELISA. sTNF-α protein levels 
were increased in the Seroli cell-germ cell co-culture media after MEHP treatment in a 
time-dependent manner. After 24 h, the amount of sTNF-α released was significantly 
increased by 3.85-fold (p<0.05). 
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Figure. 3-8. Influence of sTNF-α on NF-κB and FasL expression. 5x105 ASC-17D 
cells were incubated with the indicated concentration of mouse sTNF-α recombinant 
protein for 12 h. NF-κB and FasL protein levels were measured in both nuclear extracts 
and in total protein (each 30 μg) by western blot analysis. NF-κB levels in ASC-17D cells 
were significantly induced after sTNF-α treatment in a dose-dependent manner (A). 
Similar results occur with the levels of FasL and phospho-IκBα (B). The indicated 
concentration of anti-TNF-α antibody was added to primary Sertoli cell-germ cell 
co-cultures for 12 h to neutralize the effect of sTNF-α. A dose-dependent reduction in 
NF-κB and FasL expression levels were detected in both nuclear extract (C) and total 
protein (D) preparations by western blot analysis.  
          
 75
To test the relative contribution of TNF-α and MEHP on the induction of FasL expression, 
ASC-17D cells were exposed to MEHP in the presence or absence of recombinant mouse 
TNF-α protein (50 ng/ml). Both TNF-α and MEHP alone triggered an almost 5-fold 
increase in FasL protein expression compared with the vehicle control (Figure 2-9A). In 
combination, TNF-α and MEHP resulted in a slight hyperstimulation of FasL expression 
(6-fold).  
In primary Sertoli cell-germ cell co-cultures, the level of FasL protein expression 
was significantly suppressed by inhibitors of Sp-1 (MMA; ~58%) or NF-κB (SN50 or 
PDTC; 80%) or the anti-TNF-α antibody (15%)(Figure 3-9B). Taken together, these data 
indicate that Sertoli cell FasL expression in response to MEHP is controlled by more than 
one signaling pathway, and that TNF-α plays a key role in driving the MEHP-inducible 
expression of FasL in Sertoli cells. 
 
3.3. Discussion 
 
Previous studies have indicated that MEHP-induced Sertoli cell injury leads to an 
increase in the incidence of testicular germ cell apoptosis [159, 161, 206, 209, 210]. The 
functional participation of Fas/FasL signaling in directly triggering germ cell apoptosis 
after MEHP-induced Sertoli cell injury has been described [161, 206]. Although Sertoli 
cells express a basal level of FasL protein, a robust increase in FasL levels appears to be a 
prerequisite for MEHP-induced increases in germ cell apoptosis [161, 206, 209]. The 
goal of this study was to determine the mechanisms responsible for initiating the  
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Figure. 3-9. Relative participation of MEHP and sTNF-α on FasL expression. (A) 
MEHP (200 μM) and sTNF-α (50 ng/ml) were added to ASC-17D cells for 12 h and FasL 
protein levels were measured by western blot analysis. A 4.80- and 4.96-fold increase in 
FasL expression was observed when cells were treated singly with MEHP or sTNF-α, 
respectively. Co-treatment with both MEHP and TNF-α caused a significant increase in 
FasL levels by 5.61-fold over the control levels. (B) In the presence of MEHP, FasL 
expression in primary Sertoli cell/germ cell co-cultures was suppressed by 100 nM of 
MMA, 50 μM of SN50, 50 μM of PDTC and 10 μg/ml of anti-TNF-α antibody after 
incubation for 12 h (reduced to 57.8%, 20.3%, 19.6% and 15.1%, respectively). 
Anti-rabbit-IgG was used as a negative control. 
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increased transcription of FasL in Sertoli cells after MEHP-induced injury. This chapter 
describes a direct effect of MEHP on Sertoli cells that enhances the transcriptional 
regulation of FasL through the activation of transcription factors Sp-1 and NF-κB and an 
indirect effect triggered by the increased production and release of sTNF-α from germ 
cells resulting in the further activation of NF-κB in Sertoli cells through the activation of 
TNFR1. These observations provide further insights into the mechanisms by which germ 
cell numbers are actively reduced in the testis to compensate for the compromised 
supportive capacity of the MEHP-injured Sertoli cells in order to achieve populations of 
germ cells that can be supported by the Sertoli cell. 
In order to understand the molecular mechanisms controlling the expression of FasL 
in Sertoli cells, here the cis-regulatory elements that are important for the transcriptional 
regulation of the MEHP-induced expression of FasL were identified. Deletional analysis 
of the 5’-UAS of FasL indicated that two specific regions -1250 to -1000 bp and -500 to 
-324 bp are important for MEHP-induced FasL expression (Figure 3-4A). The decrease in 
luciferase activity in FasL-Luc-P689 construct (Figure 3-4A) suggests that inhibitory 
elements may occur in -1000 to -500 bp of the 5’-UAS of FasL. Alterations of the 
putative binding sites for Sp-1 and NF-κB identified in these regions, by site-directed 
mutagenesis abrogated FasL protein expression altogether (Figure 3-4B), indicating that 
the identified Sp-1 and NF-κB binding sites were necessary for both the basal and 
MEHP-inducible FasL expression. Although the luciferase activity of FasL-Luc-P500 
was only increased by 1.5-fold in response to MEHP treatment (Figure 3-4A), loss of this 
activation upon mutation of the NF-κB binding site established that NF-κB indeed 
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recognizes and binds to the specific motif identified on the 5’-UAS of FasL promoter and 
that NF-κB activation could result in the activation of the expression of FasL (Figure 
3-4B). Futher several experimental approaches confirm that NF-κB plays an important 
role in driving inducible FasL expression in Sertoli cells (Figure 3-5 and 3-6).  
Previous studies have indicated that the induction of FasL protein expression above 
the ubiquitous basal expression is critical for initiating large increases in germ cell 
apoptosis after Sertoli cell injury [246]. This is a concept that has been uniquely revealed 
with the MEHP-induced Sertoli cell injury model. However, understanding the 
mechanisms that specifically control the induced expression of FasL may be especially 
important for understanding the regulation of germ cell apoptosis that occurs in the testis 
during critical periods of testicular development, such as during the first wave of 
spermatogenesis [244]. Although others have reported that the basal expression of FasL 
in Sertoli cells is regulated by Sp-1 [247], observations in this thesis indicate that 
additional transcription factors participate in regulating the MEHP-inducible expression 
of FasL in Sertoli cells. Interestingly, a recent report recognized that the transcription 
factors Sp-1 and NF-κB are co-activated and co-bind to proximal and distal regulatory 
regions of the monocyte chemoattractant protein (MCP)-1 promoter and activate its 
expression [248, 249]. It was also shown that the binding of Sp-1 is a prerequisite for 
NF-κB binding to the distal activating region. This results in facilitating the transcription 
of NF-κB-dependent downstream genes. I have shown, using EMSA and ChIP assay, that 
activated Sp-1 and NF-κB are present in the nuclei of ASC-17D cells challenged by 
MEHP, and that both transcription factors bind their specific cis-regulatory elements in 
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the 5’-UAS of the FasL promoter (Figure 3-5). Basal transcription of FasL was 
influenced by the activation of both Sp-1 and NF-κB (Figure 3-4 and 3-5). Therefore, 
these observations indicate the novel insight that Sp-1 and NF-κB may be responsible for 
both basal and stress-inducible expression of the FasL gene in Sertoli cells. It is also 
possible that the two Sp-1 binding sequences in the -1250 to -1000 bp region aid in 
enhancing the response to MEHP. Precedent for this idea comes from two recent reports 
that have indicated a TFIID-enhanced, Sp-1-required, transcriptional regulation of 
IGF-binding protein 3 and cyclin D1 in granulosa and kidney cells [243, 250]. Hence, it 
is possible that TFIID with its putative transcription binding site found in the FasL -1250 
to -1000 bp promotor region, could cooperate with Sp-1 in regulating the expression of 
FasL in Sertoli cells. It is thus conceivable that these putative binding sites are indeed 
active in testicular Sertoli cells and that specific MEHP-inducible binding of Sp-1 and 
NF-κB is responsible for the increased expression of FasL, after MEHP exposure. 
NF-κB has been shown to be a common mediator of FasL induction in response to 
various stress stimuli in T cells [251] and Kupffer cells [252]. The expression and nuclear 
translocation of NF-κB subunits, p65 and p50, in rat Sertoli cells has been previously 
described [253]. A recent study demonstrated that MEHP induces the activation and 
nuclear translocation NF-κB in rat Sertoli cells [219-221]. I have further demonstrated a 
significant increase in the activation and nuclear localization of NF-κB in ASC-17D 
Sertoli cells in response to MEHP treatment (Figure 3-6A). Dose-dependent inhibition in 
FasL expression (~80%) after the addition of the NF-κB inhibitory peptide, SN50, 
established the involvement of the NF-κB signaling pathway in the regulation of FasL 
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expression (Figure 3-6B). However, the involvement of other transcription factors cannot 
be excluded as the inhibition due to SN50 was incomplete in each independent 
experiment. Similarly, addition of MMA caused a reduction in FasL expression, 
confirming that the regulation by Sp-1 was important for inducible FasL expression 
(Figure 3-6C). Taken together, these data indicate that MEHP-inducible expression of 
FasL in Sertoli cells is regulated by multiple transcription factors, including NF-κB and 
Sp-1.   
It is well-known that the NF-κB signaling pathway is activated by TNF-α in many 
types of cells [252, 254], including primary rat Sertoli cells and the MSC-1 Sertoli cell 
line [255]. In whole testis homogenates, MEHP stimulation caused a robust early increase 
in TNF-α expression (Figure 6A). TNF-α is released in the testis from specific germ cell 
subtypes (spermatocytes or round spermatids [256]), or from activated macrophages in 
the interstitial space [255]. However, testes of C57BL/6J mice did not show any evidence 
of macrophage infiltration into the seminiferous epithelium after MEHP treatment (data 
not shown). In primary Sertoli cell/germ cell co-cultures, where no macrophages are 
present, the increased production of sTNF-α after MEHP exposure was observed (Figure 
3-7B). This further supports the idea that germ cells are the source for the secretion of 
sTNF-α.  
TNF-α has been reported to regulate mammalian spermatogenesis [257-259], 
modulate Leydig cell steroidogenesis [260, 261] and influence the expression of cell-cell 
adhesion molecules [262]. To determine the functional role of TNF-α in Sertoli cells 
exposed to MEHP, the influence of sTNF-α on NF-κB activation and FasL production 
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were examined. The present study demonstrated that recombinant sTNF-α induces a 
dose-dependent increase in both NF-κB translocation and expression of FasL protein in 
ASC-17D cells (Figure 3-8A, 3-8C). A dose-dependent suppression of NF-κB 
translocation and FasL expression was observed in the presence of an anti-TNF-α 
antibody in primary Sertoli/germ cell co-cultures (Figure 3-8B, 3-8D). In the 
seminiferous epithelium, Sertoli cells are known to express TNFR1 but not TNFR2 [263]. 
Thus, I hypothesize that TNF-α is secreted as a paracrine factor from germ cells in 
response to MEHP-induced Sertoli cell injury. In effect, this allows for the regulation of 
MEHP-induced germ cell apoptosis by increasing FasL expression in Sertoli cell, through 
a TNFR1-NF-κB dependent pathway. The role of sTNF-α in FasL expression and 
apoptotic regulation is still considered controversial. In primary human keratinocytes 
treated with TNF-α, IL-1β or IFN-γ, a significant increase in cellular and membrane FasL 
expression was observed in a time- and a dose-dependent manner [264]. Injection of 
TNF-α in mice caused a rapid induction of FasL mRNA in intestinal epithelial cells via a 
NF-κB regulatory motif in FasL promoter [265]. On the other hand, some reports show 
that TNF-α is responsible for the inhibition of testicular germ cell death in the human 
seminiferous epithelium [266], and implicate a role for TNF-α in the down-regulation of 
FasL expression [267-270].  
Metalloproteinases (MPs) are essential for the processing of TNF-α precursor 
[271-274] and a number of MPs in the testis had been described [274, 275]. Interestingly, 
the TNF-α-induced disruption of Sertoli cell tight junctions has been associated with the 
production of extracellular matrix proteins, including MMP-9, collagen and TIMP-1 [276, 
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277]. Therefore, TNF-α may be involved in the physical and metabolic cooperation 
between Sertoli cells and germ cells. Further investigations regarding the mechanisms of 
MEHP-enhanced TNF-α processing and junction disruption are described in later 
chapters (chapter 4 and 5). 
NF-κB-mediated apoptosis under a variety of stimulators or stress in a number of 
cell types has been previously established [278]. Nuclear localization and NF-κB 
DNA-binding activity in Sertoli cells are increased during testicular stress-induced germ 
cell apoptosis [205]. Here, my results suggest that Sertoli cell NF-κB is a key regulator in 
triggering the pro-apoptotic process in germ cells in response to either TNF-α- or 
MEHP-induced signaling. Similarly, in the testis, NF-κB has recently been reported to 
serve as a pro-apoptotic factor to modulate germ cells in response to radiation stress 
[279-281]. While most agents that cause apoptosis also activate NF-κB, recent studies 
have pointed out that the anti-apoptotic effect of NF-κB is mediated by the regulation of 
gene expression favoring cell survival [207, 282]. Thus, the balance between apoptosis 
and survival pathways in the testis appears to involve a highly complex inter-connected 
network. 
During my experiments, the expression of FasL was upregulated by 6 h after 
MEHP exposure of cultured Sertoli cells in vitro (Figure 2-1B). In vivo results, however, 
show that MEHP caused an increase in FasL levels at an earlier (1.5 h) time point (Figure 
2-1C), suggesting that cellular responses to MEHP exposure are more responsive in the 
intact testis, where both Sertoli cells and germ cells are present. Furthermore, sTNF-α 
production was stimulated as early as 1.5 h in vivo (Figure 3-7A), indicating that germ 
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cells are very responsive to MEHP-induced Sertoli cell injury. These observations 
illustrate the temporal differences between MEHP-induced changes in FasL levels 
instigated by direct effects within Sertoli themselves as well as the participation and 
influence of germ cell factors on modulating Sertoli cell FasL levels.  
The results in this chapter show that both MEHP and TNF-α induce a significant 
increase in FasL expression. However, the combination of TNF-α and MEHP results in 
only a slight additive effect on FasL expression (Figure 3-9A). Using primary Sertoli 
cell-germ cell co-cultures, I established that inhibition of the TNF-α-triggered NF-κB 
activation pathway significantly inhibits FasL expression in the presence of MEHP 
(Figure 3-9B). Blocking the Sp-1 pathway, however, does not completely suppress FasL 
expression. These observations indicate that TNF-α secreted from germ cells may play a 
key role in MEHP-induced FasL expression in Sertoli cells. However, the differential 
participation of the direct effect of MEHP on Sertoli cells versus the indirect effect of 
germ cell TNF-α on Sertoli cells and consequent germ cell apoptosis remains to be 
investigated. 
Figure 3-10 illustrates diagrammatically the two identified mechanisms for 
increasing Sertoli cell FasL transcription that ultimately leads to an increase in germ cell 
apoptosis in response to Sertoli cell injury. Sertoli cell injury results in reduced support 
for developing germ cells and leads, through an as yet described mechanism, to the likely 
activation of matrix metalloproteinases and increased production and release of sTNF-α. 
MEHP can directly influence the activation and nuclear translocation of NF-κB and Sp-1 
within Sertoli cells, leading to the up-regulation of FasL expression. However, the  
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Figure. 3-10. A working model indicating both (a) direct effects on Sertoli cells and 
(b) indirect responses by germ cells that play a role in increasing the expression of 
FasL by Sertoli cells as a consequence of MEHP-induced injury. (a) MEHP exposure 
directly acts upon Sertoli cells and consequently leads to the activation of NF-κB and 
Sp-1 through a mechanism that has not yet been described. Activated NF-κB and Sp-1 
result in increased Sertoli cell FasL transcription and FasL protein levels on the Sertoli 
cell plasma membrane. FasL on the cell membrane can then interacts with Fas receptor 
expressed on adjacent on germ cells to trigger apoptosis. (b) In addition, MEHP-induced 
Sertoli cell injury also decreases physical, hormonal and nutritive support for germ cells 
leading to an increased production and release of the soluble form of TNF-α from these 
cells. Increases in sTNF-α are likely produced by the action of one or more 
metalloproteinase (MPs) family members. Germ cell produced sTNF-α can then binds to 
TNFR1 that is present on Sertoli cells resulting in activation of the canonical NF-κB 
activation pathway and consequent increase in FasL gene transcription. Both the direct (a) 
and indirect (b) mechanisms act in concert to ensure the adequate production of FasL to 
reduce the numbers of germ cells in the MEHP-injured testis. 
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differential contribution between the direct effects of MEHP on Sertoli cells and the 
indirect effect of germ cell factors such as TNF-α on FasL expression increases cannot be 
concluded at this time. The two predominant questions arising from the previous and 
current investigations are (a) what is the primary cellular target for MEHP in Sertoli cells 
and how does this lead to the nuclear translocation of NF-κB and Sp-1? and (b) what are 
the mechanisms that explain the increased production of sTNF-α from germ cells? Does 
this response from germ cells serve as an amplification loop for sensitizing germ cells 
that lack Sertoli cell support to FasL-mediated apoptosis? 
In summary, this chapter reports that the transcriptional regulation by both Sp-1 and 
NF-κB is necessary for the MEHP-induced expression of FasL in Sertoli cells. I also 
report the novel finding that the production of sTNF-α from germ cells can act to 
up-regulate NF-κB-dependent FasL expression, resulting in robust increases in Sertoli 
cell FasL levels. To the best of our knowledge, this is the first description of a potential 
“feed-forward” signaling mechanism by which germ cells prompt Sertoli cells to trigger 
their apoptotic elimination. By rigorously defining the critical cellular determinants 
expressed by Sertoli cells and germ cells that are required for triggering germ cell 
apoptosis, I expect to appreciably expand our knowledge of testis biology and gain 
decisive insights into mechanisms by which environmental toxicants can lead to testicular 
disease. 
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Chapter 4. TNF-α-Mediated Disruption of Spermatogenesis in Response to Sertoli 
Cell Injury is Partially Regulated by MMP-2 
 
4.1. Introduction and Rationale 
 
It is well-known that Sertoli cells provide structural and functional support to the 
developing of germ cells. Apoptosis of testicular germ cells serves as a mechanism to 
match the numbers of germ cells to the finite “supportive capacity” of Sertoli cells. 
MEHP exposure is an established model for decreasing Sertoli cell supportive capacity 
that ultimately leads to an increase in the incidence of testicular germ cell apoptosis. The 
previous chapter described a direct effect of MEHP on Sertoli cells that enhanced the 
transcriptional regulation of FasL through the activation of transcription factors Sp-1 and 
NF-κB. The previous chapter in this thesis also demonstrated an indirect effect triggered 
by the increased production and release of soluble TNF-α from germ cells, resulting in 
the further activation of NF-κB in Sertoli cells through the activation of the TNFR1 
signaling pathway. It appears that germ cells also participate in regulating their own cell 
death by releasing factors and consequently activating pro-apoptotic proteins in Sertoli 
cells. Therefore, understanding the mechanisms that specifically controls the induced 
expression of FasL and TNF-α over the basal levels is required for a complete 
understanding of the regulation of germ cell apoptosis following toxicant exposure. 
TNF-α has been reported to regulate spermatogenesis [257-259], modulate Leydig 
cell steroidogenesis [260, 261], and influence the expression of cell-cell adhesion 
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molecules [267-270]. To determine the functional significance of TNF-α in modulating 
the sensitivity of germ cells to undergo apoptosis, the influence of TNF-α on 
spermatogenesis, as well as the mechanism of TNF-α processing in the seminiferous 
epithelium, were examined. Metalloproteinases (MPs) are essential for processing the 
TNF-α precursor [271-274], and a number of MPs in the testis have been described [283]. 
Most MPs are extracellular enzymes that are released into the extracellular space as an 
inactive latent form, and are further activated through proteolytic processing. MP activity 
can be controlled by transcriptional regulation, zymogen activation and tissue inhibitors 
of metalloproteinases (TIMPs) [51, 52]. In this study, both in vivo and in vitro 
experimental approaches were used to examine the relationship between soluble TNF-α 
production and testicular germ cell apoptosis after toxicant-induced Sertoli cell injury. 
The results of these studies provide insights into the crosstalk that occurs between germ 
cells and Sertoli cells that ultimately controls germ cell survival in response to decreased 
Sertoli cell support. 
 
4.2. Results 
 
4.2.1. A decrease in TIMP-2 expression and an increase in MMP-2 are observed in the 
rodent testis after MEHP exposure 
In order to determine whether the expression of specific metalloproteinases in the 
testis were influenced by MEHP exposure, 28-day-old C57BL/6J mice were treated with 
MEHP (1g/kg) and testes were collected at various time points after exposure. Western 
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blot analysis shows that TIMP-1 and TIMP-2 expression in whole testis homogenates 
decrease in a time-dependent manner after MEHP exposure, while no significant changes 
are observed in TIMP-3 and TIMP-4 expression (Figure 4-1A). MMP-2 protein 
expression level in whole testis homogenates is increased after MEHP exposure, but no 
difference in MMP-9 protein level are observed (Figure 4-1B). An increase in the 
ADAM10 processed form (65kDa) is detected early after MEHP exposure, but its 
expression is time-dependently decreased afterward. In primary co-cultures of rat Sertoli 
cells and germ cells, TIMP-2 is only expressed in Sertoli cells and is significantly 
reduced after MEHP exposure, while MMP-2 is detected in both Sertoli cells and germ 
cells, and its expression is slightly increased in germ cells in response to MEHP challenge 
(Figure 4-1C). In order to determine the activity of MMP-2 and MMP-9, conditioned 
media from primary rat co-culture cells were collected and analyzed by gelatin 
zymography. Only MMP-2 is strongly detected in the conditioned media, and its activity 
is increased in response to MEHP exposure (Figure 4-2A). In addition, soluble MMP-2 is 
significantly increased in a time-dependent manner in response to MEHP exposure 
(Figure 4-2B). 
 
4.2.2. The gelatinase inhibitor SB-3CT decreases MMP-2 activity and suppresses soluble 
TNF-α production in primary rat Sertoli cell-germ cell co-cultures  
To better understand the response of TNF-α to MMP-2, the specific gelatinase 
inhibitor, SB-3CT, was added to primary rat co-culture cells. Gelatin zymography 
revealed that SB-3CT is able to suppress MEHP-induced endogenous MMP-2 activity in 
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Figure. 4-1. Levels of testicular TIMPs and MPs in response to MEHP exposure. 
Whole testis homogenates from 28-day-old C57BL/6J mice and total protein from 
primary Sertoli cell-germ cell co-cultures exposed to MEHP (1g/kg) were examined, and 
the quantified relative protein levels are shown as column charts. (A) TIMP1, TIMP2, 
TIMP3, and TIMP4 protein levels and (B) MMP2, MMP9, ADAM10 and ADAM17 
protein levels were determined in vivo. After MEHP exposure, TIMP1 and TIMP2 levels 
are decreased and MMP2 levels are increased shortly after treatment. (C) MMP2 and 
TIMP2 protein levels in primary co-culture cells were analyzed. TIMP2 expression is 
observed only in primary Sertoli cells, and is significantly decreased after MEHP (200 
μM) exposure. SC: Sertoli cells; GC: germ cells. Actin served as the loading control. 
Asterisks denote significant differences between the treatment and the control (*p<0.05, 
Student t-test). 
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Figure. 4-2. The activity of MMP-2 and the level of soluble MMP-2 in primary 
Sertoli cell-germ cell co-cultures. (A) MEHP-induced activation of MMP-2 in primary 
co-culture media is detected in a time-dependent manner by zymography. (B) The 
expression level of soluble MMP-2 released from primary co-culture cells in response to 
MEHP is measured by ELISA. Asterisks denote significant differences between the 
treatment and the control (*p<0.05, **p<0.01, Student t-test). 
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vitro (Figure 4-3A). Soluble TNF-α is decreased in a dose-dependent manner as well by 
ELISA (Figure 4-3B, right group). 
 
4.2.3. Recombinant MMP-2 protein increases soluble TNF-α production in primary rat 
Sertoli cell-germ cell co-cultures  
In order to understand the participation of MMP-2 in the production of soluble 
TNF-α in the testis, recombinant MMP-2 was added to primary rat Sertoli cell-germ cell 
co-cultures, and after 12 h the amount of soluble TNF-α expression was measured by 
ELISA. Soluble TNF-α is increased by the addition of MMP-2 in a dose-dependent 
manner (~5.4-fold at the highest dose of recombinant MMP-2) (Figure 4-3B, left group). 
However, MEHP treatment alone triggered a greater increase in soluble TNF-α 
(~9.46-fold, black bar). 
 
4.2.4. SB-3CT decreases soluble TNF-α and suppresses MEHP-induced germ cell 
apoptosis in vivo 
SB-3CT was IP-injected into 28-day-old C57BL/6J mice for 6 h followed by MEHP 
exposure for another 12 h. MMP2 protein expression in whole mouse testis homogenates 
slightly decreases in SB-3CT-pre-treated mice compared to MEHP treatment alone. 
Moreover, MEHP-enhanced processing of TNF-α is suppressed by SB-3CT injection 
(Figure 4-4) and MEHP-induced germ cell apoptosis is decreased as well (7.36%, 
compared to 23.33% after MEHP treatment) (Figure 4-6). Testicular histology shows that 
an obvious germ cell detachment in seminiferous tubules occurs after MEHP exposure  
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Figure. 4-3. Participation of MMP-2 in the processing of TNF-α and the inhibitory 
effect of SB-3CT on TNF-α activation in vitro. To determine the effect of MMP2 on 
TNF-α processing, 0, 5, 10, 50 ng/ml of recombinant MMP2 protein was added to 
primary Sertoli cell-germ cell co-cultures for 12 h. SB-3CT (0, 5, 10 and 20 μM) was 
added to another set of primary Sertoli cell-germ cell co-cultures for 12 h in the presence 
of MEHP to block the activity of endogenous MMP2. (A) Conditioned media from 
co-culture cells were collected and analyzed by gelatin zymography. The addition of 
SB-3CT significantly inhibits MEHP-induced MMP-2 activity. (B) The level of soluble 
TNF-α in conditioned media of co-culture cells was determined by ELISA. Significant 
differences between groups are denoted by bars with different letters (p<0.05, ANOVA).  
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Figure. 4-4. The inhibitory effect of SB-3CT on TNF-α expression and germ cell 
apoptosis in vivo. The gelatinase inhibitor SB-3CT (5 mg/kg) or vehicle (10% DMSO) 
was IP injected into C57BL/6J mice. After 6 h, SB-3CT and vehicle-treated mice were 
treated with MEHP (1 g/kg) for another 12 h. Testis homogenates were analyzed by 
western blot analysis to detect the protein expression of MMP-2 and TNF-α. The 
quantified relative protein levels were shown as column charts. β-actin served as the 
loading control. Significant differences (p<0.05, ANOVA) between groups are denoted by 
bars with different letters. 
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Figure. 4-5. The inhibitory effect of SB-3CT on testicular histology in vivo. The 
gelatinase inhibitor SB-3CT (5 mg/kg) or vehicle (10% DMSO) was IP injected into 
C57BL/6J mice. After 6 h, SB-3CT and vehicle-treated mice were treated with MEHP (1 
g/kg) for another 12 h. The histology of testis sections was performed by PAS-H staining. 
The bar represents 100 μm.  
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Figure. 4-6. The inhibitory effect of SB-3CT on germ cell apoptosis in vivo. The 
gelatinase inhibitor SB-3CT (5 mg/kg) or vehicle (10% DMSO) was IP injected into 
C57BL/6J mice. After 6 h, SB-3CT and vehicle-treated mice were treated with MEHP (1 
g/kg) for another 12 h. The germ cell apoptotic rate was determined by TUNEL assay. 
TUNEL-positive germ cells were indicated in the seminiferous tubule (arrow head). The 
bar represents 100 μm. Significant differences (p<0.05, ANOVA) between groups are 
denoted by bars with different letters. 
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(~4.5% of tubules per cross-section), but fewer germ cell detachment events are observed 
in the SB-3CT pre-treated mice (~0.2%) (Figure 4-5). The average diameter of the lumen 
in seminiferous tubules is significantly increased after MEHP exposure for 12 h 
(84.49±6.04 and 112.24±4.86 μm, in the absence and presence of MEHP, respectively) 
(Figure 4-5). However, despite these differences in lumen diameter, the average out side 
diameter of the seminiferous tubules in MEHP-treated mice testes are the same as control 
mice (175.41±1.32 and 180.08±2.14 μm, respectively), suggesting that the increase in the 
lumen dilation was not due to an increase in the luminal fluid. TUNEL-positive germ 
cells are increased after MEHP exposure, and SB-3CT pre-treatment is able to prevent 
germ cells from MEHP-induced apoptosis, especially in spermatocytes (Figure 4-6). 
These observations indicate that the suppression of MMP2 leads to the protection of germ 
cells from MEHP-induced apoptosis and preservation of the interaction between Sertoli 
cells and germ cells.  
 
4.2.5. MEHP-induced germ cell apoptosis is the consequence of MMP-2-mediated 
TNF-α processing 
In C57BL/6J mice, MEHP induces significant MMP-2 protein expression at 1 h, 
while MMP-2 expression is slightly decreased after 3 h of exposure. The increase in the 
production of soluble TNF-α is also detected at 1, 3 and 12 h. FasL expression is 
increased in a time-dependent manner from 1 to 6 h after MEHP exposure (Figure 4-7). A 
dramatic increase in MEHP-induced germ cell apoptosis is observed at 12 h and reduced 
at 24 h (Figure 4-8). Significant disruption of Sertoli cell-germ cell interaction occurrs in  
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Figure. 4-7. The effect of MEHP exposure on apoptosis protein expression in the 
testis. Testis homogenates from C57BL/6J mice were analyzed by western blot analysis 
to detect the protein expression of MMP-2, TNF-α and FasL after MEHP exposure. The 
time-dependent pattern of these proteins suggests that MEHP-induced germ cell 
apoptosis occurs through the MMP-2-mediated TNF-α activation and the consequent 
FasL signaling in vivo. β-actin served as the loading control. Asterisks denote significant 
differences between the treatment and the control (*p<0.05, Student t-test). 
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Figure. 4-8. Germ cell apoptosis by MEHP exposure in the testis. The germ cell 
apoptotic rate was determined by TUNEL assay. TUNEL-positive germ cells were 
indicated in the seminiferous tubule (arrow head).Asterisks denote significant differences 
between the treatment and the control (**p<0.01, Student t-test). 
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Figure. 4-9. Testicular histopathology in response to MEHP exposure. Histological 
analysis of testis sections with and without MEHP treatment was performed by PAS-H 
staining. The average diameter of the lumen is significantly increased in MEHP-treated 
mice (*p<0.05, Student t-test). The bar represents 100 μm. 
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the seminiferous tubules in response to MEHP (Figure 4-9). After 24 h of exposure, the 
diameter of the lumens appears to increase due to the retraction of Sertoli cell cytoplasm 
and the loss of germ cells (84.49±6.04 and 167.34±7.45 μm, 0 and 24 h after MEHP 
treatment, respectively). 
 
4.3. Discussion 
 
In peri-pubertal rodents, an initial wave of germ cell apoptosis occurs during the first 
round of spermatogenesis, which is necessary for the establishment of functional 
spermatogenesis [284]. Within the seminiferous epithelium, the dynamic interaction 
between Sertoli cells and germ cells is critical in controlling spermatogenesis. My 
previous findings demonstrated that exposure of young rodents to the Sertoli cell toxicant 
MEHP resulted in the enhanced production of the soluble TNF-α by germ cells and its 
consequent initiation of germ cell apoptosis through the activation of the FasL/Fas 
signaling pathway [285]. Here this chapter further explores the mechanisms responsible 
for the generation of sTNF-α in the seminiferous epithelium after MEHP exposure. I 
found that TIMP-2 expression is decreased in MEHP-injured Sertoli cells, allowing for 
the MMP-2-mediated TNF-α processing and a consequent increase in germ cell apoptosis 
during the peri-pubertal period of testis development. This is the first evidence showing 
the possible mechanism by which MPs are involved in the regulation of programmed cell 
death in the testis. 
Four members of the TIMP family, TIMP-1, -2, -3 and -4, interact with active sites 
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of distinct MPs with 1:1 stoichiometry and regulate the activity of MPs and their 
associated physiological and pathological processes [286]. In the mouse testis, the RNA 
levels of all four TIMPs are constitutively expressed during development [272, 287, 288]. 
The observations of C57BL/6J mouse testis homogenates indicate that a decrease in the 
protein levels of both TIMP-1 and TIMP-2 occur after MEHP exposure, while no 
significant changes are observed in TIMP-3 or TIMP-4 levels (Figure 4-1A). Only 
TIMP-2 and TIMP-4 were detectable in conditioned media of primary Sertoli cell-germ 
cell co-cultures (data not shown), further narrowing the likely participation of TIMPs in 
the seminiferous epithelium to these two TIMP family members. Previous reports have 
indicated that both TIMP-1 and TIMP-2 are expressed by Sertoli cells, TIMP-3 is found 
within interstitial cells such as Leydig cells, and TIMP-4 is present in both interstitial 
cells and Sertoli cells [289]. The results suggest that TIMP-2 is predominately expressed 
in Sertoli cells, and after MEHP exposure in vitro, its protein levels are specifically 
reduced (Figure 4-1C). The down-regulation of TIMP-2 has also been observed in human 
lung cells in response to cobalt exposure [290] and in hypoxic human endothelial cells 
[291, 292], implying that decreases in TIMP-2 levels maybe a general stress-induced 
response. Interestingly, it has been shown that TIMP-1 and TIMP-2 levels are 
up-regulated by follicle-stimulating hormone (FSH) through a cAMP-dependent 
signaling pathway [192]. This signaling pathway has also been previously shown to be 
inhibited in the rodent testis after MEHP exposure [293]. FSH influences Sertoli cell 
proliferation and the synthesis of Sertoli cell-derived products, which are essential for 
germ cell survival. A decrease in FSH corresponds to an increase in germ cell apoptosis 
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in rats [294], and therefore, MEHP-decreased Sertoli cell FSH signaling may be 
responsible, in part, for changes in Sertoli cell TIMP-2.  
The a distintegrin and metalloproteinase (ADAM) family of proteins is widely 
reported to play a role in the proteolytic shedding of membrane-bound proteins [295]. 
ADAM10 and ADAM17 both have TNF-α converting enzyme (TACE) activity [295] and 
are previously described to cleave membrane-bound TNF-α [272, 296]. In the testis, the 
processed active form of ADAM10 (65kDa) was slightly increased shortly after MEHP 
exposure, while ADAM17 expression remained low throughout the time course (Figure 
4-1B), suggesting that other protein(s) besides these two ADAM family members are 
involved in TNF-α processing in response to MEHP exposure.  
MMP-2 and MMP-9 are the major components of basal membranes between Sertoli 
cells and peritubular cells [273]. A recent study showed that MMP-2 is mainly localized 
in apical ectoplasmic specializations associated with the heads of elongate spermatids 
[297]. The present data indicate that total MMP-9 expression remains steady after MEHP 
exposure (Figure 4-1B) and no significant induction of its activity is detectable in 
conditioned media from primary co-cultures (Figure 4-2A). However, the mRNA level of 
MMP-9 is increased after 12 h of MEHP exposure (data not shown), suggesting that 
post-transcriptional regulation may occur. Interestingly, MMP-2 is found in both Sertoli 
cells and germ cells (Figure 4-1C). Total testis protein levels of MMP-2 are rapidly 
increased 1 h after MEHP treatment but then decrease by 3 h (Figure 4-1B). It is 
well-recognized that TIMP-2 is involved in the activation of pro-MMP-2 [272] which is 
also important for testicular development [298]. Time-dependent increases in the 
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expression and activity of soluble MMP-2 after MEHP exposure were detected by 
zymography and ELISA (Figure 4-2A and 4-2B), and indicate that MEHP induces the 
activation of MMP-2 in the testis. Therefore, a decrease in Sertoli cell-derived TIMP-2 
expression after MEHP treatment might contribute to the activation of MMP-2 through a 
decrease in the ratio of TIMP to MP in the testis.  
In order to address the correlation between MEHP-induced activation of MMP-2 
and MEHP-induced TNF-α processing in the testis, in vitro and in vivo experiments were 
performed using a specific gelatinase inhibitor, SB-3CT. It is commonly used in animal 
models to determine the effect of MMP2/9 inhibition on metastatic activity, proteolysis 
and apoptosis [199]. The administration of SB-3CT in primary Sertoli cell-germ cell 
co-cultures suppressed MEHP-enhanced MMP-2 activity in a dose-dependent manner 
(Figure 4-3A), as well as MEHP-induced soluble TNF-α production (Figure 4-3B). These 
observations point to a key role of MMP-2 in the processing of TNF-α in vitro. 
Interestingly, in the absence of MEHP, recombinant MMP-2 only induces ~50% of the 
soluble TNF-α that is produced after MEHP exposure (Figure 4-3B), demonstrating that 
MEHP-induced TNF-α activation may only be partially regulated by MMP-2. In vivo, a 
low dose of SB-3CT (5 mg/kg) inhibits TNF-α processing (Figure 4-4), and consequently 
results in a significant decrease in MEHP-induced germ cell apoptosis (Figure 4-6). It has 
been shown that MEHP causes the detachment and displacement of spermatogenic cells 
in guinea pigs [274]. Testicular histology shows obvious germ cell detachment in 
MEHP-treated C57BL/6J mice, but not in the testis of SB-3CT pre-treated mice (Figure 
4-5). Therefore, both in vitro and in vivo results demonstrate that a low dose of SB-3CT 
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can provide protection from MEHP-induced germ cell apoptosis, and also point to the 
significant role of MMP-2 in TNF-α processing as well as germ cell apoptosis in the 
testis.  
The complex and dynamic juncional connections between Sertoli-Sertoli cells and 
Sertoli-germ cells is highly regulated by cytokines, such as TNF-α and TGF-β3 [299]. In 
other systems, the inhibition of TNF-α decreases the permeability of lung tight junctions 
[300], and the MMP inhibitor GM-6001 decreases TNF-α-induced breakdown of 
blood-cerebrospinal fluid barrier [218]. In vitro, MEHP disrupts tight junctions between 
Sertoli cells [301] and causes germ cell detachment [302]. It has been recently suggested 
that the activation of MMP-2 disrupts the laminin/integrin complex, disturbing 
testis-specific anchoring junctions, ectoplasmic specializations, and restructuring the 
blood-testis barrier [303]. MEHP-activated MMP-2 may be, in part, responsible for 
disrupting the junctional connections in the seminiferous epithelium, as well as 
facilitating germ cell detachment from the seminiferous epithelium (chapter 5). 
The present findings, together with those in the previous chapter, have led to the 
development of a refined model shown in Figure 4-10. This model predicts that 
TIMP/MMP-regulated TNF-α processing plays a key role in the mechanism instigating 
testicular germ cell apoptosis after MEHP-induced Sertoli cell injury. MEHP exposure 
decreases Sertoli cell secretion of TIMP2 into the adluminal space and allows for the 
activation of MMP2. The consequent processing of TNF-α in germ cells allows for its 
ability to activate Sertoli cell TNFR1 and its triggering of the NFκB signaling pathway to 
produce an increase in FasL. The increased FasL protein levels instigate apoptosis of 
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Fas-positive germ cells by the classical death receptor pathway (Figure 4-7). Therefore, 
decreased TIMP-2 expression following MEHP exposure indicates that Sertoli cells first 
responds to MEHP challenge and the consequent activation of MMP-2 to initiate further 
responses in germ cells. Taken together, these findings demonstrate that changes in the 
TIMP/MMP ratio in the testis is a critical mechanism to account for the sensitivity of 
germ cell to undergo apoptosis in response to decreases in Sertoli cell supportive capacity 
during the critical period of peri-pubertal testis development. 
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Figure. 4-10. A refined working model of the complex Sertoli cell-germ cell 
interaction describing the mechanism by which Sertoli cells trigger germ cell 
apoptosis following MEHP-induced Sertoli cell injury. First, MEHP-induced decreases 
in TIMP-2 expression from Sertoli cells allows for the increased activation of MMP-2. 
Active MMP-2 can then cleave membrane bound TNF-α produced by germ cells to 
generate the soluble active form of TNF-α. The binding of sTNF-α with Sertoli cell 
TNFR1 triggers the NF-κB signaling pathway and robustly induces FasL expression. An 
increase in Sertoli cell FasL allows for the instigation of germ cell apoptosis by the 
classical death receptor pathway.  
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Chapter 5. Disruption of junctional apparatus between Sertoli cells and germ cells 
in the seminiferous epithelium by MEHP exposure 
 
5.1. Introduction and Rationale 
 
During spermatogenesis, the integrity of different cell junctions and the regulation of 
dynamic junction proteins are critical in controling the movement of germ cells across the 
seminiferous epithelium. Disruption of the adhesion between Sertoli cells and germ cells 
can cause the detachment of germ cells from the seminiferous epithelium and result in 
premature loss of germ cells and infertility [88]. In the testis, tight junctions (TJs) 
between adjacent Sertoli cells form the blood-testis barrier (BTB), allowing for 
separation of basal and adluminal compartments which is a specialized microenvironment. 
In order to allow spermatocytes to pass through, tight junctions are rapidly disassembled 
and subsequently reassembled [90]. The actin-based anchoring junctions, including 
adherens junctions (AJs) and desmosomes, are also responsible for the release of mature 
spermatids into the tubular lumen [304, 305]. The ectoplasmic specialization (ES) is a 
testis-specific junction associated with actin filaments that displays characteristics of 
adherens junctions, tight junctions and focal adhesions [95, 199].  
Sertoli cells are the primary target of MEHP, leading to the decrease in Sertoli cell 
supportive capacity. The appropriate supportive capacity of Sertoli cells is determined 
during the early stages of spermatogenesis. Many reports demonstrate that in young 
rodents, the detachment of germ cells from the seminiferous epithelium and germ cell 
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apoptosis are increased after MEHP exposure due to the injury to Sertoli cells [306]. 
Since young animals are sensitive to MEHP-induced Sertoli cell injury, MEHP exposure 
in peri-pubertal rodents is considered an appropriate model to test the dynamic crosstalk 
between Sertoli cells and germ cells. The disruption of junctional complexes in the 
seminiferus epithlelium, which leads to germ cell sloughing, may be an initial response to 
MEHP-inhibited Sertoli cell supports. 
The expression of dynamic junction proteins is controlled by transcriptional 
regulation and post-translational modification [306]. Cytokine-mediated down-regulation 
of junction proteins results in an increase in barrier permeability. Several studies have 
shown that transforming growth factor-β3 (TGF-β3) and TNF-α are involved in 
regulating the transcription of claudin-11, occludin and zonula occluden-1 (ZO-1), which 
are major components of tight junctions [307]. The administration of TNF-α in primary 
rat Sertoli cells can transiently disrupt the BTB, resulting in the destruction of 
Sertoli-germ cell adhesion [308]. In addition, TNF-α serves as an negative regulator of 
occludin expression in astrocytes through the TNFR-1 activated NF-κB pathway [283, 
309]. Therefore, TNF-α may be involved in the physical and metabolic cooperation 
between Sertoli cells and germ cells as well as impairing Sertoli-germ cell adhesion. On 
the other hand, protease-mediated junctional regulation may also have a biological role in 
cell junctions. Recent studies indicate that MMPs can disrupt the blood-brain barrier by 
degrading tight junction proteins [310]. MMPs also regulate the permeability of 
blood-retinal barrier through the proteolytic degradation of cadherin in diabetes patients 
[311, 312], and enhance the invasive ability of different tumor cells due to the loss of 
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junction connections [95, 199]. The previous chapter indicates that MMP-2-mediated 
processing of TNF-α occurs in the seminiferous tubule in response to MEHP exposure in 
peri-puberal rodents, and that TNF-α is critical for triggering germ cell apoptosis. These 
observations, together with MEHP-induced germ cell depletion, suggest a possible 
mechanism by which MMP-2 activation may be also responsible for modulating the 
dynamic crosstalk between Sertoli cells and germ cells. Here, this chapter reports that 
MEHP-induced MMP-2 activation contributes to the decreased supportive capacity of 
Sertoli cells following MEHP exposure by influencing junctional connection. These 
results provide distinctive insights into the complex regulation of the interaction between 
Sertoli cells and germ cells, which may be useful for predicting and preventing male 
reproductive disorders. 
 
5.2. Results 
 
5.2.1. MEHP exposure induces the testicular injury in the seminiferous epithelium 
28-day-old C57BL/6J mice were treated with MEHP (1 g/kg), and changes in 
testicular morphology within the seminiferous tubule were observed. The lumen size of 
the seminiferous tubule gradually increased in a time-dependent manner after MEHP 
exposure (Figure 5-1A). After exposure for 3 h, the increased lumen size due to the 
shrinkage of Sertoli cell cytoplasm was significant (Figure 5-1B); however, the germ cell 
population remained similar to controls. After exposure for 6 h, the Sertoli cell cytoplasm 
continued to shrink and vacuolization occurred within the seminiferous epithelium. The 
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edge of the lumen appeared fragmented due to the loss of Sertoli cell-germ cell 
connections. After 12 h of exposure, clusters of pachytene spermatocytes and round 
spermatids were detached from the Sertoli cells and released into the lumen. After 
exposure for 24 h, the lumen size in MEHP-treated seminiferous tubules became twice as 
large compared to controls (41.33±3.09 μm and 88.00±2.49 μm in control and 
MEHP-treated mice, respectively), resulting from the loss of germ cells and the 
contraction of Sertoli cell cytoplasm. In some MEHP-treated tubules, no round 
spermatids were found and the germ cell population consisted only of spermatogonia, 
preleptotene and pachytene spermatocytes.  
 
5.2.2. Occludin expression is decreased following MEHP exposure  
In order to understand whether MEHP exposure altered the organization of tight 
junctions within the seminiferous epithelium, expression levels of three tight junction 
proteins were determined by western blot analysis in mouse testes homogenates (Figure 
5-2A) and primary rat Sertoli cell-germ cell co-cultures (Figure 5-2B). Occludin 
expression was decreased in response to MEHP exposure in vivo and in vitro. No 
significant changes were detected in ZO-1 expression, while claudin-11 expression was 
slightly decreased after MEHP exposure. Immunohistochemistry was performed to 
determine the localization of tight junction proteins in the seminiferous tubule of control 
and MEHP-treated mice (Figure 5-3). Claudin-11 was only present in the basal 
compartment of the seminiferous epithelium, and its expression was slightly decreased at 
3 h and increased after 6 h. Occludin was mainly localized in the basal compartment, and  
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Figure. 5-1. Abnormal spermatogenesis was observed in response to MEHP 
exposure in vivo. (A) The average diameter of the testicular lumen was increased in 
28-day-old MEHP-treated C57BL/6J mice than in control mice. (*p<0.05, **p<0.01, 
Student t-test) (B) Testicular morphology in control and MEHP-treated mice was shown 
by cross-sections from paraffin-embedded testes with PAS-H staining. (a-f) MEHP 
exposure for 0, 1, 3, 6, 12, and 24 h. The length of lines indicated that the lumen size was 
increased in a time-dependent manner. The significant germ cell detachment was 
observed at 12 h after MEHP exposure (arrow head). The bar represents 50 μm. 
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Figure.5-2. MEHP exposure altered the expression of tight junction proteins in vitro 
and in vivo. The protein level of claudin-11, occludin and ZO-1 in (A) whole testis 
homogenates from 28-day-old C57BL/6J mice and in (B) primary rat Sertoli cell-germ 
cell co-cultures were determined by western blot analysis in response to MEHP exposure. 
β-actin serves as the loading control. Asterisks denote significant differences between the 
treatment and the control (*p<0.05, Student t-test). 
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Figure. 5-3. MEHP exposure altered the expression of tight junction proteins. 
Immunohistochemistry results represented the dynamic changes in the expression and the 
localization of claudin-11 (a-d), occludin (e-h) and ZO-1 (i-l) in the seminiferous tubule 
in vivo. a, e, i: MEHP 0h; b, f, j: MEHP 3h; c, g, k: MEHP 6h; d, h, l: MEHP 12h. 
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its expression was suppressed at 3-6 h after MEHP exposure. Occludin was also detected 
in the adluminal compartment after MEHP exposure, suggesting that MEHP may trigger 
the re-localization of occludin. ZO-1 was detected in both the basal and the adluminal 
compartments, and its expression remained steady after MEHP treatment.  
 
5.2.3. MEHP exposure facilitates the opening of the BTB  
Transmission electron microscopy was performed to examine the ultrastructure of 
the BTB between adjacent Sertoli cells. Tight junctions associated with actin filaments 
were intact and sealed in 28-day-old control C57BL/6J mice (Figure 5-4). After MEHP 
exposure, a slight opening of the BTB was observed at 6 h, which continued to widen at 
12 h. The distribution of associated actin filaments at the BTB was disorganized and less 
dense in MEHP-treated mice than in controls. Figure 4-4D shows the quantitative result 
of the opening of the BTB in response to MEHP exposure, demonstrating the significant 
influence of MEHP on the restructuring of the BTB.  
 
5.2.4. The expression of laminin-γ3 and integrin-β1 are decreased after MEHP exposure  
The expression levels of laminin-γ3 and integrin-β1 were determined in mouse 
testes homogenates (Figure 5-5A) and primary rat Sertoli cell-germ cell co-cultures 
(Figure 5-5B). Both laminin-γ3 and integrin-β1 expression were decreased in a 
time-dependent manner in vivo and in vitro after MEHP exposure. Interestingly, 
integrin-β1 showed different expression variants in vivo and in vitro, indicating that 
alternative splicing may occur in rats. Immunohistochemistry revealed that laminin-γ3 
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Figure.5-4. The ultrastructure of the blood-testis barrier between Sertoli cells in the 
seminiferous epithelium. The ultrastructure of the BTB in 28-day-old control and 
MEHP-treated mice (at 0, 6, and 12 h) was examined by transmission electron 
microscopy (A, B and C). White arrows indicated slight opening in junctional complex 
between adjacent Sertoli cells after MEHP exposure. SC: Sertoli cell; GC: germ cell. The 
white bar represents 500 nm with magnification x22,000. (D) The average length of 
opening in tight junctions was measured. After 12 h exposure, the gap in tight junctions 
was significantly wider than control (*p<0.05, **p<0.01, Student t-test). 
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Figure. 5-5. MEHP exposure decreased the expression of adherens junction proteins 
in vitro and in vivo. The protein level of integrin-β1 and laminin-γ3 in (A) whole testis 
homogenates from 28-day-old C57BL/6J mice and in (B) primary rat Sertoli cell-germ 
cell co-cultures were determined by western blot analysis in response to MEHP exposure. 
β-actin serves as the loading control. Asterisks denote significant differences between the 
treatment and the control (*p<0.05, Student t-test). 
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was restricted to apical ectoplasmic specializations, and that expression was decreased 
after MEHP exposure. Integrin-β1 was expressed in apical ectoplasmic specializations 
between Sertoli cells and spermatids as well as in the basement membrane, and its level 
was suppressed by MEHP exposure (Figure 5-6). 
 
5.2.5. MEHP exposure modulates the remodeling of anchoring junction  
Ultrastructures of anchoring junctions in the testis of 28-day-old control and 
MEHP-treated mice were examined by transmission electron microscopy. Anchoring 
junctions between Sertoli cells and pachytene spermatocytes were thinner in 
MEHP-treated testes than in the controls (Figure 5-7). Ectoplasmic specializations 
occurring between Sertoli cells and round spermatids were intact after 12 h of MEHP 
exposure, and associated actin filaments were normally distributed (Figure 5-8). These 
observations suggest that ES structures around early developing spermatids in mouse 
testes were not strongly disrupted by MEHP challenge. However, the apical ectoplasmic 
specializations between late elongating spermatids and Sertoli cells were blurred and 
showed fewer associated actin filaments (Figure 5-9).   
 
5.2.6. Germ cell detachment is increased in response to MEHP through MMP-2 
activation 
In primary rat co-cultures, MEHP-induced germ cell sloughing was observed after 6 
h, and after 12 h, the number of detached germ cells was dramatically increased (~4-fold) 
compared with control (Figure 5-10A). In order to understand the influence of MMP-2 
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Figure. 5-6. MEHP exposure decreased the expression of adherens junction proteins. 
Immunohistochemistry of testis cross sections showed the localization of integrin-β1 (a-d) 
and laminin-γ3 (e-h), and their expression was decreased after MEHP exposure. 
Integrin-β1 (arrows) and laminin-γ3 (arrow heads) were expressed closed to the acrosome 
of spermatids, where the ectoplasmic specialization was. The bar represents 50 μm.  
 
 
 119
 
 
 
 
 
 
 
 
 
 
 
 
Figure. 5-7. The ultrastructure of anchoring junctions between Sertoli cells and 
spermatocytes in the seminiferous epithelium. Anchoring junctions (white arrow heads) 
in 28-day-old control (A) and MEHP-treated (B) mice was examined by transmission 
electron microscopy. SC: Sertoli cell; GC: germ cell. The bar represents 500 nm with 
magnification x22,000.  
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Figure. 5-8. The ultrastructure of anchoring junctions between Sertoli cells and 
early developing spermatids in the seminiferous epithelium. Ectoplasmic 
specialization (arrow) in 28-day-old control (A) and MEHP-treated (B) mice was 
examined by transmission electron microscopy. SC: Sertoli cell; GC: germ cell. The bar 
represents 500 nm with magnification x22,000.  
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Figure. 5-9. The ultrastructure of anchoring junctions between Sertoli cells and late 
developing spermatids in the seminiferous epithelium. Ectoplasmic specialization 
(black arrow heads) in 28-day-old control (A) and MEHP-treated (B, C) mice was 
examined by transmission electron microscopy. White arrows indicated the 
disorganization of actin filaments. Small image represents the close-view of disrupted ES 
between Sertoli cells and late elongating spermatids. SC: Sertoli cell; GC: germ cell. The 
bar represents 500 nm with magnification x22,000.  
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on germ cell detachment, 50 ng/ml of recombinant MMP-2 was added to primary rat 
co-culture cells. The increase in detached germ cells following MMP-2 treatment was 
similar to that found after MEHP exposure (1.72- and 1.79-fold, respectively) (Figure 
5-10A). In addition, TIMP-2 or SB-3CT was added to primary co-cultures to suppress the 
activity of MMP-2. In the presence of MEHP, both TIMP-2 and SB-3CT were able to 
significantly reduce the amount of germ cell detachment (46.31% and 50.33% compared 
with MEHP treatment, respectively) (Figure 5-10B). 
 
5.2.7. SB-3CT administration suppresses MEHP-inhibited junction protein expression 
To further investigate the effect of MMP-2 on restructuring junctional complexes, 
the expression levels of junction proteins following SB-3CT treatment in vivo and in vitro 
were measured. In vivo, 28-day-old C57BL/6J mice were IP-injected with 5 mg/kg of 
SB-3CT for 6 h, followed by MEHP exposure (1 g/kg) for another 12 h. In vitro, primary 
rat Sertoli cell-germ cell co-cultures were treated with SB-3CT in the presence of MEHP 
for 12 h. The tight junction proteins claudin-11, occludin and ZO-1, showed no 
significant changes in response to SB-3CT treatment in vivo (Figure 5-11A); however, the 
addition of SB-3CT slightly suppressed the MEHP inhibition of occludin and claudin-11 
expression in vitro (Figure 5-11B). Laminin-γ3 and integrin-β1 were decreased by MEHP 
exposure while their expression was increased by SB-3CT treatment in the presence of 
MEHP both in vivo and in vitro. 
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Figure. 5-10. Effects of MMP-2 activation on germ cell detachment. Primary rat 
Sertoli cell-germ cell co-cultures were seeded in 6-well culture plates. After 48 h, 
co-cultures were treated with various reagents in order to determine their effects on 
disrupting the Sertoli cell-germ cell interaction. (A) Co-cultures were treated with or 
without 200 μM MEHP for 0, 6, 12 and 24 h. Detached cells in conditioned media were 
resuspended in PBS, and counted by Trypan-blue staining. The open bar represented 
control cells and the solid bar represented MEHP-treated cells. MEHP-induced germ cell 
detachment was increased in a time-dependent manner. (B) Co-cultures were treated with 
MMP-2 (50 ng/ml), TIMP-2 (50 ng/ml) or SB-3CT (5 μM) in the presence or absence of 
MEHP for 6 h. Detached germ cells in conditioned media were counted. The inhibition of 
MMP-2 by either TIMP-2 or SB-3CT significantly decreased MEHP-induced germ cell 
detachment. Asterisks denote significant differences between the treatment and the 
control (*p<0.05, **p<0.01, Student t-test). 
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Figure. 5-11. Effects of SB-3CT administration on the expression of tight junction 
and adherens junction proteins in vivo and in vitro. In vivo, 28-day-old C57BL/6J 
mice were pre-treated with 5 mg/kg of SB-3CT for 6 h and then post-treated with 1 g/kg 
of MEHP for another 12 h. In vitro, primary rat Sertoli cell-germ cell co-cultures were 
treated with SB-3CT in the presence of MEHP for 12 h. The protein level of claudin-11, 
occludin, ZO-1, integrin-β1 and laminin-γ3 in (A) whole testis homogenates and in (B) 
primary rat Sertoli cell-germ cell co-cultures were determined by western blot analysis. 
β-actin serves as the loading control. Asterisks denote significant differences between the 
treatment and the control (*p<0.05, Student t-test). 
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5.2.8. MEHP-induced germ cell detachment is independent of germ cell apoptosis 
The previous study demonstrated that MEHP triggers germ cells to undergo 
apoptosis, consequently resulting in abnormal spermatogenesis. In order to assess the 
relationship between germ cell apoptosis and germ cell detachment induced by MEHP 
exposure, primary rat Sertoli cell-germ cell co-cultures were pre-treated with a general 
caspase inhibitor z-VAD-FMK (20 μM) for 2 h, and then exposed to 200 μM of MEHP 
for various periods of time. The addition of z-VAD-FMK showed no effects on germ cell 
sloughing compared to the control group. MEHP treatment triggered more germ cell 
detachment from Sertoli cells (1.9-fold compared with control), however, high amounts 
of detached germ cells were still measured in z-VAD-FMK-pre-treated co-cultures 
(1.5-fold compared with control) (Figure 5-12), suggesting that MEHP-induced germ cell 
detachment and MEHP-triggered germ cell apoptosis are independent. 
 
5.3. Discussion 
 
In the seminiferous tubule, the integrity of different cell junctions and the turn over 
of dynamic junction proteins are critical during spermatogenesis, especially for 
controlling germ cell migration. MEHP-induced germ cell sloughing has been observed 
and reported by several research groups [33, 313]; however, the molecular mechanisms 
for triggering the detachment of germ cells from Sertoli cells in response to MEHP 
exposure are still poorly-understood. My previous study showed that MEHP-enhanced 
TNF-α processing is mediated by MMP-2 activation and is important for triggering germ  
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Figure. 5-12. MEHP-induced germ cell detachment is independent on germ cell 
apoptosis. Primary rat Sertoli cell-germ cell co-cultures were pre-treated with caspase 
inhibitor, zVAD-FMK (20 μM) for 2 h, and then exposed to 200 μM MEHP for 0, 3, and 
6 h in the presence or absence of additional z-VAD-FMK administration, as described in 
upper part of the figure. Detached cells in conditioned media were resuspended in PBS, 
and counted by Trypan-blue staining. Asterisks denote significant differences between the 
treatment and the control (*p<0.05, **p<0.01, Student t-test). 
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cell apoptosis. This chapter further analyzes the influence of MEHP-induced MMP-2 
activation on remodeling the complex junctions in the seminiferous epithelium, 
consequently causing the detachment of germ cells from Sertoli cells after MEHP 
exposure in peri-pubertal rodents.  
TNF-α and TGF-β3 are responsible for the remodeling of the dynamic BTB in adult 
rats [314]. Chronic administration of TNF-α to male rats induces significant damage to 
spermatocytes and maturing spermatids in the adluminal compartment, resulting in 
testicular atrophy [307]. Recent studies indicate that TNF-α facilitates the disassembly of 
tight junction at the BTB by targeting occludin expression, allowing for the translocation 
of preleptotene/leptotene spermatocytes through the opening barrier [308]. The activation 
of NF-κB by TNF-α down-regulates occludin expression in astrocytes [315] and ZO-1 
expression in intestinal epithelial cells [316], and also stimulates the transcription of 
myosin light chain kinase (MLCK) leading to the opening of the intestinal tight junctions 
[284]. These observations demonstrate the contribution of the TNF-α-activated NF-κB 
signaling pathway on the dynamic junction structure. My previous findings indicate that 
MEHP stimulates soluble TNF-α production by germ cells and further activates the 
NF-κB signaling pathway in Sertoli cells [317]. Here, occludin protein expression was 
decreased after MEHP exposure both in vivo and in vitro (Figure 5-2), suggesting that 
MEHP-enhanced TNF-α may contribute in suppressing occludin expression, further 
impairing the BTB structure in the seminiferous epithelium. The remodeling of tight 
junctions at the BTB was also associated with the disorganization of actin filament 
bundles, which was observed in mice testes after MEHP exposure (Figure 5-4). It has 
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been shown that the BTB in rats exhibits some interspaces of 0.01-0.02 μm between 
adjacent Sertoli cells [318]. However, these results indicate the formation of a wider and 
longer opening of the BTB in the mouse testis after MEHP exposure, demonstrating that 
MEHP-induced testicular injury involves the regulation of tight junctions in the 
seminiferous epithelium. Resent studies indicate that follicle stimulating hormone 
(FSH)-mediated cAMP/protein kinase A pathway is responsible for the suppression of 
claudin-11 transcription in mouse Sertoli cells [319, 320]. On the other hand, cAMP also 
can trigger tight junction disruption by the induction of Itch expression, resulting in the 
ubiquitination of occludin in different cell types [193]. MEHP has been shown its ability 
to inhibit FSH-stimulated cAMP accumulation [273, 321]. Decreases in claudin-11 and 
occludin expression following MEHP exposure are detected (Figure 5-2), suggesting that 
MEHP may alter the restructuring of Sertoli cell tight junctions through a 
cAMP-independent pathway. 
The effect of MEHP exposure on the structure of anchoring junction in the testis is 
also determined in this chapter. Apical ectoplasmic specializations are testis-specific 
junctions composed of tight junctions, adhreren junctions, focal contacts and gap 
junctions. Laminin-333 in germ cells and integrin-α6β1 in Sertoli cells form a focal 
adhesion complex to link two types of cells together at the apical ES [304]. The 
disruption of laminin/integrin complexes during spermiation is necessary for the release 
of mature spermatozoa into the testicular lumen [273]. Here, time-dependent decreases in 
laminin-γ3 and integrin-β1 expression after MEHP exposure in vivo and in vitro are 
observed (Figure 5-5). The ultrastructure data shows a dramatic disruption in apical 
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ectoplasmic specializations in between Setoli cells and elongating spermatids after 
MEHP exposure (Figure 5-9), but not between Sertoli cells and round spermatids (Figure 
5-8). Disconnected actin filaments are also observed at apical ectoplasmic specializations 
in MEHP-treated mice testes. It is the first evidence showing MEHP influences the 
structure of apical ectoplasmic specializations, in part, by breaking down laminin/integrin 
complexes.  
Laminin-γ3 is a MMP-2 and MT1-MMP substrate at the apical ES in the 
seminferous tubule [322]. The accumulation of integrin-β1 at the apical ES activates the 
ERK signaling pathway and further facilitates the disassembly of apical ectoplasmic 
specializations by increasing the proteolysis and consequently breaking the 
integrin-β1/laminin-γ3 complex [303, 323]. My previous results indicate that 
MEHP-induced MMP-2 activation together with consequent TNF-α processing is critical 
for triggering abnormal spermatogenesis (chapter 4). Furthermore, this study shows an 
increase in germ cell detachment from Sertoli cells in response to MEHP challenge in 
primary rat Sertoli cell-germ cell co-cultures through the MMP-2 activation (Figure 
5-10A). The administration of MMP-2 inhibitors, TIMP-2 or SB-3CT, significantly 
suppresses the detachment of germ cells in the presence of MEHP (Figure 5-10B), 
suggesting that MEHP-activated MMP-2 is responsible for breaking down the interaction 
between Sertoli cells and germ cells. In addition, SB-3CT-pre-treated mice reveal 
increases in laminin-γ3 and integrin-β1 expression in response to MEHP exposure 
(Figure 5-11A), and similar results are seen in primary rat co-cultures (Figure 5-11B). 
Tight junction protein expression is not influenced by SB-3CT treatment in vivo; however, 
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occludin and claudin-11 expression are increased in SB-3CT-treated groups in vitro. 
These observations suggest that the protection from MEHP-induced disruption of 
junctional complexes is achieved by suppressing the activity of MMP-2.  
AF-2364 [1-(2,4-dichlorobenzyl)-indazole-3-carbohydrazide], also named adjudin, 
is one kind of male contraceptive drug used to disrupt AJs in the testis. The oral 
administration of adjudin induces progressive germ cell sloughing in adult rats: 
elongating spermatids are depleted first, followed by round spermatids and spermatocytes 
[273]. MMP-2 activation is also detected during adjudin-indcued AJ disassembly [273, 
302]. Interestingly, the proteolysis of laminin-333 at the apical ES occurs at stage VIII in 
the rat testis and further influences the BTB permeability by reducing the level of 
occludin [324]. Other testicular toxicants, such as DDT, dinitrobenezene and cisplatin, 
alter Sertoli cell junctions in vitro by either influencing the protein expression levels of 
junctional complexes or stimulating the re-localization of these proteins, including 
occludin, ZO-1, N-cadherin and Cx43 [325]. 
TNF-α-induced apoptosis in epithelial cells also causes a transient increase in 
epithelial permeability, which occurs through the NF-κB signaling pathway [326]. On the 
other hand, proinflammatory cytokines also trigger the disruption of epithelial barriers 
through apoptosis-independent mechanisms [327, 328]. The disruption of cell-matrix 
interactions causes apoptosis in epithelial cells and tumor cells, which is regulated by 
Bcl-2 and DR5 signaling [329, 330]. Some reports also demonstrate that the proteolysis 
of the basement membrane initiates apoptosis in epithelial cells which is dependent upon 
the expression of integrin with its ligands [331]. The addition of the integrin-β1 antibody 
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sufficiently inhibits germ cell detachment from Sertoli cells in vitro, and these detached 
germ cells show early apoptotic signals [331]. In addition, the disappearance of the 
integrin-tetraspanin complex is necessary for the formation of apoptotic bodies [87]. 
These data suggest that the expression and location of integrin-β1 on the surface of the 
Sertoli cells is the key to limit the supportive ability of Sertoli cells and to further regulate 
both germ cell sloughing and apoptosis. The absence of the BTB may contribute to the 
massive apoptosis in zygotene-pachytene spermatocytes seen during the first wave of 
spermatogenesis in pubertal rats [332], demonstrating that the organization of the BTB is 
important to maintain the proper number of germ cells in response to the altered 
supportive capacity of Sertoli cells. However, the addition of the general caspase inhibitor, 
z-VAD, has no effect on the increase in detached germ cells from Sertoli cell in the 
presence of MEHP in vitro (Figure 4-12), suggesting that MEHP-induced germ cell 
sloughing is independent of MEHP-induced germ cell apoptosis. Similarly, testosterone 
withdrawal-induced germ cell detachment appears to be independent of germ cell 
apoptosis in adult rats [333]. 
Taken together, this chapter has determined that the disruption of junctional 
complexes is the consequence of decreased Sertoli cell supportive capacity following 
MEHP exposure (Figure 5-13). MEHP exposure causes a decrease in Sertoli cell TIMP-2 
expression which allows for MMP-2 activation in seminiferous tubules. Activated 
MMP-2 further may lead to the remodeling of tight junctions at the BTB between 
adjacent Sertoli cells by increasing the processing of TNF-α. In addition, activated 
MMP-2 directly cleaves laminin-γ3 in order to break laminin/integrin complexes at the 
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ectoplasmic specializations between Sertoli cells and spermatids. Disruption of 
ectoplasmic specializations, as well as, the remodeling of tight junctions triggers the 
detachment of premature depletion of germ cells in the seminiferous epithelium in 
response to MEHP exposure, resulting in abnormal spermatogenesis. 
 133
 
 
 
 
 
Figure. 5-13. A refined model: MEHP-induced MMP-2 activation disrupts 
junctional complexes in the serminiferous epithelium. MEHP exposure causes the 
decrease in Sertoli cell TIMP-2 expression which allows for MMP-2 activation in the 
seminiferous tubules. First, activated MMP-2 further leads to the remodeling of tight 
junctions between Sertoli cells by multiple mechanisms. Second, activated MMP-2 
directly cleaves laminin-γ3 in order to break laminin/integrin complex at the ectoplasmic 
specialization between Sertoli cells and spermatids. Disruption of ectoplasmic 
specialization as well as remodeling of tight junctions triggers the premature detachment 
of germ cells in the seminiferous epithelium in response to MEHP exposure. 
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Chapter 6. Concluding Remarks 
 
 “A scientific man ought to have no wishes, no affections… a mere heart of stone.” 
“I love fools’ experiments. I am always making them.” 
 ~~ Charles Darwin 
 
As stated in Skakkebæk’s report on testicular disorders: “Reproductive problems 
used to be analyzed separately by various professional groups, e.g. pediatric 
endocrinologists, urologists, andrologists and oncologists. …… Andrologists have been 
interested in sperm count; pediatric endocrinologists have focused on hypospadias and 
undescended testis, and oncologists on testicular cancer. Similary, epidemiologists 
traditionally analyse the incidence and risk factors separately for each disorder”[334] 
However, toxicologists also play important roles by investigating different mechanisms 
and effects of toxicant-induced reproductive problems. A better understanding of 
commom mechanisms involved in infertility and human reproductive disorder can 
provide scientific evidence in possible treatment options and improve the quality of life. 
What are the major problems with male reproductive health today? Testicular 
dysgenesis syndrome (TDS) is a common human health problem referring to symptoms 
of poor semen quality, testicular cancer, undescended testis (cryptorchidism) and 
hypospadia [335, 336]. Cryptorchidism and hypospadia are birth defects (about 2-4% and 
0.3-0.7% respectively of newborn male infants in the United States) and increase the risk 
of infertility in adults [337]. Testicular cancer is the most severe problem included in 
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TDS and has been shown to be positively correlated with other TDS symptoms, 
especially in adult men [337]. Testicular tissues containing carcinoma in situ (CIS), 
which is the precursor of invasive testicular germ cell tumors, often show a reduced 
diameter of seminiferous tubules, abnormal spermatogenesis and a thicker basement 
membrane [338]. The American Cancer Society estimates that more than 8,000 men will 
be diagnosed with testicular cancer and about 4.6% of patients will die due to this cancer 
in 2008 [339]. High cure rates have been achieved due to early detection and effective 
chemotherapy treatment. Now, scientists emphasize on how to decrease the toxicity of 
chemotherapy in addition to increasing the survival rates in humans [340]. Therefore, it is 
urgent and necessary to understand the cause of testicular disorders and their underlying 
mechanisms in order to improve the patients’ quality of life.  
Recent reports suggest that abnormal testis development, including impaired germ 
cell differentiation, hormone insufficiency and dysfunction of Sertoi cells/Leydig cells, 
can result in testicular dysgenesis [341]. Both genetic and environmental factors can 
contribute to abnormal testis development. Mutations in genes of insulin-like factor 3 
(Insl-3) and its receptor have been suggested to cause TDS [333]. However, increasing 
evidence indicates that male reproductive disorders in the human population are more 
related to environmental factors rather than genetic defects [340, 342-345]. In fact, many 
studies demonstrate that testicular disorders are the consequence of abnormal hormone 
levels which are impaired by environmental endocrine disruptors [172, 173]. These 
observations lead us to explore phthalate-induced testicular injury. 
Phthalates are used as plasticizers to impart flexibility, but the risk to human health 
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and environmental effects are still debatable. Recent studies have shown that phthalate 
metabolites can be detected in urine, serum, breast milk and saliva of most of the general 
human population [180], indicating a significant daily exposure. In human studies, 
phthalates may affect the perinatal testicular and genital development [346]. In 2002, the 
Food and Drug Administration (FDA) reported the caution against human exposure to 
DEHP: “Exposure to DEHP has produced a range of adverse effects in laboratory 
animals, but of greatest concern are effects on the development of the male reproductive 
system and production of normal sperm in young animals. We have not received reports 
of these adverse events in humans, but there have been no studies to rule them out. 
However, in view of the available animal data, precautions should be taken to limit the 
exposure of the developing male to DEHP” [179, 340, 347]. In 2007, California was the 
first state in the United States to prohibit the use of phthalates in children’s toys. In 2008, 
President Bush signed the "Consumer Product Safety Improvement Act of 2008" to 
permanently ban phthalates and lead from children’s toys and child care items [348]. 
However, we have to be aware that the level of human exposure to phthalate is still much 
lower than the dosage applied to animal models.  
A number of possible mechanisms have been shown to explain the molecular target 
of phthalate toxicity in the testis, including the suppression of FSH-mediated cAMP 
signaling [189, 349], the alteration of cytoskeletons in Sertoli cells [161], and the 
induction of Fas signaling in the initiation of germ cell apoptosis [350]. Interestingly, in 
utero dibutyl phthalate (DBP) exposure to rats has similar pathologies to human TDS, 
such as cryptorchidism, hypospadias, infertility, reduced spermatogenesis and 
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multinucleated gonocytes [351, 352]. Similar results are observed with DEHP and butyl 
benzyl phthalate (BBP)-exposed fetal rats, including suppression of testosterone levels, 
delayed peritubular myoid cell differentiation, malformations of the epididyis, an 
increased rate of Sertoli cell-only tubules and widespread loss of germ cells [353]. Even 
though theses symptoms are observed at the fetal age, microarray analysis indicates that 
prepubertal exposure to DBP triggers a similar gene expression pattern in the testis [354]. 
This suggests the conservation of distinct biomarkers following phthalate exposure at 
fetal and prepubertal age, and that phthalate-induced testicular injury during the fetal and 
prepubertal stages may share the same mechanisms in rodents. Experiments of this thesis 
focus on the investigation of how a specific environmental toxicant, MEHP, influences 
the male reproductive system by causing abnormal spermatogenesis. Even though my 
experiments are carried out in peri-pubertal rodents, I still appreciate the knowledge of 
MEHP-induced testicular injury at this critical period of time. A better understanding of 
the physiological impact of environmental toxicants on testicular development certainly 
provide insights into human reproductive disorders, and further enhance the development 
of useful therapeutic strategies. 
The foundation of supporting testicular development relies on Sertoli cells. Using 
this MEHP exposure model in peri-pubertal rodents, I have successfully investigated the 
outcome of Sertoli cell injury, such as the increase in germ cell apoptosis and the 
disruption of junctions in the seminiferous epithelium. My observations also suggest a 
complicated paracrine interaction between Sertoli cells and germ cells that occurs 
following MEHP exposure. I may also predict a potential mechanism by which the 
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alteration of cell-cell interactions responsible for inducing human testicular dysgenesis. 
The remaining questions left behind regarding the mechanism of toxicant-induced 
testicular injury, abnormal spermatogenesis, and the relevance to human reproductive 
health are discussed as followed: 
Chapter 3 focused on the TNF-α-mediated NF-κB signaling pathway as the 
consequence of MEHP-induced Sertoli cell injury. However, I can not ignore the fact that 
Sp-1 plays an important role in basal and inducible FasL expression. It is well-known that 
Sp-1 can be induced by stress, such as oxidative stress, which is important for regulating 
neuron survival [355]; DNA damage, which causes the hyper-phosphorylation of Sp-1 
[356], and shear stress through phosphorylation that inhibits MT1-MMP expression in 
endothelium [357]. However, the direct mechanism triggering Sp-1 activation is still 
poorly-understood. Casein kinase 2 (CK2) and phosphoinositide-3-kinase 
(PI3K)-mediated regulation of Sp-1 and Sp-3 causes transcriptional inhibition of 
macrophage lipoprotein lipase expression [358]. TNF-α has also been reported to 
suppress NH3 expression by modulating Sp-1 and Sp-3 in human intestinal epithelial 
cells [359]. Therefore, the signaling pathway induced by MEHP exposure would be even 
more complicated. A recent study indicates that Sp-1 activation is necessary for triggering 
TRAIL signaling in breast cancer [360]. Since MEHP-activated Sp-1 up-regulates FasL 
expression in Sertoli cells, another death ligand, TRAIL, may also be responsible for 
triggering germ cell apoptosis.  
The novel findings of this thesis present the role of TIMP/MMP in regulating 
MEHP-induced germ cell apoptosis (chapter 4). However, the regulation of 
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MEHP-suppressed TIMP-2 expression has yet to be discovered. Increases in cAMP 
induces the expression of TIMP-1 and TIMP-2 in human fibrosacroma cells and further 
facilitates the invasiveness of cancer cells [193]. MEHP-impaired cAMP signaling alters 
the expression of many downstream genes [361], so it is necessary to evaluate the 
participation of cAMP signaling in controlling TIMP-2 expression in the testis.  
The balance of MMP and TIMP is extremely important for maintaining biological 
functions in both normal cells and tumor cells. Even though I emphasize the decrease in 
TIMP-2/MMP-2 ratio as the consequence of decreased Sertoli cell support by MEHP 
exposure, investigating the role of other MPs in response to MEHP is also critical. For 
example, TIMP-1 expression is also decreased after MEHP treatment. Increases in 
TIMP-1 facilitate the attachment of germ cells to Sertoli cells in vitro, and involves the 
restructuring of the seminiferous epithelium during testis development [362], suggesting 
different physiological functions of TIMP-1 may occur. 
This thesis reports protease-mediated disruption of junctions in the seminiferous 
epithelium in response to MEHP (chapter 5). Cytokine-mediated regulation of junctional 
complexes, especially tight junctions, is still unclear. TNF-α decreases the mRNA 
stability of coxsackie and adenovirus-receptor-like membrane protein (CLMP), a novel 
tight junction protein, through the JNK pathway [363]. CLMP expression is also 
controlled by Sp-1 in the Sertoli cell line TM4 [364]. TNF-α and IFN-γ treatment change 
the lipid composition of the intestinal epithelial barrier and displaces occludin into 
detergent-soluble fractions, leading to the dysfunction of the barrier [365]. Therefore, 
MEHP-enhanced TNF-α or MEHP-activated Sp-1 may regulate the breakdown of tight 
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junctions by several mechanisms.  
Recent studies suggest that interleukin-1α (IL-1α) perturbs the arrangement of actin 
filaments at the BTB, which facilitates the movement of preleptotene spermatocytes 
across the BTB [311]. Instead of altering the expression of junctional proteins, IL-1α 
influences the localization away from the contact site between cells. This thesis observes 
similar results of disorganized actin filaments at the BTB and the apical ES after MEHP 
exposure. At the BTB, MEHP exposure significantly decreases occludin expression, but 
not claudin-11 and ZO-1. The effect of MEHP on the remodeling of the BTB may involve 
a similar pathway as IL-1α. On the other hand, the translocation of ZO-1 and ZO-2 from 
the BTB to Sertoli cell cytoplasm is observed in testicular germ cell tumors, resulting in 
the loss of the BTB function [319, 320]. Lanthanum tracer studies combined with 
immunostaining may provide knowledge of the distribution of ZO family proteins in 
response to MEHP and their effect on the integrity of the BTB.  
Another interesting study involves the degradation of junctional proteins in response 
to MEHP. It has been reported that occludin is the target of the E3 ubiquitin-ligase Itch 
through a cAMP-dependent pathway [193]. MEHP inhibits FSH binding on Sertoli cells 
and further decreases cAMP signaling [366]. Therefore, MEHP-suppressed occludin 
expression at the BTB may be regulated by a cAMP-independent mechanism. Additional 
research in our laboratory investigates the functional participation of Itch in germ cell 
apoptosis in response to MEHP, especially in the regulation of c-FLIP, an anti-apoptotic 
factor. It should provide useful information in evaluating the turnover rate of junctional 
proteins after MEHP exposure by measuring the level of degradation. However, it is 
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definitely not easy to decode the complicated cross-talk in the seminiferous epithelium, 
especially junctional connections. 
An increasing number of studies suggest that anchoring junctions in the testis could 
be new targets for developing male contraceptive drugs [367-369]. For example, a 
non-hormonal male contraceptive, adjudin, causes reversible germ cell loss in the 
seminiferous tubule by disrupting the adhesion between Sertoli cells and germ cells 
without influencing hormone levels [323]. In rats, normal spermatogenesis can be 
recovered 210 days after the removal of this drug [370, 371]. Adjudin is currently in 
phase II human trials [95, 372], suggesting a great potential for targeting junctions in the 
seminiferous epithelim as a method of birth control. Even though phthalates may not be 
suitable for developing male contraceptives, as a toxicant-injury model, I appreciate the 
knowledge into the molecular level of junctional connections in the testis. 
I believe that the long-term goal of studing toxicology is to prevent human disease 
and to provide clues to better therapeutic stretagies as well as to improve the quality of 
life. The ability of germ cells to “sense” the decreased supportive capacity of Sertoli cells 
is crucial for maintaining homeostasis in the tesis. We still have to keep in mind that not 
all chemicals can cause testicular injury, and not all phthalates can trigger the same 
reaction. The level of phthalate exposure in the human population may not equal the 
amount in animal studies; however, experiments in animal models can be applied to the 
relevance of human health at some level. Therefore, the identification of different factors 
which influence cell-cell interaction in the seminiferous epithelium at the cellular and 
molecular basis will be important. 
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Chapter 7. Supplement 
 
7.1. Introduction and Rationale 
 
Understanding the complex mechanisms and signaling pathways involved in 
modulating germ cell survival and apoptosis after Sertoli cell injury can provide insights 
into abnormal spermatogenesis, human testicular disease and male infertility. However, 
beyond the research results in previous chapters, other fundamental observations also 
need to be demonstrated. This supplemental chapter contains (1) MEHP does-response 
experiment in 28-day-old C57BL/6J mice; (2) the ultrastructure of the seminiferous 
tubule in 28-day-old C57BL/6J mice by TEM, and the morphology of different cells that 
I use throughout this thesis; (3) the apoptotic index in 28-day-old C57BL/6J mice during 
testicular development; and (4) the characteristics of TNFR-1/2 gene deficient mice.  
It has been shown that peri-pubertal rodents are more sensitive to testicular injury by 
phthalates than adult rodents [159, 199]. The loss of germ cells is a common feature 
observed after MEHP exposure, specifically spermatocytes and early round spermatids 
[373]. In order to test the sensitivity of germ cells to undergo apoptosis, it is necessary to 
determine the dose-response of MEHP exposure in peri-pubertal rodents (Section 7.2). 
Additionally, the detailed ultrastructure of the seminiferous tubules in peri-pubertal mice 
can also provide information for recognizing the process of normal spermatogenesis 
(Section 7.3). 
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During the first 2-3 weeks after birth in rodents, the first wave of apoptosis occurs, 
which is important for further functional spermatogenesis. At the same time, 
spermatogonia divide rapidly, and start to produce spermatocytes and spermatids. 
Therefore, the rapid large increase in the number of spermatogenic cells causes an 
unbalanced population in the seminiferous tubule, leading to a decrease in the supportive 
capacity of Sertoli cells. This is similar to the MEHP-induced decrease in Sertoli cell 
support that I hypothesized in previous chapters. I am also interested if MMP-2, TNF-α 
and FasL are differentially activated during developmental processes, and if this 
activation correlates with the first wave of germ cell apoptosis (Section 7.4). 
The working model presented in this thesis demonstrates that MEHP-enhanced 
TNF-α plays an important role in regulating FasL-mediated germ cell apoptosis and 
junctional connections in the seminifeous epithelium. TNF-a can act on two different 
receptors: TNFR1 (p55/60) and TNFR2 (p75/80). TNFR1 is constitutively expressed in 
most tissues while TNFR2 expression is highly regulated and present in the immune 
system [262]. In the mouse testis, Sertoli cells express TNFR1, but not TNFR2 [374]. In 
order to further determine the relative contribution of TNF-α in triggering germ cell 
apoptosis and remodeling the junctional complexes in response to MEHP exposure, 
TNFR-1/2 gene deficient mice are a good model to distinguish the influence of TNF-α 
signaling by MEHP exposure as well as during the development (Section 7.5).  
 
7.2. MEHP-induced the testicular injury: a dose-response experiment 
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In order to test the sensitivity of germ cells to undergo apoptosis in response to 
MEHP exposure, 28-day-old C57BL/6J mice were exposed to 0.1-1 g/kg of MEHP. The 
apoptotic related gene expression and the apoptotic index were determined by western 
blot analysis and TUNEL assay. 
 
7.2.1. Testicular histopathology of C57BL/6J in response to MEHP exposure 
Testicular histopathology of C57BL/6J mice in response to various doses of MEHP 
exposure was performed by PAS-H staining (Figure 7-1). MEHP exposure first caused 
the retraction of Sertoli cell cytoplasm, and the dose of MEHP increase, the lumen 
diameter also increased. At high dose of MEHP (0.8, 1 and 1.5 g/kg), germ cell 
detachment was observed in some seminiferous tubules. 
 
7.2.2. MEHP-induced expression of apoptotic related genes is increased in a 
dose-dependent manner 
Total protein from whole testes homogenates in 28-day-old C57BL/6J mice was 
analyzed by western blot (Figure 7-2). FasL and TNF-α expression were 
dose-dependently increased after MEHP exposure. Increases in both the precursor and the 
processed forms of TNF-α could be due to increases in germ cell populations during 
testis development, suggesting that germ cells are the source of TNF-α expression in the 
seminiferous tubule. FLIP expression was also increased in a dose dependent manner. 
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Figure. 7-1. The testicular histopathology in response to MEHP exposure. Testicular 
cross-sections of paraffin-embedded tissue from 28-day-old C57BL/6J mice were 
examined by PAS-H staining. C57BL/6J mice were treated with various doses of MEHP 
for 12 h. A-G: 0, 0.1, 0.2, 0.4, 0.8, 1 and 1.5 g/kg of MEHP. The lumen size is increased 
at higher dose of MEHP exposure. Germ cell detachment is also observed with higher 
dose of MEHP. The bar represents 100 μm.
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Figure. 7-2. Apoptotic related protein expression in mice testes in response to MEHP. 
28-day-old C57BL/6J mice are treated with various doses of MEHP for 12 h. FLIP, 
TNF-α and FasL expression in whole mice testis homogenates are determined by 
standard western blot analysis. β-actin is the loading control. 
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7.2.3. MEHP exposure triggers germ cell apoptosis 
The apoptotic index in germ cells in MEHP-treated C57BL/6J mice was determined 
by TUNEL assay (Figure 7-3). The administration of 0.4 g/kg of MEHP induced a 
significant increase in germ cell apoptosis. High dose of MEHP (1 and 1.5 g/kg) triggers 
a stable induction of the apoptotic rate in germ cells. However, germ cell apoptosis was 
decreased at 0.8 g/kg of MEHP exposure. The induction of germ cell apoptosis is also 
consistent with the dose-dependent induction of FasL and TNF-α expression (Figure 7-2).  
 
7.3. The ultrastructure of mice testes in vivo and cell morphology in vitro 
 
7.3.1. Ultrastructures of mice testes examined by TEM 
TEM was performed to observe detailed ultrastructures inside the seminiferous 
tubule of 28-day-old C57BL/6J mice. The basal compartment of tubules contains Sertoli 
cells, spermatogonia and preleptotene/leptotene spermatocytes (Figure 7-4A and 7-4B). 
The adluminal compartment contains Sertoli cells, pachytene spermatocytes, round 
spermatids and elongate spermatids (Figure 7-4C and 7-4D). Tight junctions forming the 
blood-testis barrier are located between neighboring Sertoli cells, and are used to divide 
the seminiferous tubules into two compartments (Figure 7-5A and 7-5B). Anchoring 
junctions between Sertoli cells and spermatids are used to connect these two types of 
cells together (Figure 7-5C–7-5F). Figure 7-6 shows different types of germ cells 
associated with Sertoli cells in the seminiferous epithelium.  
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Figure. 7-3. Apoptotic index in mice testes after MEHP exposure. 28-day-old 
C57BL/6J mice were treated with various doses of MEHP for 12 h. Apoptotic index in 
germ cells is determined by examining testicular cross-sections with TUNEL assay. (A) 
The apoptotic index is calculated as the percentage of seminiferous tubules containing 
more than three TUNEL-positive germ cells in each cross-section. (B) Testicular 
histology indicates more TUNEL-positive tubules present at 1g/kg exposure. The bar 
represents 100 μm. 
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Figure. 7-4. The ultrastructure of the seminiferous tubule in 28-day-old C57BL/6J 
mice. (A, B) The basal compartment of the tubule contains Sertoli cells (SC), 
preleptotene spermatocytes (Pl), and spermatogonia. (C, D) The adluminal compartment 
of the tubule contains Sertoli cells (SC), pachytene spermatocytes (P), and spermatid (SP). 
White arrows indicate the BTB between Sertoli cells. SP-2/3: step 2 or 3 spermatid; SP-9: 
step 9 spermatid; Rb: residual body; m2˚m: secondary spermatocyte; L: the testicular 
lumen; *: the interstitial space. The bar represents 5 μm with magnification x3,500. 
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Figure. 7-5. The ultrastructure of tight junctions and anchoring junctions in 
28-day-old C57BL/6J mice. (A) Preleptotene spermatocytes (Pl) and (B) 
Preleptotene-leptotene spermatocytes (Pl-L) are located in the basal compartment of the 
seminiferous tubule. White arrows indicate the BTB (tight junction, TJ) between Sertoli 
cells (SC). *: the interstitial space. (C, D) Actin-based anchoring junctions (AJ) between 
Sertoli cells and early developing round spermatid are shown as white arrows. P: 
pachytene spermatocytes; SP-3: step 3 spermatid; M: mitochondria. (E, F) The apical 
ectoplasmic specializations (ES) are present at the interface between Sertoli cells and late 
spermatids (white arrows). SP-9: step 9 spermatid; G: golgi apparatus. The bar represents 
2 μm with magnification x 5,600-22,000. 
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7.3.2. The morphology of Sertoli cell lines and primary co-cultures 
The young mouse Sertoli cell line, TM4, was seeded in 6-well plates. After MEHP 
exposure, the cytoplasm of TM4 cells was extended and the shape of cells became longer 
than non-treated cells (Figure 7-7). More vacuolization in the cytoplasm was observed in 
MEHP-treated TM4 cells.  
The adult rat Sertoli cell line, ASC-17D, was seeded and incubated at 33°C for 24 h 
and then transferred to 40°C for 48 h. ASC-17D Cells are Sertoli Cells that were 
originally isolated from sexually mature Sprague Dawley rats and immortalized with a 
temperature-sensitive mutant of the SV40 virus, tsA255. This virus promotes ASC17D 
cells to divide at a permissive temperature (33°C) and to differentiate at a non-permissive 
temperature (40°C). The differentiated cells are larger and their shape varies from that of 
the mitotic cells (Figure 7-8), suggesting that distinct differences occur between the 
dividing and the differentiated cells.  
Primary co-culture cells (2x106) were seeded in 6-well plates and treated with 200 
μM MEHP for 12 h. Germ cells were grown on the top of Sertoli cell monolayer (Figure 
7-10). More vacuolization in the Sertoli cell cytoplasm were observed in MEHP-treated 
cells. 
 
7.4. Apoptotic wave of germ cells in mice during testicular development 
 
TNF-α and FasL expression in whole testis homogenates from C57BL/6J mice at 7, 
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Figure. 7-6. The ultrastructure of different types of germ cells in 28-day-old 
C57BL/6J mice. (A-C) Permatocytes, (D-G) Spermatids, (H) Residual body. SC: Sertoli 
cells; Pl: Preleptotene spermatocytes; Z: zygotene spermatocytes; P: pachytene 
spermatocytes; SV: sex vesicle; Step 1: step 1 spermatids; *: the interstitial space; M: 
mitochondria. White arrow heads indicate the BTB and white arrows indicate the 
synmaptonemal complex in spermatocytes. The bar represents 2 μm with magnification x 
5,600-22,000.
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Figure. 7-6 (continued). The ultrastructure of different types of germ cells in 
28-day-old C57BL/6J mice. SC: Sertoli cells; P: pachytene spermatocytes AV: 
acrosomal vesicle; A: acrosome; Step 1: step 1 spermatids; Step 3: step 3 spermatids; Step 
9: step 9 spermatids; Step 14: step 14 spermatids; M: mitochondria; Rb: residual body. 
White arrow heads indicate the BTB and white arrows indicate the synmaptonemal 
complex in spermatocytes. The bar represents 2 μm with magnification x 11,000-22,000. 
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Figure. 7-7. The morphology of the Sertoli cell line, TM4. TM4 cells (5x105) were 
seeded in 6-well plates and treated with 200 μM MEHP for 12 h. (A) Non-treated TM4 
cells. (B) MEHP-treated TM4 cells. After MEHP exposure, the cytoplasm of TM4 cells 
was extended and the shape of cells became longer than non-treated cells. More 
vacuolization of the cytoplasm was observed in MEHP-treated TM4 cells. Left images 
represent TM4 population with magnification 10x. The close-view of TM4 cells is shown 
on the right panel.
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Figure. 7-8. The morphology of the Sertoli cell line, ASC-17D. ASC-17D cells (5x105) 
were seeded in 6-well plates. (A) ASC-17D cells at the permissive temperature (33°C). 
(B) ASC-17D cells at the non-permissive temperature (40°C). After switching to 
non-permissive temperature, the size of ASC-17D cells increased. Left images represent 
ASC-17D cell population with magnification 10x. The close-view of ASC-17D cell is 
shown on the right panel. 
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Figure. 7-9. The morphology of primary rat Sertoli cell-germ cell co-cultures. 
Primary co-culture cells (2x106) were seeded in 6-well plates and treated with 200 μM 
MEHP for 12 h. Germ cells were grown on the top of the Sertoli cell monolayer. (A) 
Non-treated primary co-culture cells. (B) MEHP-treated primary co-culture cells. More 
vacuolization in the Sertoli cell cytoplasm was observed in MEHP-treated cells. Left 
images represent primary co-culture cell population with magnification 10x. The 
close-view of cells is shown on the right panel. 
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14, 18, 21, 28 and 44 day were determined by western blot analysis (Figure 7-10A). 
Increases in both TNF-α expression (26 kDa) and processing (17 kDa) were observed as 
the age increased. This can be explained by the increase in the number of germ cells 
which produce TNF-α in the seminiferous tubules during testicular development. FasL 
expression was increased at 18, 21 and 28 day after birth while it was decreased at 44 
days. The apoptotic index indicated that 21-day-old C57BL/6J wild-type mice have the 
highest apoptotic rate of germ cells (Figure 7-10B), suggesting that FasL/Fas signaling is 
involved in regulating germ cell apoptosis during the peri-pubertal age.  
 
7.5. Characterization of germ cell apoptosis and testicular histology in TNFR-1/2 
gene-deficient mice 
 
7.5.1. Physiological features of TNFR-1/2 gene deficient mice 
An initial characterization of TNFR-1/2 gene deficient mice indicated a decrease in 
the testis weight at both 28 and 44 days, as well as a decrease in sperm production in 
adults (Table 7-1). Although these mice are fertile, these phenotypes point to a 
dysregulation in the homeostatic control of the numbers of germ cells in the testis of 
these gene-deficient mice. 
 
7.5.2. Germ cell apoptosis in TNFR-1/2-/- mice is altered by MEHP exposure  
In order to estimate the functional significance of TNF-α signaling on germ cell 
apoptosis, TNFR-1/2-/- mice were challenged with 1g/kg of MEHP for various periods of  
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Figure. 7-10. Germ cell apoptosis during testicular development. (A) Testis 
homogenates from 7, 14, 18, 21, 28 and 44-day-old C57BL/6J mice were analyzed by 
western blot analysis to detect the protein expression of FasL and TNF-α. β-actin served 
as the loading control. (B) The germ cell apoptosis in C57BL/6J mice during the 
development were determined by TUNEL assay. 
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Table. 7-1. Physiological parameters of the testis in TNFR-1/2+/+mice and 
TNFR-1/2-/-mice a 
 
 Body weight (g) Testis weight (g) 
Spermatids/
g testis/day 
(x107) 
 28d 44d 28d 44d 44d 
TNFR-1/2+/+ 
15.08±0.90 
(19) 
22.72±0.66  
(6) 
0.059±0.005  
(19) b 
0.095±0.006  
(6)c 
3.47±0.04 
(6) d 
TNFR-1/2-/- 
15.54±0.78 
(18) 
21.40±0.01 
(4) 
0.045±0.004  
(18) b 
0.051±0.004  
(4) c 
1.91±0.05 
(4) d 
 
a Data from the characterization of all physiological parameters are represented as the 
mean ± SEM, and numbers of examined mice in each strain are indicated in 
parentheses. 
b-d Group values within each parameter are significantly different (p<0.05, ANOVA 
followed by Tukey test for post hoc.) 
 
 160
time. Testicular histopathology indicated normal morphology of testes in TNFR-1/2-/- 
mice (Figure 7-11). Surprisingly, germ cell apoptosis was increased in TNFR-1/2-/- mice 
in a time-dependent manner (Figure 7-12). No significant induction of germ cell 
apoptosis in the TNFR-1/2+/+ mice suggests that they are not sensitive to MEHP exposure, 
possibly due to their different genetic background. In addition, the changes in testicular 
morphology in TNFR-1/2-/- mice after MEHP treatment indicated that the loss of TNFR 
increased the sensitivity to MEHP exposure. The decrease in FasL expression and the 
increase incidence in germ cell apoptosis in TNFR-1/2-/- after MEHP exposure (Figure 
7-13) suggest that either Fas/FasL signaling is not critical for germ cell apoptosis or that a 
FasL-independent pathway compensates for the loss of TNFR in the testis. Tumor 
necrosis factor-related apoptosis-inducing ligand (TRAIL) and its receptor DR5 also 
belong to TNF family and are present in the testis [375] and have been shown to control 
extrinsic apoptotic signals in the testis . Interestingly, both TRAIL and DR5 are strongly 
induced in the testis early after MEHP treatment (Figure 7-13). These observations point 
to a compensation effect between different extrinsic apoptotic pathways in the testis. 
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Figure. 7-11. The testicular histology of TNFR-1/2+/+ mice and TNFR-1/2-/- mice. The 
histology of testis cross sections in 28-day-old TNFR-1/2+/+ mice and TNFR-1/2-/- mice 
are examined by PAS-H staining. The bar represents 100 μm. 
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Figure. 7-12. The functional participation of TNF-α/TNFR signaling in germ cell 
apoptosis. (A) Germ cell apoptosis in TNFR-1/2+/+ mice (open bars) and TNFR-1/2-/- 
mice (solid bars) were determined by TUNEL assay. (B-E) The histology of testis cross 
sections shows the distribution of TUNEL-positive germ cells in TNFR-1/2+/+ mice and 
TNFR-1/2-/- mice after MEHP exposure for 12 h. B: TNFR-1/2+/+ mice; C: MEHP-treated 
TNFR-1/2+/+ mice; D: TNFR-1/2-/- mice; E: MEHP-treated TNFR-1/2-/- mice. The bar 
represents 100 μm. 
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Figure. 7-13. The functional participation of TNF-α/TNFR signaling in germ cell 
apoptosis. After 12 h of MEHP treatment, the testis homogenates from TNFR-1/2+/+ and 
TNFR-1/2-/- mice were analyzed by western blot analysis to detect the protein expression 
of FasL, TNF-α, DR5 and TRAIL. β-actin served as the loading control. 
 
 164
Chapter 8. Summary 
 
This thesis demonstrates the mechanisms of MEHP exposure in the disruption of 
Sertoli cell-germ cell interactions, leading to abnormal spermatogenesis (Figure 8-1). In 
response to MEHP-reduced supportive capacity of Sertoli cells, germ cells undergo 
apoptosis in order to minimize the population. However, germ cells also play a part in 
promoting their programmed death by releasing factors which stimulate pro-apoptotic 
proteins in Sertoli cells. In addition, the MEHP-triggered physical disconnection between 
Sertoli cells and germ cells forces the premature depletion of germ cells to occur. A 
refined model presented in Figure 8-1 maps out the experimental findings of this thesis: 
 
1. MEHP directly influence the activation and nuclear translocation of NF-κB and 
Sp-1 within Sertoli cells, resulting in the up-regulation of FasL expression 
(Chapter 3). 
2. MEHP exposure decreases Sertoli cell secretion of TIMP-2 into the adluminal 
space and allows for the activation of MMP-2 (Chapter 4). 
3. Sertoli cell injury results in reduced support for developing germ cells and 
leads to the activation of MMP-2 and increased production of soluble TNF-α 
(Chapter 4).  
4. Increased soluble TNF-α binding to TNFR1 in Sertoli cells activates the NF-κB 
signaling pathway and turns on the robust expression of FasL (Chapter 3). 
5. An amplification loop through TNF-α signaling occurs in response to MEHP 
exposure for sensitizing germ cells by decreasing Sertoli cell support and 
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contributes to FasL-mediated apoptosis (Chapter 3-4). 
6. Activated MMP-2 leads to remodeling of the tight junctions at the BTB 
between adjacent Sertoli cells possibly by increasing the processing of TNF-α 
(Chapter 5).  
7. Activated MMP-2 cleaves laminin-γ3 in order to break the laminin/integrin 
complex at the apical ectoplasmic specialization between Sertoli cells and 
spermatids (Chapter 5).  
8. Disruption of ectoplasmic specialization as well as the remodeling of tight 
junctions triggers the detachment of premature germ cells in the seminiferous 
epithelium in response to MEHP exposure (Chapter 5). 
9. MEHP-induced germ cell sloughing is independent of MEHP-induced germ 
cell apoptosis (Chapter 5). 
10. TIMP/MMP ratio in the testis is a critical mechanism to account for the 
sensitivity of germ cell sub-types to undergo apoptosis in response to decreases 
in the Sertoli cell supportive capacity in peri-pubertal rodents (Chapter 3-5). 
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Figure. 8-1. A refined model indicates the effect of MEHP exposure on the 
dynamic interactions of Sertoli cells and germ cells, leading to abnormal 
spermatogenesis. MEHP exposure induces FasL expression through the 
transcriptional regulation of NF-κB and Sp-1 in Sertoli cells. Increases in FasL 
expression induce Fas signaling in germ cells and trigger germ cell apoptosis. At the 
same time, MEHP exposure decreases the supportive capacity of Sertoli cells by 
suppressing TIMP-2 expression, consequently stimulating MMP-2 activation. 
Activated MMP-2 increases the processing of TNF-α in germ cells, further 
influencing NF-κB activation and the induction of FasL expression in Sertoli cells. 
MMP-2 is also responsible for disruption of junctional complexes in the 
seminiferous epithelium by directly impacting the expression of junctional proteins 
or through TNF-α-mediated remodeling of junctions. 
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